Duquesne University

Duquesne Scholarship Collection
Electronic Theses and Dissertations
Summer 2013

Differential Expressions of Nodal-Signal Transducers and Global
Transcriptional Repression Commit Vegetal Cells in
Eleutherodactylus Coqui to Form Nutritional Endoderm
Suman Chatterjee

Follow this and additional works at: https://dsc.duq.edu/etd

Recommended Citation
Chatterjee, S. (2013). Differential Expressions of Nodal-Signal Transducers and Global Transcriptional
Repression Commit Vegetal Cells in Eleutherodactylus Coqui to Form Nutritional Endoderm (Doctoral
dissertation, Duquesne University). Retrieved from https://dsc.duq.edu/etd/394

This Immediate Access is brought to you for free and open access by Duquesne Scholarship Collection. It has been
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Duquesne
Scholarship Collection.

DIFFERENTIAL EXPRESSION OF NODAL-SIGNAL TRANSDUCERS AND
GLOBAL TRANSCRIPTIONAL REPRESSION COMMIT VEGETAL CELLS IN
ELEUTHERODACTYLUS COQUI TO FORM NUTRITIONAL ENDODERM

A Dissertation
Submitted to the Bayer School of Natural and Environmental Sciences

Duquesne University

In partial fulfillment of the requirements for
the degree of Doctor of Philosophy

By
Suman Chatterjee

August 2013

Copyright by
Suman Chatterjee

2013

DIFFERENTIAL EXPRESSION OF NODAL-SIGNAL TRANSDUCERS AND
GLOBAL TRANSCRIPTIONAL REPRESSION COMMIT VEGETAL CELLS IN
ELEUTHERODACTYLUS COQUI TO FORM NUTRITIONAL ENDODERM

By
Suman Chatterjee
Approved April 11, 2013

________________________________
Richard P. Elinson
Professor of Biological Sciences
(Committee Chair)

________________________________
Philip E. Auron
Professor of Biological Sciences
(Committee Member)

________________________________
John A. Pollock
Associate Professor of Biological Sciences
(Committee Member)

________________________________
Charles A. Ettensohn
Professor of Biological Sciences
Carnegie Mellon University, Pittsburgh
(Committee Member)

________________________________
David W. Seybert
Dean, Bayer School of Natural &
Environmental Sciences
Professor of Chemistry and
Biochemistry

________________________________
Joseph R. McCormick
Chair, Department Biological Sciences
Associate Professor of Biological
Sciences

iii

ABSTRACT

DIFFERENTIAL EXPRESSION OF NODAL-SIGNAL TRANSDUCERS AND
GLOBAL TRANSCRIPTIONAL REPRESSION COMMIT VEGETAL CELLS IN
ELEUTHERODACTYLUS COQUI TO FORM NUTRITIONAL ENDODERM

By
Suman Chatterjee
August 2013

Dissertation supervised by Richard P. Elinson, Ph.D.
The vegetal core cells of a Xenopus laevis embryo commit to mesendoderm via
the Nodal-signaling pathway. In Eleutherodactylus coqui, a direct developing frog,
mesendoderm is specified at the marginal zone of the early gastrulae and vegetal core
cells transform into nutritional endoderm. It is a novel tissue consisting of transient, yolk
rich cells that provide nutrition, but do not differentiate into adult tissues. We
hypothesized that a disruption of Nodal-signaling is responsible for committing vegetal
core cells to nutritional endoderm. I report a dual regulation involved in the generation of
nutritional endoderm. First, differential expression of Nodal-signaling components like
Smad2 and Smad4 was observed during early gastrulation between cells in the marginal
zone and in the vegetal core. Although EcSmad2 RNA, as well as both native and the
active forms of EcSmad2, were detected in the vegetal core by qPCR and western blot
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respectively, western analysis revealed that Smad4 isoforms were expressed at a low
level during early gastrulation. Immunostaining showed that only 12% and 50% of
vegetal core cells were positive for nuclear Smad2 and Smad4 signals, respectively,
compared to 100% in marginal zone cells. These differential expressions may indicate a
signaling blockade in vegetal core cells. Second, I found global transcription repression
in vegetal core cells by immunostaining. At late blastula, both the marginal zone and
vegetal core cell were transcriptionally silent. At the onset of gastrulation, marginal zone
cells, but not vegetal core ones, became transcriptionally active. This indicates the
occurrence of a mid-blastula transition in the marginal zone by early gastrulation. Global
transcriptional repression prevails in the vegetal core through development. A
combination of differential Nodal-signaling and global transcriptional repression in
vegetal core cells may account for its lack of differentiation.
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CHAPTER ONE: INTRODUCTION

Complete or holoblastic cleavage similar to that in the extant, biphasic, amphibian
model system Xenopus laevis, is considered primitive. It is found in invertebrates like
annelids and mollusks, in deuterostome outgroups of craniates, namely sea urchins,
tunicates, amphioxus, and in placental mammals. Transition to incomplete, meroblastic
cleavage happened five times in the whole vertebrate phylogenetic distribution, including
lineages leading to the development of hagfish, sharks and other cartilaginous fishes,
teleosts, coelacanth, and amniotes (Collazo et al., 1994; Chea et al., 2005; Elinson, 2009;
Takeuchi et al., 2009). In the course of evolution of terrestrial vertebrates, the two major
groups, the amphibians and the amniotes, acquired fundamental differences in their early
development. Characterized by the presence of extraembryonic membranes, gastrulation
through a primitive streak, and meroblastic cleavage, amniote embryos are likely derived
from embryos like those of extant amphibians (Collazo et al., 1994; Elinson, 2009).
Whereas the entire amphibian egg develops into embryonic tissues, both extraembryonic
as well as embryonic tissues develop from amniote eggs. The amniote gastrula is
different from amphibians, as the embryo is composed of several flat layers requiring
body folds after gastrulation to produce the characteristic three-tubed chordate embryo
(Elinson, 2009).
An increase in the amount of yolk in eggs could account for these differences,
which arose 360 million years ago (Elinson and Beckham, 2002; Elinson, 2009). Increase
in yolk makes holoblastic cleavage difficult and favors the appearance of meroblastic
cleavage in the course of evolution. To investigate the impact of increased yolk on
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embryonic patterning, we analyzed the development of large eggs from
Eleutherodactylus coqui.
E. coqui, the direct developing Puerto Rican tree frog, possesses a novel tissue,
the nutritional endoderm. Nutritional endoderm (NE) arises in addition to the three germ
layers endoderm, mesoderm and ectoderm, during early embryonic development
(Buchholz et al., 2007). NE provides nutrition to the developing froglets, but does not
differentiate into any organs in adults. Direct development is the process of formation of
adult morphology as a direct consequence of embryogenesis, without the free-swimming
larval stage of the more familiar biphasic amphibian. Although the fundamental
mechanisms of direct development remain relatively unexplored, it is a common
alternative life history strategy in recent amphibians (Jennings and Hanken, 1998).
For my Ph.D. dissertation, I investigated the molecular events, including the roles
of some important signaling molecules underlying the generation of NE. In addition, I
address the mechanism of its origin in E. coqui development.

I. Direct development and Eleutherodactylus coqui:
A. Indirect development: A common mode of anuran development.
Amphibians are a diverse group of animals including frogs and toads, which
belong to the order Anura. Anurans usually exhibit indirect development, characterized
by an intermediate aquatic larva between the embryo and the terrestrial adult. These freeswimming larvae, known as tadpoles, are drastically different from their adults in terms
of morphology as well as life style. The process of transformation of tadpoles into adults
is metamorphosis, which involves profound morphological, physiological, biochemical,

2

ethological and environmental changes (Dent, 1968; Just et al., 1981). This indirect
development is very common in anurans and extensively documented in the life history
of the model organism system of African clawed frog, X. laevis.

B. Direct development: An evolutionary significant adaptation:
Direct development, on the other hand, is the alternative strategy of development,
where adults develop directly from the embryo skipping the intermediate free-swimming
larva. The term “direct-development” has been used in many contexts. Duellman and
Trueb (1986) suggested a direct correlation between the adoption of a terrestrial life style
and the need of direct development. Absence of tadpoles in the life history of direct
developers also raises the question of whether they undergo thyroid hormone-dependent
metamorphosis (Callery and Elinson, 2000a). A more ecological definition was provided
by Wake (1980), in which he included animals, which hatch as non-feeding tadpoles and
undergo metamorphosis once their endogenous supply of yolk is exhausted.
Nectophrynoides malcolmi, an anuran, would be an example of this type of development.
Although it is considered a direct developer, a relatively non-motile tadpole form exists
in its life history, which does not explore for food.
The most radical example of direct development is exhibited by the genus
Eleutherodactylus (Salthe and Mecham, 1974). With only a little hint of their
metamorphic ancestry in their life history (Townsend and Stewart, 1985), the
embryogenesis of these anurans is highly modified. The extraordinary success of such a
developmental strategy is well advocated by the presence of more than 450 species
within the genus, which makes Eleutherodactylus the most species-rich vertebrate genus
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(Hanken, 1992). Recent studies indicated the presence of 882 species of New World
frogs that belong to the subfamily Eleutherodactylinae of the family Leptodactylidae. All
these species breed on land and show direct development (Hedges et al., 2008). They lay
eggs on land, where the eggs hatch into froglets. The geographical distribution of these
frogs range from southern parts of the United States to northern Argentina, but are most
diverse in Central America, the West Indies, and South America (Frost, 2007; Hedges et
al., 2008; Heinicke et al. 2007).

C. Eleutherodactylus coqui, the direct developing, Puerto Rican tree frog.
The Eleutherodactylid frogs are K-strategists, characterized by high parental care
investment per clutch. A clutch usually consists of 30 embryos. The embryos are large
and filled with yolk to compensate for the lack of feeding tadpoles (Townsend and
Stewart, 1985; Elinson, 1987a, b). E. coqui has been studied in detail (Elinson, 1990;
Elinson and Beckham, 2002). Fertilization is internal and the embryos, after being laid,
are brooded by the male until hatching (Elinson, 1990). The diameter of an E. coqui egg
is 3.5 mm, whereas that of a X. laevis egg is 1.3 mm. This difference in the size indicates
a volume ratio of 20:1 between the two species (Elinson, 1987). This large maternal
storage of nutrients in the form of yolk favors the prolonged intra-oval development and
production of young froglets directly. This common arboreal tree frog is endemic to the
Caribbean island of Puerto Rico, where it is also considered as a “national symbol”
(Joglar, 1998; Velo-Antón et al., 2007). In the late 1980s, E. coqui was accidentally
introduced to Hawaii (Kraus et al., 1999), where it is considered a pest as a consequence
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of affecting the state‟s floriculture and nursery industries and property values (Beard,
2007).

D. Characteristics of direct development in E. coqui
Many structural features that characterize an aquatic embryo and a tadpole are
rudimentary or lacking in the life history of direct developers (Elinson, 2001 & 2013). E.
coqui embryos showcase a fairly unremarkable development until the late neural plate
stage, which is marked by the appearance of both fore- and hind-limb buds (Elinson and
Fang, 1998; Townsend and Stewart, 1985). Unusual characteristics of the direct
developing E. coqui are: (1) early and simultaneous appearance of limbs, (2) no horny
mouth parts or adhesive organ, (3) great reduction in size of gills, (4) absence of a coiled
intestine, (5) presence of a large yolk reserve, (6) development of a large membranous
but non-muscular tail, (7) presence of egg tooth which is different from a tadpole‟s
keratinous teeth and beak (Townsend and Stewart, 1985), (8) absence of a hatching gland
as they use their egg tooth to break open the jelly capsule for hatching, (9) incomplete
development of operculum (Callery and Elinson, 2000a), (10) absence of cement glands,
which are required by the non-motile aquatic embryos to attach themselves to a
substratum (Fang and Elinson, 1996, 1999; Elinson, 2013), and (11) absence of lateral
line organs, sense organs used by aquatic organisms like tadpoles to detect water currents
(Schlosser et al., 1999; Elinson, 2013).
The large quantities of yolk serve as a source of nutrients and minerals like
calcium, magnesium, and phosphorous to build the body of growing froglets (Packard et
al., 1996). Utilization of yolk during direct development involves a rapid decrease in the

5

dry yolk mass with a proportional gain in weight of the embryonic carcass, highlighting
the importance of yolk in direct development (Packard et al., 1996). Although the
increase in yolk makes holoblastic cleavage difficult and favors the appearance of
meroblastic cleavages in the course of evolution, E. coqui embryos undergo holoblastic
cleavage and the yolk is compartmentalized into individual cells as NE (Elinson, 1987;
Buchholz et al., 2007; Elinson, 2009). The NE attaches to the gut, encased within a
vascular intestinal sac and persists as a nutrient source even after hatching (Lynn, 1942;
Valett and Jameson, 1961; Buchholz et al., 2007; Singamsetty and Elinson, 2010).
Development of froglets from embryos in E. coqui requires thyroid hormone, like the
indirect developers. This period of their life history is called “cryptic metamorphosis”
(Callery and Elinson, 2000b; Elinson, 2013).

E. Thyroid-dependent metamorphosis in E. coqui:
Thyroid hormone plays crucial roles in the “cryptic metamorphosis” of E. coqui.
When thyroid hormone synthesis is blocked by addition of methimazole, an anti-thyroid
drug, development arrests at TS12 (staging according to Townsend and Stewart, 1985).
Such arrested TS12 embryos have a frog-like head, eyes, legs, and general body
morphology, but lack complete formation of skin, body musculature, jaw cartilage, and
digestive tract (Callery and Elinson, 2000b; Singamsetty and Elinson, 2010; Elinson,
2013). Such developmentally arrested embryos do not hatch and stay inside their
fertilization membrane and jelly coats. All of these methimazole effects are reversible
upon addition of thyroid hormone (Callery and Elinson, 2000b; Singamsetty and Elinson,
2010). E. coqui is characterized by the presence of a highly vascularized tail, used for
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respiration rather than swimming. As swimming is not part of the life style, the tail loses
most of the musculature (Elinson, 2013). This tail is reabsorbed by the action of thyroid
hormone after hatching around TS15 (Callery and Elinson, 2000b; Elinson, 2013). Over
the course of embryogenesis, utilization of yolk and disappearance of NE are regulated
by thyroid hormone (Singamsetty and Elinson, 2010).

II. Early embryonic development in X. laevis:
Over the last couple of decades, application of advanced molecular tools to the
examination of development in the model organism system, X. laevis, has increased our
knowledge of processes involved in generation of an embryo from an egg and formation
of an adult from an embryo.

A. Origin of three germ layers:
Gastrulating metazoan embryos generate three germ layers - endoderm,
mesoderm and ectoderm, from which organs arise. Unlike ectoderm or mesoderm, the
induction and differentiation of endodermal cells and formation of the respective organs
from endoderm was poorly understood. In last decade, however, genetic and molecular
approaches involving zebrafish mutants and X. laevis and knockout mice have advanced
our understanding of endoderm development and differentiation.
In amphibian oocytes, establishment of animal-vegetal (A/V) axis and formation
of germ plasm are crucial events. Upon fertilization, the dorsal-ventral (D/V) polarity is
developed as a second axis. Temporal and spatial superimposition of these two axes then
serves as the blue print for the basic body plan (Harland and Gerhart, 1997). The cells of
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the three prospective germ layers become committed to their individual fates at
gastrulation (Horb and Slack, 2001; Takeuchi et al., 2009). The ectoderm is formed from
the pigmented animal hemisphere and gives rise to epidermis and nervous system.
Endoderm, the innermost layer of the three, is derived from the yolky vegetal hemisphere
and becomes committed to form the gut and associated organs, including the epithelial
lining of the liver, gall bladder, pancreas and respiratory system (Dale and Slack, 1987;
Stainier, 2002; Fukuda and Kikuchi, 2005). Finally, mesoderm originates as an annulus at
the equator (Clements et al., 1999) and forms blood, heart, muscle, kidneys and skeleton.
Mesoderm also differentiates into the smooth muscle and connective tissues of the gut
(Chalmers and Slack, 1998). All of these cell fate determinations are specified by the
combined activity of different signaling pathways and interplay among essential
molecular determinants. One crucial pathway is the Nodal-signaling pathway, which
plays pivotal roles in endoderm/ mesoderm induction and left – right axis determination
(Schier, 2009).

B. Early embryogenesis:
In X. laevis, fertilization is followed by twelve rapid and synchronous divisions
leading to the formation of a blastula (Heasman, 2006). The first cell cycle lasts 90minutes, whereas each of the next 11 divisions continues for 20 to 30 minutes. These
rapid cell cycles consist of only DNA replication and mitosis with no gap phases. These
early embryonic cells are transcriptionally quiescent, and depend solely upon maternal
supplied stockpiles of proteins and RNAs for survival (Newport and Kirschner, 1982;
Kisielewska and Blow, 2012). These divisions lead to the formation of an embryonic
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mass of 4000 cells, enclosing a fluid filled blastocoel cavity (Heasman, 2006). After the
twelfth division, the cell cycle gradually slows down and lasts about 50 minutes. The
divisions become asynchronous and are characterized by appearance of gap phases. The
cell-cycle changes from checkpoint unregulated to checkpoint regulated ones. This
transition was first described by Signoret and Lefresne as “transition blastuleenne”
(Korzh, 2009; Signoret and Lefresne, 1971). Later, Gerhart (1980) referred to it as the
mid-blastula transition (MBT), a critical event, which marks the onset of embryonic gene
expression (Gerhart, 1980; Heasman, 2006; Shiokawa, 2012).
MBT is also referred to as MZT for Maternal-to-Zygotic transition (Tadros and
Lipshitz, 2009). MBT is extensively characterized in various model organisms such as
Caenorhabditis elegans (nematode), Drosophila melanogaster (insect),
Strongylocentrotus purpuratus (echinoderm), Danio rerio (fish), and X. laevis
(amphibian). MBT is also evident in plants (Baroux et al., 2008). Morphologically, the
mid-blastula embryo consists of three regions, the animal cap forming the roof of the
blastocoel, the equatorial or marginal zone forming the walls of the blastocoel, and the
vegetal mass, which constitutes the floor of the blastocoel. At a molecular level, two
processes characterize MBT: elimination of a subset of maternal mRNAs and beginning
of zygotic genome transcription.
Until the beginning of MBT, all the RNAs and proteins are maternally derived.
Experimental analysis in zebrafish and X. laevis has indicated that at MBT the
nucleocytoplasmic (N/C) ratio increases, which in turn promotes maternal supply of
replication factors (Shimuta et al., 2002; Gotoh et al., 2011). This results in stalled
replication forks, which activates a physiological checkpoint preventing cells from
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entering into mitosis (Shimuta et al., 2002; Gotoh et al., 2011). In addition to the
beginning of zygotic gene expression at MBT, some cells acquire mobility ultimately
leading to gastrulation, which is marked by decreased mitoses and formation of the dorsal
lip of the blastopore in the 15th cycle (Shimuta et al., 2002; Heasman, 2006; Gotoh et al.,
2011).
The dorsal blastopore lip is the site where the Spemann organizer gene network is
established. The organizer plays important roles in patterning the three germ layers.
Analogous to the node in amniotes, Spemann organizer causes the neuralization of the
ectoderm, dorsalization of the mesoderm and anteriorization of the endoderm (Gilbert,
2000). As a result of gastrulation, the embryonic ball converts into three layers, forming
the definitive D/V and A/P axes.
Experimental analysis of formation, specification, differentiation and interaction
of three germ layers in X. laevis has provided evidence that the vegetal hemisphere of the
embryo gives rise to the endoderm (Dale and Slack, 1987; Horb and Slack, 2001,
Heasman, 2006). Complex morphogenetic events during gastrulation transform the
vegetal region into the archenteron, the tubular primitive gut. The cells from the original
vegetal surface are internalized to cover the floor of the archenteric cavity, whereas the
surface cells from the animal border of the blastopore lip of the gastrula and constitute
the roof of archenteron. Finally, the archenteron cavity is closed and replaced by the
definitive lumen of the gut (Chalmers and Slack, 2000).

III. Nodal-signaling underlying endoderm/mesoderm specification:
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A complicated and interconnected network of different signaling pathways guides
development of an early vertebrate embryo. One such pathway is the Nodal-signaling
pathway, which determines many important fates during vertebrate embryogenesis.
Ectopic expression of various members of the TGF- family, like Activin and Nodal
proteins such as Xnr-1, Xnr-2 and Derriere, induce the animal cap cells of early X. laevis
embryos to express mesendoderm specific genes (Clements, 2001). When Nodal
expression is blocked in the vegetal half of early embryos by the use of dominant
negative forms of Nodal (Osada and Wright, 1999), Activin receptors (Clements et al.,
1999; Yasuo and Lemaire, 1999; Chang and Hemmati-Brivanlou, 2000), and Derriere
(Sun et al., 1999), it reduces or totally abrogates expression of mesendoderm specific
genes (Stainier, 2002). These results strongly suggest an essential role of TGF-
signaling in X. laevis endoderm/mesoderm formation during early embryogenesis.
Like most TGF- signals, Nodal ligands activate serine/threonine kinase
receptors, which in turn phosphorylate Smad proteins to regulate endoderm/mesoderm
specific genes (Schier, 2003; Shen, 2007; Wu and Hill, 2009) (Fig. 1). The Nodal signal
is received by type I and II Activin receptor duo and co-receptors EGF-CFC. A core
Nodal-signaling pathway consists of several steps. Receptor complex activation leads to
the phosphorylation and activation of cytoplasmic Smad2/3 proteins, which in association
with Smad4 translocate into the nucleus to bind with additional transcription factors to
regulate endoderm/mesoderm specific genes (Schier, 2009) (Fig. 1). Several extracellular
factors, like modifying enzymes, inducers, and antagonists as well as intracellular ones
like transcriptional cofactors, proteins involved in receptor trafficking, and miRNAs,
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regulate this pathway. In the following paragraphs, different components of the signaling
cascade are described in detail.

A. The ligands:
Nodals, in addition to endoderm/mesoderm induction, are involved in establishing
development of the left-right axis (Burdine and Schier, 2000; Capdevila et al., 2000;
Hamada et al., 2002; Mercola and Levin, 2001). The Nodal-signaling pathway has been
genetically and biochemically dissected in several vertebrate model systems including
zebrafish, X. laevis, and mouse (Stainier, 2002; Schier, 2009). Activation of Nodal genes
is spatially restricted. Nodal ligands can act locally as well as morphogens, acting at a
distance in a concentration-gradient dependent manner (Chen and Schier, 2001; Green
2002, Gurdon and Bourillot 2001; Meno et al., 2001). Adjacent to the presumptive
mesoderm in the vegetal half of the X. laevis embryos, Nodal genes are expressed,
overlapping with the endoderm precursors. Higher levels of Nodal signaling in and close
to the source produce endoderm but lower levels lead to the development of mesoderm in
the neighboring cells (Schier, 2003; Schier and Talbot, 2005; Shen, 2007).
The Nodal proteins of the TGF-β superfamily are abundant only in chordates. So
far the group of proteins include one Nodal in mouse, three proteins - Cyclops, Squint
and South-paw in zebrafish, and Xnr1, 2, 4, 5, 6, and Derriere in X. laevis (Whitman,
2001; Stainier, 2002; Schier, 2003, 2009). Unlike Wnt and Notch pathways, Nodal
signaling is not found in D. melanogaster or C. elegans, which suggests more specific
roles for this pathway during vertebrate development than these other highly conserved
ones (Schier, 2003). Experiments in X. laevis and other vertebrate systems have revealed
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that Nodals possess similar biochemical activities, and their functional specificity is
determined by complex regulation of Nodal gene expression. Additional complexity in
ligand functioning could result from heterodimerization with other TGF- family
members, which in turn could lead to cooperative interactions or mutual inhibition
(Eimon and Harland, 2002).
Nodal proteins are translated as proproteins consisting of a prodomain and a
ligand domain. In response to specific signals, subtilisin-like proprotein convertases Spc1
and Spc4 proteolytically cleave the proproteins at R-X-(K/R)-R and R-X-X-R consensus
sequences and produce the active Nodal ligand (Fig. 1) (Beck et al., 2002; Schier and
Shen 2000; Schier 2009). While these convertases are involved in the processing of the
proproteins, latent TGF- binding proteins (LTBP) contribute to the maturation and
presentation of the signals by binding to the peptide. Altmann et al. (2002) illustrated the
role of X. laevis LTBP-1 in potentiation of Nodal and Activin signaling. Proteins like
Lefty and Cerberus act as extracellular inhibitors and can restrict Nodal signaling
spatially and temporally by binding to Nodal itself (Adamson et al., 2001; Branford and
Yost, 2002; Chen and Schier, 2002; Feldman et al., 2002, Meno et al., 2001).

B. The Nodal receptors:
Receptors for the TGF- superfamily ligands are composed of a cysteine-rich
extracellular domain, a single pass transmembrane domain, and a highly conserved
intracellular serine/ threonine kinase domain (Kimelman, 2006). Different Activin
isoforms and the other members of the TGF- superfamily of ligands turn on signaling by
binding to a heteromeric complex between a type I and a type II serine-threonine kinase
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receptors. There are seven type I and five type II receptors including those for Activins.
These Activin receptors are represented by Activin receptor-like kinase 4 (ALK4), a type
I receptor, and Activin receptor type IIA (Acvr2a, or ActRIIA) and Activin receptor type
IIB (Acvr2b, or ActRIIB), the type II receptors (Mathews and Vale, 1991; Attisano and
Wrana, 2002; Reissman et al., 2001; Yeo and Whitman, 2001; Yan et al., 2002; Shi and
Massagué, 2003). A second type I receptor, ALK2 has been reported, but it is not
involved in transduction of the signals (Willis et al., 1996; ten Dijke et al., 1994;
Tsuchida et al., 1993). Another example of type I receptor is ALK7, which is
instrumental in propagating signals from Activin B specifically, as shown in murine
pancreatic  cell line (Tsuchida et al., 2004). An example of X. laevis type I receptor is
XALK4, which is maternally contributed to the embryo. Overexpression of XALK4
induces mesoderm formation in X. laevis embryos and explants (Hemmati-Brivanlou et
al., 1992; Mathews et al., 1992).
Activin type II receptors are highly conserved, showing ~98% sequence
homology among human, mouse and rat. ActRIIA is an important member in conveying
Nodal signals downstream. The open reading frame (ORF) of X. laevis ActRIIA homolog
is 1545 bp (Xenbase: XB-GENE-865037), which produces a peptide of 514 amino acids
with a predicted molecular weight of 57.9 kDa.
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Fig. 1: Nodal signaling pathway involved in endoderm/mesoderm specification. In
the presence of proper cues, convertase proteins cleave Nodal pro-proteins to generate
active Nodal ligands. Availability of active ligands brings preformed dimers of TGF
receptors type I and type II together on the cell surface. Upon type I receptor
phosphorylation by type II, an active ligand-receptor heteromeric complex is formed.
Anchoring proteins like SARA, and an adaptor protein, like Dab2, recruit inactive
Smad2/3 molecules from the cytoplasm to the active receptor complex, where active type
I receptor phosphorylates the C-terminal domain of Smad2/3. Active Smad2/3 dislodges
from the complex and forms a complex with the co-Smad protein Smad4. Active
Smad2/3/4 complexes translocate inside the nucleus and bind specific transcription
factors, already recruited on the genes. The formation of such multi-protein
transcriptional activation complexes leads to the expression of endoderm/mesoderm
specific target genes. In the case of endoderm specification, the active Smad2/3/4
complex usually binds a Mixer-like transcription factor. For mesoderm specification, it is
FoxH1, which accommodates Smad2/3/4. (Scheme modified after Schier, 2003)
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Fig. 1:
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C. Active receptor complex formation and signal transduction:
The signals from Nodal ligands bring together pre-formed dimers of type II
receptors and dimers of type I receptors to form the heterotetrameric active receptor
complex (Fig. 1). It is the type II receptor, not type I, which binds the ligands. The type I
receptor binds to the pre-formed type II-ligand complex and initiates signal transduction.
Overexpression studies in X. laevis have suggested the involvement of Activin receptor
ActRIB (ALK4), ActRIIA and ActRIIB in Nodal signaling (Reissman et al., 2001; Yeo
and Whitman, 2001). The type II receptor is constitutively active, and within the ligandbound receptor complex, it phosphorylates and activates type I receptor at several serine
and threonine residues in a glycine and serine (GS) rich juxtamembrane domain
(Kimelman, 2006). This GS-domain is highly conserved among all the members of the
type I receptor family members. Phosphorylation of this GS-domain leads to the
recruitment of receptor-regulated Smads from the cytoplasm.
Members of the extracellular GPI-anchored protein family EGF-CFP are required
as co-receptors in the type I/II receptor coupling mechanisms (Schier and Shen, 2000;
Dorey and Hill, 2002; Onuma et al., 2006; Schier, 2009). The EGF-CFP family includes
one-eyed pinhead of zebrafish, FRL-1 of frogs, chick CFC, and mouse and human Cripto
and Criptic (Shen and Shier, 2000). Although the actual mechanism is unknown, it is
believed that the coreceptors change the confirmation of ALK4 to allow interaction with
Nodals. An alternative hypothesis also exists, which states that EGF-CFC proteins
provide an additional interaction surface for Nodals or can change the confirmation of
Nodals to allow binding with the Activin receptors (Schier, 2003). Activins themselves
can activate the receptors without EGF-CFC proteins, which raises questions regarding
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the requirement of the EGF-CFC proteins (Gritsman et al., 1999; Schier and Shen, 2000;
Whitman, 2001). Studies in X. laevis showed that the EGF-CFC protein, FRL-1 is
involved in MAPK signaling. FRL-1 behaves like a neural inducer by activating MAPK
and inhibiting BMP pathway (Kinoshita et al., 1995; Yabe et al., 2003).
Nodal receptor complex activation leads to the phosphorylation of regulatory
Smads in the cytoplasm. Phosphorylation of Smad2 and possibly of Smad3 activates the
Smads. Activated Smads bind their partner Smad4, forming a multi-protein complex to
translocate into the nucleus. Inside the nucleus, this complex of proteins act as
transcription factors to activate the transcription of distinct but partially overlapping sets
of Nodal downstream genes (Kumar et al., 2001; Lee et al., 2001; Yeo and Whitman,
2001; Ross and Hill, 2008; Schier, 2009). In X. laevis, the nuclear accumulation of the
Smad complexes occurs only after MBT (Saka et al., 2007).

D. Downstream targets:
In the case of endoderm/mesoderm specification in X. laevis, the most widely
studied transcription factor that associates with phospho-Smad2/3 is Forkhead protein
FoxH1, initially known as Fast1, which regulates the downstream targets of Nodals
(Whitman 2001). FoxH1/Fast was identified in X. laevis, where it bound an Activin
response element (ARE) in the promoter region of the mesendodermal gene mix2 (Chen
et al., 1996; Watanabe and Whitman, 1999). Enhancer elements adjacent to lim1,
goosecoid, lefty2, Nodal, and pitx2 mediate Nodal signaling via FoxH1-phospho-Smad2
interaction. In X. laevis and zebrafish, FoxH1 is required for the formation of mesoderm,
but not endoderm (Watanabe and Whitman, 1999; Pogoda et al., 2000; Sirotkin et al.,
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2000). This result suggests presence of additional transcription factors that recruit
Smad2/3 for endoderm specification (Stainier, 2002).
There are certain members in the Mix family of paired-class homeodomain
transcription factors, which also bind phospho-Smad2 (PSmad2). Some important
members sharing this function are Mm1 in mouse (Pearce and Evans, 1999; Robb et al.,
2000), Bonnie and clyde or Bon (Alexander et al., 1999; Kikuchi et al., 2000), Mtx1 and
2 (Hirata et al., 2000) in zebrafish, and seven proteins in X. laevis (Rosa et al., 1989;
Mead et al., 1996; Vize et al., 1996; Ecochard et al., 1998; Henry and Melton, 1998;
Lemaire et al., 1998; Tada et al., 1998). All of these proteins bind active Smad2 via a
short motif present not only in them, but interestingly also in FoxH1 (Germain et al.,
2000).
The endodermally expressed gene Mix1 in X. laevis was initially identified
through its responsiveness to mesodermal inducers (Rosa, 1989) and implicated in
endoderm specification (Lemaire et al., 1998). Henry and Melton (1998) established that
X. laevis Mixer is exclusively expressed in the endodermal precursors during early
gastrulation. Ectopic expression of Mixer gene led to the activation of endoderm specific
genes in animal cap cells. Experiments with zebrafish Mix family member bon revealed
that bon expression happens before the onset of Sox17 expression, and bon mutants fail to
develop 90% of their endoderm (Alexander et al., 1999). In X. laevis, FoxH1 probably
also regulates the expression of Mixer, an idea supported by the presence of a FoxH1binding site in the Mixer gene promoter. Smad2 mutant cells extensively colonized
ectodermal and mesodermal lineages, but failed to form definitive endoderm during
gastrulation. These findings identify Smad2 as the key nodal effector for endoderm and
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mesoderm specification. Smad3 could compensate during mesoderm formation, but only
when Smad2 is absent (Tremblay et al., 2000; Stainier, 2002).

E. Regulators of Nodal expression:
A turning point in the molecular understanding of X. laevis endoderm
specification was the discovery that VegT, a T-box transcription factor, is both necessary
and sufficient for endoderm formation (Lustig et al., 1996; Stennard et al., 1996; Zhang
and King, 1996; Horb and Thomsen, 1997; Zhang et al., 1998; Xanthos et al., 2001). The
striking evidence was provided by Zhang et al. (1998), showing that depletion of the
maternal supply of the VegT RNA blocked endoderm specification leading to a disruption
of germ layer patterning in the X. laevis blastula. This study also illustrated for the first
time, that asymmetric expression of maternal VegT in the vegetal half of the X. laevis
oocyte is required for both mesoderm and endoderm specification (D‟Souza et al., 2003;
Stennard et al., 1996; Xanthos et al., 2001; Zhang et al., 1998).
VegT regulates endoderm formation in several ways. It activates the expression of
several TGF- family members like Xnr1, Xnr2, Xnr4 and Derriere (Kofron et al., 1999;
Hyde and Old, 2000). It also directly regulates the expression of Bix1 and Bix4, members
of Mix type homeobox gene family (Tada et al., 1998; Casey et al., 1999). VegT becomes
an essential controller of Nodal signaling, which in addition to the maintenance of its
own expression, activates the zygotic expression of VegT. These events lead to the
establishment of a positive feedback loop for endoderm specification in vegetal cells
(Clements et al., 2001; Clements and Woodland, 2003) as well as a key synergy between
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VegT and Nodal actions in endoderm and mesoderm specification (Clements and
Woodland, 2003).
Another important VegT target is the ultimate endodermal determinant gene
Sox17. Sox17 is a transcriptional regulator containing high mobility group (HMG) DNAbinding domain, which was first implicated in endoderm specification in X. laevis
(Hudson et al., 1997). When Sox17 was over-expressed in animal cap explants, it
promoted endodermal gene expression. Blocking Sox17 activity in cells fated to become
endoderm, promoted those cells to become mesoderm or ectoderm (Clements and
Woodlands, 2000). Sinner et al. (2004) showed that Sox17 is involved in the activation of
-catenin, also required for transcription of endodermal target genes in X. laevis. Sox17
can act as an antagonist towards Wnt signaling (Zorn et al., 1999). Studies in mouse
submucosal gland cell lines showed inhibitory effects of Sox17 expression on Wnt3/catenin-mediated activation of Lef-1 promoter (Liu et al., 2010). Sox17 is an essential
component of the transcriptional network that defines the extraembryonic endoderm
(Niakan et al., 2010). According to reports in X. laevis, Sox17 is directly involved in the
regulation of many important genes such as Hnf1, Foxa2, Foxa4, Edd, and Zfp202
(Dickinson et al., 2005; Howard et al., 2007; Hudson et al., 1997; Sinner et al., 2004,
2006; Patterson et al., 2008).

IV. Smad2: The key effector of Nodal signaling.
During early vertebrate embryogenesis, Smad2 signaling in response to the
signals from TGF- ligand including Nodals, Activins, and Vg1-related proteins, is
important and essential for germ layer specification and axial patterning (Ho et al., 2010).
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Experiments in D. melanogaster and C. elegans first identified Smads as the downstream
targets of the type I receptor. Following these findings, use of degenerate PCR and
independent functional expression screens in X. laevis identified vertebrate Smad
homologs of D. melanogaster Mad and C. elegans Sma. A total of nine vertebrate
homologs have been identified, and the number is still increasing. In X. laevis, the
expression of either full length or the C-terminal half of Smad2 had the mesoderm
inducing effects of Activin on animal blastomeres (Baker and Harland 1996; Graff et al.,
1996; Whitman 1998). In mice, mutation in Smad2 gene abrogated all the derivatives of
embryonic germ layers (Nomura and Li, 1998; Weinstein et al., 1998; Heyer et al., 1999).
Chimeric studies in Smad2 mutant cells also showed these cells were able to colonize
ectodermal and mesodermal lineages, but failed to colonize the definitive endodermal
lineage during gastrulation (Tremblay et al., 2000). These results suggest that Smad2 is
the key Nodal effector, necessary for endoderm specification.

A. Types:
There are three distinct categories of Smads. The Pathway-specific or Receptorregulated Smads (R-Smads) such as Smad1, Smad2, Smad3, Smad5 and Smad8, are
directly phosphorylated by active type I receptor. When over-expressed, they are able to
phenocopy a signaling pathway. R-Smads 1, 5, and 8 are the principal substrates for BMP
and anti-Mullerian receptors, whereas Smad2 and Smad3 serve as transducers of signals
from TGF-, Activin, and Nodal receptors (Massagué et al., 2005). The Co-Smad,
Smad4, that is shared among multiple signaling pathways, and oligomerizes with
activated R-Smads. The Inhibitory Smads (I-Smads), like Smad6 and Smad7, inhibit
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TGF-β superfamily signaling. I-Smad inhibition is accomplished by competing with RSmad for receptor binding and marking the receptor for degradation upon binding
(Moustakas et al., 2001). There is a high level of sequence conservation among the
different vertebrate homologs.

B. Domain structure:
Smad2 is composed of two highly conserved domains, the N-terminal Mad
homology 1 (MH1) and the C-terminal Mad homology 2 (MH2) domains (Fig. 2). A less
conserved, linker region separates these two domains. Functional studies involving point
and deletion mutational analysis together with X-ray crystallography of MH1 and MH2
domains revealed insights into the principal interactions of Smad proteins with other
proteins and with DNA (Shi and Massagué, 2003; Massagué 2005). These structural
studies indicate an association between MH1 and MH2 in the inactive state, but upon
receptor activation, the structure opens up to initiate the effector function of each domain
(Baker and Harland 1996; Hata et al., 1997).
Sequence and structural analysis indicates a strong similarity between MH1
domain and the diverse His-Me (histidine-metal-ion) finger family of endonucleases.
This similarity suggests that the MH1 domain might have evolved from an ancient
enzymatic domain, which lost its catalytic function but retained the DNA binding power
(Grishin, 2001). The MH1 domain is a DNA binding module, which is stabilized by a
closely attached zinc atom. MH1 promotes two important functions, regulation of nuclear
import and transcription via binding with DNA and other nuclear proteins. The DNA
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binding feature of MH1 is achieved by a -hairpin structure, conserved in all R-Smads
and Smad4.
The MH2 domain, a highly conserved domain among all known Smads, is the
most versatile protein-interacting module in any signaling cascade. It contains multiple
-helices and loops surrounding a -sandwich (Shi, 2001). The MH2 domain structure
resembles that of a forkhead-associated (FHA) domain, a phospho-peptide binding
domain commonly found in many transcription and signaling factors (Li et al., 2000). A
conserved C-terminal Ser-Ser-X-Ser (SSXS) motif is present at the end of the MH2
domain. Receptor-mediated phosphorylation of the last two serine residues is crucial for
activation (Fig. 2). Functions of the MH2 domain include oligomerization with different
or the same types of Smads, recognition by type I receptors, and interaction with
cytoplasmic adaptors and several other transcription factors. On the surface of the MH2
domain, a set of repeating hydrophobic patches is present that mediates Smad2‟s
interaction with other proteins like cytoplasmic retention proteins, nucleoporins and DNA
binding cofactors (Massagué et al., 2005).
The linker region, which lies between MH1 and MH2, serves as a binding site for
proteins like Smurf (Smad ubiquitination-related factor) ubiquitin ligase. Moreover, this
region provides sites for phosphorylation by several important classes of protein kinases
like MAPK (Fig. 2). In the case of Smad4, the linker region also contains a nuclear
export signal (NES).
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Fig. 2: Smad2 phosphorylation. Smad2 protein consists of MH1 and MH2 domains
with a linker region in the middle. The linker region is responsible for connecting Smad2
signaling to Ras/MAPK pathway. Phosphorylation of Smad2 at S465 and S467 by Nodal,
Activin or TGF receptor(s) leads to its activation. This in turn specifies the endodermal
and mesodermal cell fates in X. laevis development. Growth factors activate the
Ras/MAPK pathway, which in turn induces MAPK. Four specific sites (T220, S245,
S250 and S255) in the linker region are phosphorylated by MAPK, which acts in
opposition to the TGF receptor mediated Smad2 activation. (Scheme modified from
Kretzschmar et al., 1997; Massagué, 2003; Ross and Hill, 2008)
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Fig. 2:
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C. Activation:
Smad2 is phosphorylated by type I receptor at its highly conserved C-terminal
S465/467 residues (Fig. 2). These two conserved serines together with a third, nonphosphorylated serine, S464 constitute an evolutionary conserved SSXS motif in all RSmads (Abdollah et al., 1997; Souchelnytskyi et al., 1997). S 465 and S467 residues were
identified as the two major ligand-receptor regulated phosphorylation sites by
radiochemical sequencing and phospho-amino acid analysis of phosphorylated peptides
of Smad2 (Souchelnytskyi et al., 1997). The phosphorylation of these sites happens
sequentially following an obligate order. S467 residue is first recognized by the type I
receptor kinase, which then displays a new recognition sequence leading to the
phosphorylation of S465. When Souchelnytskyi et al. (1997) replaced S467 with the
phosphomimetic aspartic acid residue (SA) in vitro, phosphorylation of S465 was not
restrained. This result suggests that presence of negative charge at S467 is enough to
induce the second phosphorylation at S465. Mutations at these two C-terminal serine
residues (S465/467) as well as at all three serine residues (S464/465/467) of Smad2 in
independent studies, blocked nodal-signaling (Macías-Silva et al., 1996; Souchelnytskyi
et al. 1997).
Substrate specification is an important event at the onset of Nodal signaling. The
L45 loop structure in type I receptor and L3 loop in Smad2 or Smad3 are involved in
substrate specificity. Such specific structural interactions make TGF- and Activin
receptors specifically phosphorylate the R-Smads like Smad2/3, whereas Smads1/5/8 are
phosphorylated by bone morphogenetic protein or BMP-pathway receptors (Chen et al.,
1998). Unphosphorylated Smad2/3 proteins usually reside in the cytoplasm as monomers.
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Phosphorylation of the SSXS motif leads to homo-oligomerization, which in turn quickly
forms hetero-oligomers along with the co-Smad protein, Smad4 (Correia et al., 2001;
Kawabata et al., 1998). Inactive Smad2 proteins in the cytoplasm are intrinsically autoinhibited via intramolecular interaction between the MH1 and the MH2 domains (Hata et
al., 1997), and the presence of a unique loop structure in the MH2 domain of Smad4
protein inhibits its oligomerization in absence of any signals (Tada et al., 1999). Receptor
mediated phosphorylation induces conformational changes, and that is sufficient to
remove the auto-inhibitions.

D. Shuttling between cytoplasm and nucleus:
The proper anchoring of Smad2 proteins to the receptor complex involves a
cytoplasmic protein called Smad Anchor for Receptor Activation (SARA) and the
adaptor molecule Dab2 that specifically forms a bridge between the inactive Smad2 and
the receptor complex (Fig. 1). This is an essential scaffolding step for proper activation of
the Smad2 protein. This stable interaction in turn inhibits the nuclear import of Smad2
(Tsukazaki et al., 1998; Xu et al., 2000; Ross and Hill, 2008).
Type I receptor phosphorylation of Smad2 disrupts the association between
SARA and Smad2, resulting in the release Smad2 from the scaffolding complex. This
event leads to the subsequent exposure of the nuclear localization signal (NLS) on Smad2
MH2 domain (Xu et al., 2000) and makes Smad2 available to interact with Smad4 (Shi
and Massagué, 2003). Receptor-mediated phosphorylation of R-Smads is also reported to
augment its affinity for Smad4 (Shi and Massagué, 2003).
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All R-Smads, as well as co-Smads, such as human Smad4 and X. laevis Smad4
are cytoplasmic, whereas X. laevis Smad4 along with I-Smads reside inside the nucleus
(Howell et al., 1999; Shi and Massagué, 2003). In the case of X. laevis, the heterooligomerization is preferred between Smad2 and Smad4. The MH1 domain of Smad3
contains a lysine rich motif, which acts as NLS (Xiao et al., 2000; Xiao et al., 2001). In
the case of Smad3, C-terminal phosphorylation leads to conformational changes exposing
the NLS, which is then bound by importin1 and undergoes Ran-dependent nuclear
translocation (Xiao et al., 2000). In the case of Smad2, the nuclear import is NLSindependent, and it occurs in a cytosolic-factor-independent manner, involving the MH2
domain (Xu et al., 2000). The difference in the import mechanisms between Smad2 and
Smad3 is due to the presence of the unique exon 3 in Smad2 MH1 domain (Kurisaki et
al., 2001). Inside the nucleus, Smad3 and Smad4 can bind directly, but with a lower
affinity to the Smad-binding elements (SBEs), which have a minimal motif of 5‟CAGAC-3‟. Such binding is mediated by a conserved -hairpin loop and an additional helix 2 structures present in the MH1 domain (Kusanagi et al., 2001). Smad2, in contrast,
lacks the DNA binding ability to SBE because of its unique exon 3 encoded sequence in
MH1 (Yagi et al., 1999).
An alternative mechanism of Smad2/3 nuclear import and export is based on the
finding that R-Smad MH2 domain can interact directly with the components of nuclear
pore complex, especially CAN/Nup214 and Nup153. Direct contact between the nuclear
pore complex and Smad2/3 allows the R-Smads to undergo constant shuttling (Liu et al.,
1997; Inman et al., 2002; Xu et al., 2002).
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E. Downstream targets:
Experiments in X. laevis embryos have identified two classes of transcription
factors that are involved in the recruitment of phosphorylated Smad2-Smad4 complexes
to the promoters of Nodal signaling target genes. The transcription factor FoxH1a and
FoxH1b can recruit the complex to ARE within the promoters of genes like Mix.2 (Chen,
1996; Howell, 2002, Ross and Hill, 2008). Mixer, Milk (Bix2) and Bix3, members of the
X. laevis Mix transcription factor family, can also recruit the complex to the distal
elements within the promoter region of mesoderm specific genes like goosecoid
(Germain et al., 2000; Randal et al., 2002). Although these different transcription factors
interact with activated Smad2 via a common proline-rich motif called Smad interaction
motif (SIM), FoxH1 factors possess the Fast/FoxH1 motif (FM), which helps them to
interact specifically with Smad2 (Randall et al., 2004). At the end of its performance as a
transcription factor, Smad2 dissociates from the complex followed by dephosphorylation.
Finally the inactive Smad2 is exported back to the cytoplasm (Derynck and Zhang,
2003).

F. Linker region acting as a bridge between Nodal signaling and the MitogenActivated Protein Kinase pathway:
Phosphorylation of Smad2 by mitogen-activated protein kinases (MAPKs) can
also have an effect on TGF- signaling. MAPK phosphorylation sites are usually
abundant in the linker region between the MH1 and the MH2 domain of Smad2/3 and
Smad4, with some lying in the MH1 domain (Fig. 2). Smad2/3 and Smad4 are usually
phosphorylated at proline directed serine/threonine residues by MAPKs Erk1 and Erk2

30

and also by stress-activated MAP kinase p38 and JNK (Javelaud and Mauviel, 2006).
These MAPK induced phosphorylations of Smad2 can have different effects.
Phosphorylation of T8, T220, S245, S250 and S255 on Smad2 linker region and T179,
S204, S208, and S213 on Smad3 linker region by mitogens such as EGF, hepatocyte
growth factor (HGF), MEK kinase 1 (MEKK1), JNK stimulate TGF- signaling,
showing a synergy between the TGF- and MAPK signaling (Funaba et al., 2002;
LaBonne and Whitman 1994). Smad2-dependent formation of mesoderm in X. laevis
coincides with the regions of peak MAPK activation (Schohl and Fagotto, 2002). In
contrast, oncogenic Ras, which stimulates Erk1 and Erk2, inhibits TGF- signaling. In
this case, Smad2/3 linker phosphorylation by MAPK blocks their transcriptional activity
and nuclear accumulation (Kretzschmar et al., 1999) (Fig. 2). Finally, such
phosphorylation of Smad2/3 leads to the proteasome regulated degradation.

V. Smad2exon3, an alternatively spliced variant of Smad2:
Although there is 91% amino acid sequence identity between Smad2 and Smad3,
their biological activities are different. Unlike Smad3 and Smad4, Smad2 cannot bind
directly to DNA. Kurokawa et al. (1998) showed that Smad3 can bind the Evi-1
transcriptional regulator, but Smad2 cannot. Although both Smad2 and Smad3 are
essential signal transducers of the TGF- pathway and TGF- is more potent than
Activin. Studies in HaCaT cells revealed that TGF- can phosphorylate both Smad2 and
Smad3, but Activin can only phosphorylate Smad3 (Shimizu et al., 1998). These
functional differences were explained by the presence of an alternatively spliced variant
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of Smad2 protein, called Smad2exon3, which is present in various cell types including
X. laevis (Yagi et al., 1999; Faure et al., 2000).
A 30 amino acid sequence is present in the Smad2 MH1 domain, which is not
present in that of Smad3. There are 11 exons that compose the Smad2 gene ORF. Exon 3
is translated into these 30 amino acids, which are in the middle of MH1 domain.
Although the functional superiority of Smad2exon3 over wild type Smad2 in terms of
DNA binding has been experimentally demonstrated, the overall transcriptional
activation by the two isoforms was similar. Although the presence of an extra 30 amino
acids inhibits Smad2‟s direct DNA binding via the MH1 domain, it cannot block
activated Smad2 from its indirect binding to DNA. DNA-binding factors like FAST1 or
FAST2 interact and bind the MH2 domain of Smad2. Functionally, Smad2exon3 is
equivalent to Smad3 and may substitute for it in certain cell types lacking Smad3
expression (Yagi et al., 1999).

VI. Smad4, the co-Smad:
Smad4, a member of common-mediator Smad (Co-Smad) family of proteins,
binds receptor-activated Phospho-Smad2 (PSmad2) followed by nuclear translocation.
This complex mediates the endoderm/mesoderm specific transcriptional regulation in X.
laevis. Smad4 was originally identified as the product of DPC tumor suppressor gene in
pancreatic cancer cells (Hahn et al., 1996). Involvement of Smad4 in TGF signaling is
not only suggested in mammals (Lagna et al., 1996; Zhang et al., 1996) but also held as
an important mediator of Activin- and BMP-signaling in X. laevis embryos (Lagna et al.,
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1996; Zhang et al., 1996). Smad4 interacts with activated R-Smads via its C-terminal
domain (Hata et al., 1997; Wu et al., 1997).
In X. laevis, two isoforms of Smad4,  and , have been identified (LeSueus and
Graff, 1999; Masuyama et al., 1999; Howell et al., 1999; Hill, 2001). XSmad4 is the
potential X. laevis ortholog of hSmad4. Its ORF is 1650 bp in length producing a 549
amino acid protein with a predicted molecular weight of 59.8 kDa. XSmad4, also known
as Smad10, is not an alternatively spliced isoform, but a product of a different gene
(Watanabe et al., 2000). It has a 1683 bp ORF, which produces a 560 amino acid protein
with a predicted molecular weight of 61.2 kDa.
According to Howell et al. (1999), these two isoforms show strikingly different
temporal expression patterns in early X. laevis embryos. Adult tissues were also
characterized by their expression in different ratios, which suggests isoform specific
roles. From MBT until the onset of midgastrula stages, expression of XSmad4 is much
higher than that of XSmad4, whereas at the midgastrula stages, the reverse expression
pattern for the two isoforms has been observed (Howell et al., 1999). XSmad4 protein
expression predominates during the early embryonic development in X. laevis and was
part of two different activin induced Smad/transcription factor complexes, which bind
ARE on Mix2 gene. Moreover, TGF- family members regulating transcription differ
between these two time frames (Howell et al., 1999). Therefore, it is predicted that during
early X. laevis embryonic development, maternal Activin-like and/or BMP signaling
targets a set of zygotic gene expression via XSmad4. At midgastrulation, when other
TGF- members like derriere (Sun et al., 1999), Xnr-1, Xnr-2, and Xnr-3 (Jones et al.,
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1995; Smith et al., 1995) and BMP4 (Nishimatsu et al., 1992) are expressed, the pathway
is mediated by XSmad4.
Although the nuclear import of R-Smads does not need Smad4 (Liu et al., 1997),
it co-translocates with R-Smads (Hoodless et al., 1999; Liu et al., 1997; Watanabe et al.,
2000). Unlike the ligand-dependent import of R-Smads, Smad4 shuttles continuously
between the cytoplasm and the nucleus because of the combined effects of the NLS in the
MH1 domain and an NES in its linker region (Inman et al., 2002). Surprisingly,
XSmad4, not XSmad4, lacks the NES. Therefore XSmad4 is almost exclusive to the
nucleus, whereas XSmad4 resides in the cytoplasm in the absence of any signal due to
the presence of NES (Masuyama et al., 1999). Also, XSmad4 and not XSmad4, is
phosphorylated, but the purpose is unknown (Masuyama et al., 1999).
Pierreus et al. (2000) and Watanabe et al. (2000) provided evidence that Smad4
undergoes nucleocytoplasmic shuttling on its own without involving R-Smads. The
common Smad4 (Smad4 in X. laevis) possesses multiple motifs in its MH1 domain in
addition to the NES in the linker region, which helps Smad4 in nuclear translocation
without Smad2/3 (Xiao et al., 2003).
Smad2-independent nuclear translocation of Smad4 has been reported in several
instances, especially when it serves as a co-Smad in multiple signaling pathways. In
response to BMP4 signals, Smad4 binds with activated Smad1, not Smad2, and
undergoes nuclear translocation (Lagna et al., 1996). There are also several instances,
where Smad4 translocates inside the nucleus without being in a complex with active
Smad2 or Smad3 in a TGF--inducible manner. SMIF, a Smad4-interacting protein
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forms a TGF-/BMP4-inducible complex with Smad4 and translocates inside the nucleus
in a Smad4 dependent manner (Bai et al., 2002).

VII. Mesendoderm specification in E. coqui: A comparative analysis.
E. coqui excludes the feeding tadpole from its ontogeny and the young froglet
emerges directly from the embryo (Callery et al., 2001). To compensate absence of a
larval phase, the eggs are supplied with enough yolk to support the embryo to reach their
froglet stage (Fang et al., 2000; Elinson and Beckham, 2002). As a consequence, the first
and foremost difference in the early development between E. coqui and X. laevis, a
metamorphosing frog, is the huge size of the egg in E. coqui (Elinson, 1987). The
presence of a large amount of yolk shifted the early embryogenic events towards the
animal pole of the zygote.

A. Early events:
Unlike X. laevis, the first horizontal cleavage in E. coqui occurs at the 16-cell
stage (Elinson and Beckham, 2002). This cleavage produces eight small animal
blastomeres, which represent barely 1% of the total embryo volume (Ninomiya et al.,
2001). Although relatively small in size, these blastomeres contribute to both the
mesoderm and ectoderm. Due to the presence of so much yolk, the cleavage furrows
extend very slowly resulting in large, incompletely divided, vegetal yolky cells. The
appearance of the blastopore lip equatorially, much closer to the animal pole than that in
X. laevis, marks the onset of gastrulation (Beckham et al., 2003). The mesendoderm
inducing activity, presumably under the influence of TGF- signaling is localized
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equatorially and sub-equatorially in the early gastrula and restricted to the superficial
marginal zone cells (Ninomiya et al., 2001). Consequently, most of the vegetal region of
the early gastrula lacks mesendoderm-inducing activity (Fig. 3) (Ninomiya et al., 2001).
Unlike E. coqui, the mesoderm-inducing activity is expressed throughout the vegetal
region of a X. laevis gastrula.

B. Mesendoderm inducers - VegT, Vg1 and Sox17:
The key initiator of both mesoderm and endoderm in X. laevis is the T-box
transcription factor VegT. Spatial restriction of maternal VegT and Vg1 RNAs to the
vegetal cortex in the oocyte leads to the mesendoderm induction in vegetal half (Fig. 3).
In X. laevis, VegT is necessary and sufficient to regulate endoderm formation by
controlling Nodal gene expression and by directly activating transcription of endodermal
determinants (Zhang et al., 1998; Clements et al., 2001; Xanthos et al., 2001). Zhang et
al. (1998) and Xanthos et al. (2001) provided evidence that depletion of maternal VegT
RNA causes lack of endodermal markers and mesoderm inducing signals in early
embryos. This implicated the essential role of VegT in endoderm and mesoderm
specification in X. laevis early embryos (Zhang et al., 1998; Xanthos et al., 2001). VegT
is the important regulator of several TGF- signals including Derriere and Xnrs 1, 2, 4, 5,
and 6 (Clements et al., 1999, 2003; Kofron et al., 1999; Rex et al., 2002; Sun et al., 1999;
Takashi et al., 2000). This interplay between VegT and Nodals is absolutely necessary for
mesoderm induction (Hemmati-Brivanlou and Melton, 1992: Piccolo et al., 1999) and
sustenance of endoderm specific gene expression (Zhang et al., 1998; Clements et al.,
1999, 2003; Yasuo and Lemaire, 1999; Chang and Hemmati-Brivanlou, 2000; Engleka et
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Fig. 3: Comparison of fate maps between X. laevis and E. coqui (in sagittal views,
drawn to scale). In X. laevis, VegT and Vg1 RNAs (red), localized to the oocyte vegetal
(V) cortex, lead to Nodal signaling (green) in the vegetal half. This leads to endoderm
(yellow) and mesoderm (red) in the fate map. In E. coqui, EcVegT and EcVg1 RNA
location is near the animal pole and Nodal signaling is hypothesized to be restricted to the
peripheral marginal and sub- marginal zones. Absence of VegT activity and Nodal
signaling, in the vegetal core is hypothesized to lead to nutritional endoderm (ne)
development. (Modified after Elinson and del Pino, 2011, with permission)
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Fig. 3:
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al., 2001; Xanthos et al., 2001). Clements et al. (2003) suggested a strong synergism
between VegT and TGF- signals, which is used by VegT to augment the cell‟s
sensitivity towards TGF signals. VegT induces several other downstream targets, which
are implicated in the specification of endoderm. These targets include Mix/Bix/Mixer
family members, GATAs 4, 5, and 6, and Xsox17 and  (Hudson, 1997; Tada et al.,
1998; Casey et al., 1999; Clements et al., 1999, 2003; Weber et al., 2000; Xanthos et al.,
2001).
In the X. laevis embryo, a TGF- superfamily member, Vg1, is expressed as
maternal RNA in the vegetal hemisphere cells, which produce endoderm and induce
mesoderm formation (Rebaglaiti et al., 1985; Weeks and Melton, 1987). Mutant Vg1
ligand studies by Joseph and Melton (1998) provided evidence that blocking Vg1
signaling results in embryos lacking dorsal mesoderm and axial structures. A large
amount of Vg1 precursor proteins are synthesized and localized in the vegetal half of the
X. laevis oocyte, but are only selective processed after fertilization to produce the mature
protein in response to cortical rotation event (Thomsen and Melton, 1993). This small
amount of potent mature Vg1 protein then initiates dorsal mesoderm formation and the
turning on of several endodermal marker genes (Gamer and Wright, 1995; Henry et al.,
1996). One such gene is Xlhbox8, which encodes a transcription factor expressed in
vegetal core (VC) cells and later in pancreas (Gamer and Wright, 1995; Henry et al.,
1996; Wright et al., 1988).
In X. laevis oocytes, VegT regulates the expression of the endoderm specific
transcription factors like Sox7 (Zhang et al., 2005) and Sox17 (Yasuo & Lemaire 1999;
Clements et al., 1999; Clements & Woodland 2003; Howard et al., 2007; Zhang et al,
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2007). Sox7 and Sox17 are F-type Soxs, a group of Sox proteins based on degree of
sequence similarities within their HMG domains (Zhang et al, 2007). In X. laevis, Sox7
mRNA is maternally contributed and localizes to the vegetal half of the early embryo
(Zhang et al, 2007). Zhang et al. (2005a) showed VegT regulates the expression of Sox7
and blocking Sox7 expression leads to the inhibition of VegT‟s effects in animal cap.
Zhang et al. (2005a, 2005b) also illustrated the direct involvement of Sox7 in regulation
of expression of mesoderm-inducing Nodal-genes such as Xnr1, Xnr2, Xnr4, Xnr5, and
Xnr6.
The other F-type Sox, Sox17, is involved exclusively in endodermal specification.
Hudson et al. (1997) showed that two transcription factors, Sox17 and Sox17, are
expressed in the whole vegetal half fated to form endoderm in the X. laevis embryo.
Nodal-signaling via intermediates like Mixer-like and GATA proteins in X. laevis
activates Sox17 expression (Engleka et al., 2001; Shivdasani, 2002; Clements and
Woodland, 2003; Loose and Patient, 2004; Zhang and Klymkowsky, 2007). Unlike Sox7,
Sox17 activates only Xnr4 (Sinner et al., 2004; Zhang et al., 2005b; Zhang and
Klymkowsky, 2007). It also cooperates with -catenin in initiation of transcription of
endoderm specific target genes in X. laevis (Sinner et al., 2004).
In animal cap explants, over-expression of Sox17 augmented endodermal gene
expression (Stainier, 2002). Disruption of Sox17 expression in vegetal cells fated to
become endoderm, forced the cells to enter mesodermal or ectodermal lineages
(Clements and Woodland, 2000; Stainier, 2002). According to Engleka et al. (2001), both
VegT and Nodal are required for Sox17 expression at gastrula, but only VegT is
necessary to initiate Sox17 expression at MBT. They also reported that misexpression of
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Sox17 in the marginal zone of the early embryo led to the inhibition of expression of
mesodermal genes. This result suggests incompatibility of Sox17 with mesoderm
specification. Sox17 also blocks expression of mesodermal markers like Xbra and
MyoD (Engleka et al., 2001). These results corroborate the idea that activation of Sox17
by VegT in the vegetal hemisphere of X. laevis oocyte (Fig. 3) defines the endodermal
domain, and the response of Sox17 to Nodal signal is biased against mesoderm
specification (Engleka et al., 2001).
EcVegT and EcVg1 cDNAs, the E. coqui orthologs of X. laevis VegT and Vg1,
were cloned in our laboratory. In situ hybridization in full-grown E. coqui oocytes
detected presence of the EcVegT and EcVg1 RNAs near the animal pole (Beckham et al.,
2003) in contrast to X. laevis, where VegT and Vg1 RNAs are at the vegetal cortex
(Zhang and King, 1996; Melton, 1987). The results in E. coqui were confirmed by RTPCR analysis (Beckham et al., 2003). In situ hybridization in E. coqui early embryos,
detected zygotic EcVegT expression in the marginal zone (MZ) during early gastrulation
(Beckham et al., 2003). The expression of EcVegT in the marginal zone of the embryo
became stronger by mid-gastrulation (Beckham et al., 2003).
Although, in situ hybridization data on EcSox17 RNA met the expectation of
being present only in the marginal zone of the E. coqui early embryos, RT-PCR results
revealed the presence of the RNA in both the MZ and the VC (Buchholz et al., 2007).
The maternal contribution of EcSox17 in E. coqui could account for the presence of
EcSox17 RNA in the VC. Sox17 RNA is not present in X. laevis eggs (Hudson et al.,
1997). The function of EcSox17 RNA in vegetal cells remains elusive. As a consequence,
EcSox17 expression data could not be used to distinguish NE from DE.
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Recombinant analysis by Ninomiya et al. (2001) revealed the presence of strong
mesoderm inducing activity in the outermost cells of the MZ of E. coqui early embryos.
This study did not detect mesoderm-inducing activity in the blastocoel floor and VC of
the embryo. Expression of Brachyury (EcBra), the E. coqui homolog of X. laevis Xbra,
an early mesoderm marker, was detected around the entire MZ (Ninomiya et al., 2001).
Based on these data, the E. coqui fate map (Fig. 3) was generated (Elinson and del
Pino, 2012). Unlike X. laevis, EcVegT and EcVeg1 RNA localization towards the animal
pole leads to mesendoderm specification towards the marginal zone in the fate map and
absence of any mesendoderm inducing activity in the VC cells from late blastula and
early gastrula (Elinson and del Pino, 2012).

C. Germ plasm in E. coqui:
In spite of the deviations described above, localization of germ plasm to the
vegetal cortex is conserved in both E. coqui and X. laevis. Germ cells arise early in frog
development due to this cytoplasmic localization. Frog germ plasm contains
mitochondria, an electron dense nuage material, and many germ plasm specific RNAs.
Germ plasm RNAs in X. laevis include dazl, nanos1, Xpat, and DEADSouth (King et al.,
2005). These RNAs are localized at the vegetal cortex during oogenesis. After
fertilization, they form islands of germ plasm, and during cleavage, these islands
segregate to a small number of cells. Such cells are called primordial germ cells (PGCs),
and they migrate from the endoderm to the genital ridges of the future gonads.
In E. coqui, islands of germ plasm were identified by DiOC6 staining and by
Ecdazl and EcDEADSouth RNA localization (Elinson et al., 2011). The islands cover a
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large part of the vegetal cortex of the cleaving embryo. These distributions of RNAs,
although similar to that in X. laevis, are comparatively more extensive.
During gastrulation in X. laevis, cells containing germ plasm maintain totipotency
despite the presence of maternal VegT RNA. They are prevented from acquiring an
endodermal fate, and finally give rise to the PGCs (Venkatarama et al., 2010). The fate of
the germ plasm containing cells is determined by a global transcriptional repression of
those specific blastomeres. The other blastomeres, which are not transcriptionally
repressed, become committed to the endodermal fate. Both the endodermal and PGC
lineages originate from the vegetal cytoplasm in X. laevis, but the latter do not respond to
VegT (Venkatarama et al., 2010).

VIII. Nutritional endoderm, the novel tissue in E. coqui:
E. coqui eggs, with elevated levels of yolk, have a large vegetal region devoid of
molecular determinants (Ninomiya et al., 2001; Beckham et al., 2003). The absence of
molecular determinants in the VC is responsible to form the novel tissue NE in this direct
developing frog (Buchholz et al., 2007). Presence of NE in E. coqui dramatically changes
the fate map relative to the X. laevis fate map (Fig. 3).
NE consists of transient, yolk rich cells that provide nutrition to the growing
embryo but do not differentiate into any definitive endodermal tissues. NE is grossly a
mass of large yolky cells attached to the differentiated intestinal tube. These cells
disappear from the differentiated intestine after the yolk is utilized (Buchholz et al.,
2007). There are several lines of evidence that support the idea that NE performs only a
nutritional role. Lack of endoderm specific molecular determinants like VegT from NE
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provides evidence that NE does not behave like regular endodermal cells. When the gut
of a newly hatched froglet was examined, there were two types of grossly different
tissues. One of them is the translucent tissue, which forms the differentiating stomach and
intestine, and the other type is the yolky NE (Buchholz et al., 2007). Histological
examination emphasized the sharp distinction between the two tissues. Fate mapping,
performed by injecting FDA into the large vegetal cells of cleaving embryos, resulted
into a strong labeling of only the large yolky cells, not the differentiated gut tissue
(Buchholz et al., 2007). Instead of differentiating, the mass of labeled yolky cells
decreased in number, and label remained only in the mesonephros and cloaca. The
labeling of mesonephros indicated that the FDA was being cleared from blood, which
suggests FDA uptake into circulation when the labeled cells died. This result suggested
death as the fate of these large yolky cells. In attempt to show death in NE cell, Buchholz
et al. (2007) performed TUNEL staining, but failed to detect labeled cell nuclei. Also,
nuclear histological changes associated with apoptosis in X. laevis such as nuclear
fragmentation or chromatin condensation (Ishizuya-Oka and Ueda, 1996), were not
observed in E. coqui (Buchholz et al., 2007).
It is evident that NE lacks the signaling pathways and events related to
mesendoderm specification. Whether NE is present in indirect developers like X. laevis,
Rana, or other frogs with tadpoles, has not been determined. Detection of such cells,
which would be only a minor component of the yolk rich endoderm, would require a
more detailed fate mapping than has been done so far (Buchholz et al., 2007; Elinson,
2008).
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IX. Global transcriptional status:
NE cells disappear in the course of development and do not contribute to any
differentiated tissues in E. coqui froglets. In contrast to MZ cells, VC cells during early
E. coqui embryogenesis lack expressions of molecular determinants of mesendoderm
inducers such as EcVegT, EcVg1, and mesodermal marker like EcBra. These results
could account for the lack of mesendodermal development for the VC, but the presence
of EcSox17 RNA in VC cells suggests a way to bypass the usual endodermal signaling
routes. It is expected that the presence of transcription factors in E. coqui early embryos
should also perform their anticipated role, but that depends on the functional status of the
most important transcribing enzyme, RNA polymerase II.

A. Regulation of RNAP II CTD-phosphorylation in transcription:
RNA polymerase II (RNAP II) is a eukaryotic enzyme that catalyzes transcription
of mRNA, snRNA, and microRNA. In other words, the most important enzyme for gene
expression is RNAP II. RNAP II is a 550 kDa multiprotein complex, with 12 subunits. It
interacts with a wide range of transcription factors that are required for it to bind to its
promoters and begin transcription. The C-terminal domain (CTD) of RNAP II is an
unusual extension, which is attached to the C-terminus of the largest subunit and serves
as a flexible binding scaffold for transcription factors (Phatnani and Greenleaf, 2006).
The transcription factors to be bound depend on the phosphorylation status of the CTD
repeats. This repeat domain is evolutionarily conserved. In fungi, plants, and animals, the
CTD contains 25 to 52 tandem copies of the consensus heptapeptide repeat
Y1S2P3T4S5P6S7 (Corden, 1990; Phatnani and Greenleaf, 2006; Venkatarama et al.,
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2010). Regulation of phosphorylation of this heptapeptide repeat determines the
transcriptional status of a cell (Venkatarama et al., 2010). Unphosphorylated RNAP II is
recruited to a promoter to form the initiation complex (Fig. 4). Within the pre-initiation
complex, each of the CTD-serine 5 (P-Ser5)‟s is phosphorylated by the cyclin dependent
kinase CDK7 (Price, 2000; Phatnani and Greenleaf, 2006; Sutherland and Bickmore,
2009; Venkatarama et al., 2010). P-Ser5 marks transcription initiation. This is followed
by transcription elongation, which occurs only when the CTD-serine 2 (P-Ser2)‟s are
phosphorylated by cyclin-dependent kinase CDK9 (Fig. 4) (Price, 2000; Phatnani and
Greenleaf, 2006; Sutherland and Bickmore, 2009; Venkatarama et al., 2010).
Based on the reports of Phatnani and Greenleaf (2006) and Sutherland and
Bickmore (2009), a working model for transcription initiation and elongation correlated
with CTD phosphorylation has been proposed (Fig. 4). According to the model, the
RNAP II CTD repeat Y1S2P3T4S5P6S7 exists in four phosphorylation states along the
body of a gene during expression. First, in the pre-initiation complex at the gene
promoter, the CTD repeat is hypo-phosphorylated (non-P), and the enzyme is associated
with a set of general factors and mediators. Second, the Ser5 residue of the repeat is
phosphorylated (Ser5P) by CDK7 or by the kinase activity of the general transcription
factor (GTF), TFIIH. This event leads to transcription initiation at the 5‟ end of the gene,
accompanied by the binding of a 5‟end-processing factor like capping enzyme. Third, an
elongation-phase kinase like CDK9 phosphorylates Ser2 exclusively to create a dually
phosphorylated state of CTD (Ser2P,5P), which is essential for elongation. Finally,
towards the 3‟end of the gene, Ser2 residues dominate, while Ser5 positions are mostly
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dephosphorylated by protein phosphatase (PPase) (Phatnani and Greenleaf, 2006;
Sutherland and Bickmore, 2009).

B. Global transcriptional status as a fate determinant:
In D. melanogaster and C. elegans, global repression of transcription is a wellknown phenomenon, preventing the germ cell lineage from acquiring the somatic fate
(Seydoux et al., 1996; Van Doren et al., 1998; Strome and Lehmann, 2007). Use of
specific monoclonal antibodies H14 and H5 against P-Ser5 and P-Ser2, respectively,
revealed that global gene expression is very low or absent in the germline, whereas the
neighboring somatic cells showed global gene expression (Seydoux and Dunn, 1997;
Ghosh and Seydoux, 2008). In these invertebrate model systems, the RNAPII activity is
blocked in the germline temporarily via regulation of the phosphorylation state of the
RNAPII CTD. In C. elegans, involvement of protein factors like OMA-1/OMA-2
(Guven-Ozkan et al., 2008) and PIE-1 (Seydoux et al., 1996) leads to the complete
inhibition of CDK7 and partial blockage to CDK9 functioning transcriptional repression
targeting both initiation and elongation steps (Ghosh and Seydoux, 2008). In D.
melanogaster, repression of CTD-Ser2 phosphorylation is inhibited by expression of
polar granule component (pgc). Polar Granule Component is reported to interact with
CDK9 and prevent it from entering the transcription site (Hanyu-Nakamura et al., 2008).
In pgc-null mutants stocks of D. melanogaster, poles cells become degraded before
reaching the gonad (Hanyu-Nakamura et al., 2008; Timinszky et al., 2008).
Global transcriptional repression also occurs in the germ line precursor cells in the
ascidian Halocynthia roretzi (Tomioka et al., 2002). Recent reports in mouse strongly
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Fig. 4: A working model for the existence of four phosphorylation states of RNAP II
CTD. The RNAP II CTD repeat Y1S2P3T4S5P6S7 is hypo-phosphorylated (non-P) in the
pre-initiation complex at the promoter of a gene. Ser5 phosphorylation (Ser5P) by CDK7
or TFIIH is responsible for transcription initiation. CDK9 phosphorylates Ser2
exclusively and a dually phosphorylated state of CTD (Ser2P,5P) leads to elongation. At
the 3‟end of the gene, Ser2P remains active, Ser5P is de-phosphorylated by PPase.
(Based on Phatnani and Greenleaf, 2006; Sutherland and Bickmore, 2009).
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Fig. 4:
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suggest the presence of global transcriptional repression as a means to protect PGC
identity during migration in mammalian germline (Seki et al., 2007).
In X. laevis, a similar event has been documented, where PGCs are formed from
cells containing germ plasm islands at the vegetal cortex, while the neighboring regions
of the vegetal half become committed to endodermal fates (Venkatarama et al., 2010).
Palancade et al. (2001) reported the existence of several distinct cycles of RNAP II CTD
phosphorylation, which correlate with active transcription in X. laevis. At fertilization,
the RNAP II CTD is almost completely de-phosphorylated with only a few
phosphorylated forms being present, as detected by the monoclonal antibody (H14 and
H5) staining. This correlates to a very low level of overall transcription. Twelve divisions
later, at MBT, when zygotic gene expression kicks in, RNAP II CTD undergoes hyperphosphorylation to a maximum level for both P-Ser5 and P-Ser2 (Venkatarama et al.,
2010).
In X. laevis PGCs, although VegT RNA is present, its downstream targets are not
expressed due to the global transcriptional block at MBT. The neighboring somatic cells
at the same time showed the presence of hyper-phosphorylated RNAP II CTD and
become committed to an endodermal fate. Such transcriptional blockage existed in PGCs
for at least ten hours until neural tube has been specified (Venkatarama et al., 2010).
Although transcriptional blockage in PGCs was accompanied by differences in the
amounts of histone linker proteins and DNA methylation, no significant changes in
chromatin remodeling were observed that could account for the global transcriptional
repression (Venkatarama et al., 2010). Therefore, regulation via RNAP II CTD
phosphorylation appears to be pivotal in maintaining the germline in both invertebrates
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and vertebrates. The evolutionary conservation of this phenomenon makes it worthwhile
to investigate whether such event also occur in E. coqui during early embryogenesis.
The presence of germ plasm has been documented in the vegetal half of E. coqui
embryos (Elinson et al., 2011). Germ plasm markers such as Ecdazl and EcDEADSouth
were detected towards the vegetal surface of E. coqui early embryos. Although, no
correlation has been established between the vegetal location of germ plasm islands and
generation of NE, it is enough to speculate that a global transcriptional repression event
also could occur in E. coqui vegetal half. Such a repression could provide an explanation
for why NE does not behave like definitive endoderm, despite the presence of
endodermal determinants like EcSox17.

X. Current investigation:
Direct development in E. coqui is accompanied by the emergence of NE in
addition to the three germ layers. Unlike X. laevis, NE develops from the VC of the
embryo, whereas the neighboring MZ cells become committed to the mesendoderm fate.
In this dissertation, I investigate the probable causes underlying the origin of NE by
asking whether NE develops because of the absence of the molecular determinants of
Nodal signaling in the VC in contrast to MZ. More specifically, I characterize the
expression of the Nodal signal transducer, Smad2 during early embryogenesis. I also
address the functional aspect of this tissue, which provides only nutrients to the growing
embryos, but does not differentiate. Lack of differentiation raises the question of the
functional inertness of these cells, which could be a consequence of the nature of its gene
expression. My study includes the following aims:
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(1) Cloning the EcSmad2 gene: The role of Smad2 in germ layer specification has
been well documented in X. laevis and other vertebrate species, but nothing is known for
direct developing amphibians. Smad2 is not only an essential component of Nodal
signaling, but it also serves as a hub connecting many important signaling pathways. As
the genome of E. coqui is not sequenced, I clone the Smad2 cDNA from E. coqui to
examine its expression.
(2) Establishing temporal and spatial expression patterns for EcSmad2: The only
temporal expression profile of Smad2 protein in embryos is available in X. laevis. Spatial
and temporal RNA expression patterns have not yet been reported in any frog. It will be
important to find out whether EcSmad2 RNA is maternally contributed and whether it is
present throughout all of the early developmental stages. It is possible that EcSmad2
expression is spatially restricted to the MZ only. Altogether, it will be helpful to generate
a complete profile of temporal and spatial EcSmad2 expression.
(3) Phospho-EcSmad2, EcSmad4 and ActRIIA protein expression in the
prospective definitive endoderm vs. prospective nutritional endoderm: The VC of E.
coqui does not develop into definitive endoderm; rather it develops into the NE. If nodal
signaling does not occur in the vegetal core of E. coqui blastulae and gastrulae, then
Smad2 should be phosphorylated in the superficial MZ, but not in the VC. To test this
hypothesis, I will analyze protein expression of both native and active forms of EcSmad2.
Although a lot of work has been done on X. laevis Smad2 protein expression, a complete
profile for temporal and spatial expression of Smad2 and PSmad2 does not exist.
Creating such a profile is instrumental for our understanding of Nodal signaling in frogs,
especially the direct developing ones. I will look at the expression profiles of the co-
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Smad, Smad4, and one of the activin receptors ActRIIA. Although some work has been
done with the receptor at the protein level, Smad4 protein expression has not been
examined. Looking at all of these components of Nodal signaling in the prospective
definitive endoderm vs. prospective NE will furnish us with new ideas about E. coqui
early embryogenesis.
(4) Detection of cellular location of PSmad2, Smad4 and receptor ActRIIA in
prospective definitive endoderm vs. prospective NE: The presence of an active form of
protein does not necessarily indicate the pathway is active, especially when VC is not
differentiating. It will be important to find out whether the active Smad2 or Smad4
proteins are cytoplasmic or are inside the nucleus. Identification of cellular locations of
Smad2 and these other components of the pathway will provide crucial information to
determine whether the pathway is active in NE.
(5) Determination of transcriptional status of NE cells: Finally, determination of
transcriptional status of NE cells will help us understand better the nature of this tissue.
Determining the transcriptional status may provide us with an explanation for why the
VC cells of early embryos do not undergo differentiation. I will explore differences in
transcriptional activity between those VC cells and those from the MZ.
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CHAPTER TWO: MATERIALS AND METHODS

I. Animals, oocytes, and embryos:
Adult E. coqui frogs were captured on the Big Island of Hawaii following
Injurious Wildlife Export permits from the Department of Land and Natural Resources of
Hawaii. Male and female frogs were kept as pairs as a reproductive colony at Duquesne
University. Adults and embryos were maintained following the protocols approved by the
Institutional Animal Care and Use Committee (IACUC). Female frogs in each pair lay
fertilized eggs in clutches, which are then guarded by the male frogs.
Clutches of embryos were collected and kept in a plastic petri dish with a filter
paper soaked in 20% Steinberg‟s solution, made by dilution of a 200% Steinberg‟s
solution. The 200% Steinberg‟s solution was made by adding 100 mls of two separate
20X stock solutions - A and B (Stock A = 1.16 M NaCl, 13.41 mM KCl, 16.59 mM
MgSO4.7H2O, 6.7 mM Ca(NO)3; Stock B = 10 mM Tris.HCl, pH 7.4) to a total 1000 ml
volume with deionized water (dIH2O). Embryos were gently separated from each other
using watchmaker‟s forceps in order to ensure proper development. E. coqui embryos are
staged according to the table by Townsend and Stewart (1985). Each stage is given a TS
number starting from TS3 to TS15, with TS15 denoting the hatching froglets. Embryos
from stages earlier than TS3 (neural tube formation) were staged according to the
Nieuwkoop and Faber (1994) stages for X. laevis. Embryos with a thick animal cap, small
blastocoel, and absence of a dorsal lip are considered to be at NF8. NF10 is characterized
by the presence of a very thin animal cap, a large blastocoel, and the appearance of the
dorsal lip (Fig. 5).
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Fig. 5: Stages of E. coqui development. Cleavage is represented by 4-cell and 8-cells
stages. NF8 represents a pre-gastrulation stage and NF10 is gastrulation. Eight postgastrulation stages are TS3, TS4, TS5, TS6, TS7, and TS8, which were used for various
experiments. Figures taken from Winter Edition of Biohistory Research Hall, 2012
(www.brh.co.jp)
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Fig 5:
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Ovarian oocyte collection was performed by removal of ovary from a sacrificed,
reproductively retired female frog. A female frog was anesthetized in 0.1% MS222
(Tricaine methane sulfonate), pH 7.4 and killed by decapitation. Ovaries were dissected
out and placed in 200% Steinberg‟s solution until ready to use. Full-grown oocytes were
defolliculated with watchmaker‟s forceps after incubating for one hour in Ca2+ free 200%
Steinberg‟s solution (116 mM NaCl, 1.34 mM KCl, 0.8 mM MgSO4, 9.2 mM Tris, pH
7.4) with 1 mM EGTA (Beckham et al., 2003).

II. Dejellying and removal of fertilization membrane:
In order to perform experiments using molecular techniques, embryos at desired
stages were transferred to a new petri dish. They were flooded with 20% Steinberg‟s
solution to cause swelling of the outer jelly layer. Fine forceps (No. 5, Dumont Electronic
quality, Switzerland) were used to remove the outer and middle jelly layers. Pre-gastrula
stage embryos were subjected to additional treatments to remove the inner jelly layer and
the fertilization membrane. First, they were incubated in 3% cysteine, pH 8 [L-(+)Cysteine, Hydrochloride, Monohydrate; J.T.Baker] for 8 – 10 minutes with gentle
swirling to remove the inner jelly layer. After thoroughly rinsing three to four times with
copious amounts of 20% Steinberg‟s solution, embryos were incubated in Hennen‟s
solution for 45 – 50 seconds to weaken the fertilization membrane. Hennen‟s solution
consists of 2 % cysteine, 0.2% papain (Sigma) and 0.2% -chymotrypsin (Type II, from
bovine pancreas), pH 8.0 (Hennen, 1973). Embryos were immediately washed three to
four times with excess amounts of 20% Steinberg‟s solution and transferred to a new
petri dish containing 1% Bovine Serum Albumin (BSA, Fraction V, Heat Shock
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Isolation, OmniPur) in 100% Steinberg‟s solution. In this final medium, the weakened
fertilization membrane was carefully removed with fine forceps under a dissecting
microscope.

III. Dissection of embryos:
After dejellying and removing the fertilization membrane as described above,
embryos were dissected in 100% Steinberg‟s solution with 1% BSA. Without fertilization
membranes, pre-gastrulation and gastrulation stage embryos flattened and appeared like a
flatbread. At these early stages, embryos were physically manipulated with the help of a
loop made from human hair attached to the end of glass Pasteur pipette. First, the
embryos were positioned with their animal pole facing upward. At NF8, it was easy to
detect vegetal surface by the presence of bigger cells. A fine incision was made with
forceps in a circle around the animal cap and the cap was removed. After this, the embryo
was turned upside down bringing the vegetal pole up. Fine incisions were made using a
hair loop to separate out the thin, peripheral MZ tissue (prospective definitive endoderm
or DE) consisting of both dorsal and ventral sides from the larger inner VC tissue
(prospective NE) (Fig. 6). Finally the MZ and the VC were separated into different
microfuge tubes for further use. For NF 10 embryos, the presence of a more translucent
animal cap and the appearance of the blastopore lip made the dissection of prospective
DE and NE much easier. For post-gastrulation stages when the embryonic regions have
already developed, dissections became much less complicated. For all post-gastrulation
stages the whole embryo was dissected into the embryonic tissues and the NE as shown
in Fig. 6.
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Fig. 6: Dissection of blastula (NF8) and early gastrula (NF10) into MZ and VC. (A)
Diagrams of NF8 and NF10 stages. (B) Diagram of the sagittal and the vegetal sections
of NF8/NF10 embryos with the red dotted line indicating the positions of MZ and VC
tissues and paths of dissections. (C) Photograph of the three pieces of dissected tissues
corresponding to the vegetal view diagram. [Taken from Buchholz et al., 2007, with
permission.]
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Fig 6:
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IV. Dissociation and isolation of individual cells from different tissues:
Dissociation of MZ and VC cells was required for the immunostaining
experiments. Once the MZ and VC were dissected, they were transferred to separate
small petri dishes containing Ca2+-Mg2+-free modified 100% Steinberg‟s solution [68
mM NaCl, 1.34 mM KCl, 4.05 mM Na2HPO4, 0.73 mM KH2PO4, 1.0 mM EGTA.Na2
with final pH 7.4] (modified from Ninomiya et al., 2001). Incubation for 10 – 15 minutes
in this solution dissociated cells from their respective tissues, after which cells were
washed in 1X PBS and were ready to use.
This solution only worked well for embryos from NF8, NF10, and TS3 stages.
For more mature embryos with more definitive and rigid body structures, the dissociation
medium was not enough even after incubating for more than an hour. For dissociation of
NE cells from embryos at TS6, TS8, TS11, and TS14 stages, dissected NE tissues were
incubated in Ca2+-free 200% Steinberg‟s solution with 1.0 mM EGTA [116.4 mM NaCl,
1.342 mM KCl, 0.812 mM MgSO4.7H2O, 4.05 mM Na2HPO4, 0.73 mM KH2PO4, pH
7.4, along with 1.0 mM final concentration of EGTA (pH 7.0)] (modified from Shibuya
and Masui, 1988) for at least an hour.

V. Trizol RNA Extraction:
RNAs were isolated from whole embryos as well as from dissected prospective
DE and prospective NE following the Trizol RNA extraction protocol standardized in our
laboratory. Five dejellied whole embryos with their fertilization membranes or five pieces
of individual tissues from dissected embryos were transferred into a 1.5 ml microfuge
tube. A clean glass Pasteur pipette was used to remove excess buffer solution. Microfuge
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pestles were cleaned with RNAse Zap solution (Ambion, Cat. # 9780. 9782) and rinsed
two to three times with Diethylpyrocarbonate (DEPC, Sigma) treated deionized water
(dIH2O). DEPC-dIH2O was made by addition of 1 ml of DEPC to 1000 ml of dIH 2O,
which was autoclaved after overnight incubation at room temperature. 400 l of ice-cold
Trizol reagent (Invitrogen) was added to each tube containing whole embryos and 200 l
to the tubes containing dissected tissues. Embryos or tissues were homogenized using
RNAse free pestles attached to an electrical homogenizer. All the samples were
homogenized vigorously for two to three minutes followed by addition of 400 or 200 l
of Trizol to each tube, depending on the sample type, and mixed thoroughly. After five
minutes incubation at room temperature, 400 or 200 l chloroform was added to
respective tubes. Tubes were rigorously shaken for 15 to 20 seconds. Mixtures were
incubated for three minutes at room temperature and centrifuged at 16,100 xg for 10
minutes. As a result of centrifugation, all RNAs were present in an aqueous phase at the
top of each tube, and the aqueous phase was carefully transferred to new 1.5 ml
microfuge tubes without disturbing the interphase. Depending on the sample type, 500 or
250 l of isopropanol was added to each tube and swirled gently. Samples were
incubated at room temperature for 10 minutes. Tubes were centrifuged for 10 minutes at
16,100 xg. All supernatants were carefully discarded, keeping the pellets at the bottom of
each tube. One ml of 70% ethanol was added to each pellet and vortexed for 30 seconds
for proper washing. Tubes were spun at 16,100 xg for 10 minutes. Supernatants were
discarded and pellets were air dried by laying the tubes with the cap open on the tabletop
for 20 – 25 minutes at room temperature. Dried pellets were dissolved in 25 l of DEPC-
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dIH2O. 25 l of 8M LiCl was added to each tube along with 1 l of glycogen, and the
tubes were stored at -20oC overnight.
The next day, the tubes were centrifuged for 15 minutes at 16,100 xg at 4oC.
Supernatants were discarded, and pellets were washed with 500 l of 70% ethanol by
gently vortexing. Tubes were centrifuged again for 10 minutes 16,100 xg at 4oC. After
discarding the supernatants from each tube, pellets were air dried and dissolved in 30 l
of DEPC-dIH2O by incubating tubes at 60oC for 5 minutes. This was followed by gentle
vortexing of the tubes and brief spinning. DNAse treatment was performed by adding 7.5
l of DEPC-dIH2O, 10.0 l of DNAse reaction buffer (Promega), 2.0 l of RNAse free
DNAse (Promega) and 0.5 l of RNAse inhibitor (Takara) to each tube, mixing gently,
and incubating the tubes at 37oC for 45 minutes. After incubation, tubes were centrifuged
briefly, and 150 l of DEPC-dIH2O + 200 l of PCI (Phenol: Chloroform: Isoamyl
alcohol:: 25: 24: 1) was added to each tube and vortexed rigorously for 30 seconds. Tubes
were centrifuged for 5 minutes at 16,100 rcf at room temperature. The upper aqueous
layers (~180 l) were transferred very carefully to new 1.5 microfuge tubes without
disturbing the interface of the two layers, which consists of digested genomic DNA and
proteins. 18 l of 3M Sodium Acetate pH 6.0, and 500 l of ice-cold ethanol were added
to each tube and stored at – 200C overnight.
The following day, the tubes were centrifuged for 15 minutes at 15,700 xg at
room temperature. Supernatants were discarded and pellets were washed with 70%
ethanol and air dried as before. Finally pellets were dissolved in 25 l of DEPC-dIH2O.
One l of RNA was mixed with 99 l of DEPC-dIH2O and quantified at 260 nm using a
UV spectrophotometer (Beckman DU 530).
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VI. Reverse transcription to produce cDNA:
A total of 2-5 g RNA was used as a template to synthesize the first strand of
cDNA by reverse transcription. A 50 l reaction was set up in a 1.5 ml microfuge tube on
ice by adding the following reagents in order: 10 l 5X RT Buffer (Promega), 2.5 l 100
mM dNTPs (USB), 5 l of 500 nM/l 12-18 mer Oligo (dT) (Promega), 2-5 g of RNA
in a volume of 10 l, and 2 l RNAse Inhibitor (NEB). The final volume of the mix was
adjusted to 47.5 l by adding DEPC-dIH2O. Reactions were initiated by adding 2.5 l of
M-MLV-RT enzyme (500 units, Promega) to each reaction. Reagents were mixed well by
pipetting up and down and finally by brief spinning in a tabletop micro-centrifuge. Tubes
were incubated in a 370C water bath for a minimum of 2 hours. Each reaction was
accompanied with a negative RT reaction, which contained all the mentioned reagents
except for M-MLV-RT enzyme. Once, the incubation was over, cDNA samples were
purified by running the reaction mixtures through the spin-50 mini-columns (USA
Scientific). Retrieved purified cDNA samples were stored at – 200C until ready to use.

VII. Cloning the EcSmad2 gene:
The complete ORF of EcSmad2, most of the 5‟UTR and the complete 3‟UTR
ending with Poly(A) tail were cloned in four steps:

A. Degenerate PCR cloning of the EcSmad2 ORF:
Three sets of forward and reverse degenerate primers were designed based on
Clustal analysis (Clustal w1.81) of Smad2 ORF sequences of X. laevis, X. tropicalis, Mus
musculus and Homo sapiens (Fig. 7).
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Fig. 7: Degenerate primers for cloning EcSmad2. (A) Three forward and three reverse
degenerate primers. Red letters represent the degenerate code. (B) Positions of the three
pairs of degenerate PCR primers on the hypothetical EcSmad2 ORF, based on sequence
comparison with other species. The expected product sizes are: Reaction # 1: F1-R1 =
~1400 bp, Reaction # 2: F1-R2 = ~1190 bp, Reaction # 3: F1-R3 = ~470 bp, Reaction #
4: F2-R1 = ~1100 bp, Reaction # 5: F3-R1 = ~750 bp,
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Fig. 7 (A):
Primer
Name
EcSmad2
-F1
EcSmad2
-F2
EcSmad2
-F3
EcSmad2
-R1
EcSmad2
-R2
EcSmad2
-R3

Sequence

Length
(bp)

5’- ATGTCSTCSATYTTGCCATTYACBCC -3’

26

Tm (50
mM
NaCl)
60.60C

5’- ACAGGCCTTTACAGCTTCTCTGAACA -3’

26

60.00C

5’- CCTGGATATATYAGTGAAGATGGAGA -3’

26

54.40C

5’- TTABGACATGCTTGAGCADCGSACTG -3’

26

61.20C

5’- GACTGAGCSAGRAGAGCAGCAAAYTC -3’

26

61.30C

5’- ACTTCATCYTTTTTMAGRTTAAAAGC -3’

26

51.70C

[Degenerate Code: B = C, G, or T, D = A, G or T, M = A or C, R
= A or G, S = C or G, Y = C or T; F = forward and R =
reverse]
Fig. 7 (B):
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Gradient PCR reactions were set up for each of the above combination of primers
in a TGradient Thermocycler (Whatman, Biometra). Each 20 l reaction mix consisted of
2 l 10X PCR Reaction Buffer (Invitrogen, Carlsbad, CA), 0.6 l of 50 mM MgCl2
(Invitrogen, Carlsbad, CA), 0.4 l of 10mM dNTPs (Fisher), 0.1 l of Taq DNA
Polymerase (Invitrogen, Carlsbad, CA), 1.0 l of template cDNA, 1.0 l of each of the
forward and reverse primers, and 13.9 l of DEPC-dIH2O. The cDNA from E. coqui
embryos of neurula stage (TS3) was used as template in each reaction. A doublet of
bands was obtained for reactions 4 and 5 at expected sizes using the following program:
940C – 3 minutes
940C – 45 seconds
520C – 45 seconds

29 Cycles

720C – 1 minute 30 seconds
720C – 10 minutes
40C – Over night hold
The amplified PCR products from reactions 4 (F2-R1) and 5 (F3-R1) were run at
100 V for 45 minutes on a 1.5% Agarose gel with 2 l of 5 mg/ml Ethidium Bromide
(EtBr). A Kodak imaging system was used to illuminate the gel with UV light to take a
photograph followed by the excision of the desired sized bands using a sharp razor blade.
DNA fragments from the excised gel pieces were extracted using GeneJET TMGel
Extraction Kit (Fermentas, Cat # K0691). DNA was eluted from the column in 50 l
DEPC-dIH2O, and the concentration of DNA was measured using a UV
spectrophotometer (Beckman DU 530).
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The F2-R1 and F3-R1 DNA fragments were ligated into a pGEM vector using
Promega Ligation pGEM-Teasy Vector System (Cat # A3600). The ligated vectors were
transformed into JM 109 High Efficiency Competent cells following Promega‟s
transformation protocol. Finally, 100 l from each transformation reaction culture was
plated on LB/Ampicillin/IPTG/X-Gal plates. Twenty colonies from each plate were
screened for the right inserts by PCR using nested primers. Two such positive colonies
from each type were selected and grown overnight in 500 l LB medium. The following
day, 50 l of those overnight cultures were used to inoculate 5 ml LB medium and
incubated overnight in a 370C shaker. The following day, plasmid DNA was extracted
using GeneJETTMPlasmid Miniprep Kit (Fermentas, Cat # K0502). A PCR reaction with
the same set of nested primers was done again to verify the presence of the right clone in
those DNA samples. The clones were sequenced at the DNA Sequencing Facility,
University of Pittsburgh, Pittsburgh, PA using ABI 3100 Sequencer (Applied Biosystems
Inc., Foster City, CA).

B. Cloning the EcSmad2 3’UTR from an E. coqui Ovarian cDNA Library:
In order to obtain the 3‟UTR region of EcSmad2, I used PCR on Custom
SMARTTM cDNA Library in TriplEx2TM (Clontech, Cat # CS1023u). The RNA source
for this library was E. coqui ovary. Random fragments of E. coqui ovarian cDNAs were
used as inserts. Based on the previous sequencing results, an exact forward primer for the
EcSmad2 ORF was designed towards the 3‟ end (Fig. 8). As I did not know the
orientation of the insert, I designed two primers for the vector sequence – forward
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Fig. 8: Primers for cloning the 3’UTR. (A) Exact EcSmad2 and TriplEx2 vector
primers. (B) Diagram showing positions and directions of 5‟ pTriplEx2 Seq Pri and 3‟
pTriplEx2 Seq Pri on the TriplEx2 vector. MCS (green bar) stands for the multiple
cloning site, which contains complete or incomplete fragments of E. coqui genes. (C)
Diagram showing position and direction of EcSmad2-F18 forward primer.
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Fig. 8:
(A)
Primer
Name
EcSmad2F18
5’ pTriplEx2
Seq Pri
3’ pTriplEx2
Seq Pri

Sequence
5’-GGGCTTTGAAGCAGTTTACCAGTTAACG-3’

28

Tm (50
mM
NaCl)
60.00C

5’-GCCAAGCTCCGAGATCTGGACGAGC-3’

25

65.00C

5’-GAATTGTAATACGACTCACTATAGGGCGAA-3’

30

57.80C
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Length
(bp)

(5‟ pTriplEx2 Seq Pri) and reverse (3‟ pTriplEx2 Seq Pri) flanking the Multiple Cloning
Site (MCS).
PCR reactions were set up using EcSmad2-F18 with 5‟ pTriplEx2 Seq Pri and
EcSmad2-F18 with 3‟ pTriplEx2 Seq Pri in 50 l total volume as follow: 6.5 l 10X PCR
Reaction Buffer A (Fisher), 1.0 l of 10mM dNTPs (Fisher), 0.5 l of Taq DNA
Polymerase (Fisher), 5.0 l of ovarian library cDNA as template, 4.0 l of each of the
forward and reverse primers, and 29.0 l of DEPC-dIH2O. Reaction with EcSmad2-F18
and 3‟ pTriplEx2 Seq Pri produced a band using the following program:
940C – 3 minutes
940C – 45 seconds
560C – 45 seconds

29 Cycles

720C – 1 minute 30 seconds
720C – 10 minutes
40C – Over night hold
The amplified PCR product obtained only from reaction with EcSmad2-F18 and
3‟ pTriplEx2 Seq Pri, was gel extracted, ligated into a cloning vector, transformed,
screened and sequenced as described in section VII.A.

C. Cloning the 5’ UTR and initial segment of EcSmad2 ORF using 5’RACE:
The initial 5‟ end of the ORF and the whole 5‟ UTR was cloned using the
5‟RACE PCR Kit (Invitrogen, Carlsbad, CA; Cat # 18374-058). Invitrogen‟s protocol for
5‟ RACE system for Rapid Amplification of cDNA Ends, Version 2.0 was followed with
some minor modifications. According to the protocol, gene specific primers (GSP) were
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designed for EcSmad2 – GSP1, GSP2 and GSP3. These were reverse primers and
running towards the beginning of the ORF (Fig 9).
A PCR of dC-tailed cDNA was done using the following recipe: 5.0 l 10X PCR
Buffer, 3.0 l of 25mM MgCl2, 2.0 l of 10mM dNTPs mix, 3.0 l of nested GSP2
primer (10 M solution), 3.0 l of Abridged Anchor primer (10 M solution), 10.0 l of
dC-tailed cDNA as template, 23.0 l of DEPC-dIH2O and 0.5 l of Taq DNA
Polymerase (5 units/l). Product was obtained using the following program:
940C – 5 minutes
940C – 1 minute
550C – 1 minute 30 seconds

29 Cycles

720C – 2 minutes
720C – 10 minutes
40C – Over night hold
The product was further verified to contain EcSmad2 sequence by doing PCR
with nested GSP3 reverse and GSP4 forward primers. The 5‟RACE product was gel
extracted, ligated into cloning vector, transformed, screened and sequenced as described
in section VII.A. Finally, when the full ORF sequence was known, one forward and one
reverse exact primer were designed (Table 1) to amplify the full ORF sequence using
PCR with high fidelity Taq Polymerase, Pfu Ultra fusion Hs DNA polymerase
(Stratagene, Cat # 600670) as follow: 5.0 l 10X Pfu Ultra Rxn Buffer, 2.0 l of 10mM
dNTPs mix, 3.0 l of EcSmad2 Full ORF FP (10 M solution), 3.0 l of EcSmad2 Full
ORF RP (10 M solution), 4.0 l of TS3 whole embryo cDNA as template, 32.0 l of
DEPC-dIH2O and 1.0 l of Pfu Ultra fusion Hs DNA polymerase.
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Fig. 9: Primers for 5’RACE to clone 5’ UTR and the initial segment of the ORF. (A)
Primers used in 5‟RACE. (B) Positions and directions of primers. GSP1 and GSP2 are
designed based on the known EcSmad2 sequence (green bar). GSP3 and GSP4 are
designed based on the preliminary sequencing data on the 5‟RACE product.
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Fig. 9:
(A)
Primer
Name

Sequence

EcSmad2RP16 GSP1
EcSmad2RP17 GSP2

5’-GCATATTCACAATTTTCAAT -3’

20

Tm (50
mM
NaCl)
44.50C

5’-CCAGAGACGACAGTAGATAACGTGCGGTAA-3’

30

62.20C

EcSmad2RP18 GSP3
EcSmad2FP19 GSP4

5’-GGCGGCCATCTAGAGACCTGGTTTGTTCA-3’

29

65.00C

5’-GACAGGCCAGCTGGACGAACTCG-3’

23

64.00C

(B)
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Length
(bp)

Table 1: EcSmad2 Full ORF amplification primers. EcSmad2 full ORF forward and
reverse primers were used to amplify the full ORF for both the isoforms of the gene.

Table 2: qPCR primers. One pair of EcSmad2 specific primers, EcSmad2-qPCR FP1
and EcSmad2-qPCR RP1 was used for all the qPCR experiments. EcL8 F4 and EcL8 R5
primers were used as endogenous controls.
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Table 1:
Primer
Name

Length
(bp)

Tm (50
mM
NaCl)

5’-ATGTCCTCCATACTGCCCTTTACACC -3’

26

60.20C

5’-TTAGGACATGCTTGAGCAGCGGA-3’

23

60.70C

Sequence

Length
(bp)

Tm (50
mM
NaCl)

5’-CCCTTTACACCTCCCGTTGTGAAACGT -3’

27

62.50C

5’-CCTTCTCGAGTTCGTCCAGCTGGC-3’

24

63.40C

EcL8-F4

5’-GAAGGTCATCTCTTCTGCAAACAGAGC -3’

27

61.00C

EcL8-R5

5’-TAAGACCAACTTTGCGACCAGCTGG-3’

25

63.00C

EcSmad2
-Full ORF
FP
EcSmad2
-Full ORF
RP

Sequence

Table 2:
Primer
Name
EcSmad2
-qPCR
FP1
EcSmad2
-qPCR
RP1

Following program was used:
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950C – 3 minutes
950C – 30 seconds
550C – 45 seconds

34 Cycles

720C – 1 minute 15 seconds
720C – 5 minutes
40C – Over night hold
Products were gel extracted, ligated into cloning vector, transformed and screened
as previously described. Two clones for each of the isoforms of EcSmad2 (Full ORF and
exon3) were stored at – 800C as freezer stocks.

VIII. Quantitative PCR (qPCR) Analysis:
The detection of temporal and spatial regulation of EcSmad2 expression was done
using Ct method of qPCR. I designed EcSmad2 ORF specific forward and reverse
primers (Table 2), which would produce a small band of around 175 bp, ideal for qPCR
analysis. Specific primers were used for the ribosomal protein coding gene EcL8, which
served as the endogenous control.
For temporal expression, cDNAs for qPCR were synthesized using 5 g of RNAs
extracted from whole E. coqui oocytes and embryos at various stages of development –
NF8, NF10, TS3, TS4, TS5, TS6, TS7, and TS8. Both EcL8 and EcSmad2 primer
efficiencies were first tested as described by Singamsetty (2009). In order to ensure good
quality of cDNAs, a regular reverse transcriptase PCR (RT-PCR) was performed before
every qPCR run.

77

To do a relative quantification, reactions were set up in MicroAmp fast optical 48
or 96 well plates (Applied Biosystems, Foster City, CA). The total volume for each
reaction was 20 l. First, a master mix for each gene was made in a 1.5 ml sterile
microfuge tube. Each reaction mix contained 1.5 l of cDNA template (150 – 200 ng),
0.6 l of each of the forward and reverse primers, 7.3 l of DEPC-dIH2O and 10.0 l of
2X MaximaTM SYBR Green/ROX qPCR Master Mix (Fermentas, cat # K0221). Care was
taken at every step of assembling the reactions and pipetting mixes into the wells. Every
reaction was represented in triplicates on the reaction plates. Plates were then sealed with
MicroAmp 48 or 96-well optical adhesive films (Applied Biosystems, Foster City, CA).
The reactions were run on StepOne Real Time PCR System (Applied Biosystems,
Foster City, CA). A Ct method of qPCR program was set to run, and a melt curve was
obtained for amplification phase each time. EcSmad2 was amplified for 40 cycles with
the following parameters:
Initial denaturation: @ 940C for 10 minutes
Denaturing: @ 940C for 50 seconds
Annealing: @ 560C for 50 seconds
Extension: @ 720C for 1 minute 15 seconds
The experiments were analyzed using StepOne V2.0. The data was exported as an
Excel spread sheet and processed in Microsoft Excel 7.0. Final RQ values for each set
were then plotted to show the relative EcSmad2 expression.
For spatial expression, cDNAs for qPCR were synthesized using 5 g of RNAs
extracted from dissected DE and NE tissues of embryos at various stages of development.
I followed same protocol as described for temporal expression.
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IX. In vitro transcription of capped mRNA and microinjection into embryos:
Ambion mMESSAGE mMACHINETM Kit FOR SP6 (Ambion, Cat # 1340) was
used to synthesize capped mRNA of X. laevis EGFP tagged Smad2 cDNA (XeSmad2EGFP). The construct was a gift from Dr. Chenbei Chang. The plasmid vector was
CS105 pDH105 and the linearizing enzyme was AscI. The Ambion instruction manual
was followed with a minor modification. The transcription reaction was carried out at
370C for three hours instead of one. Transcribed capped RNAs were treated with DNaseI
and recovered using phenol: chloroform extraction and isopropanol precipitation as per
the instructions provided with the kit. All RNA samples were quantified by UV
absorbance at 260 nm and stored at – 200C until needed.
X. laevis and E. coqui embryos were cultured in 5% Ficoll (Fisher, Cat # BP525100) dissolved in 20% Steinberg‟s solution throughout the microinjection procedure. For
practice purposes, X. laevis embryos to be injected were placed in a drop of the medium
on a RNAse free silane-prep glass slide (Sigma). In the case of the bigger E. coqui
embryos, they were placed on a square piece of Nitex Nylon screen cloth no. 2380. The
square screen cloth with the embryos on it was kept immersed in the microinjection
medium in a 60x15 mm plastic petri dish (VWR). All the petri dishes and the screen
cloths were cleaned with RNAse away (Molecular Bioproducts) prior to use. A needle
puller (KOPF Needle/ Pipette puller, Model 730) was used to make glass needles and the
tips were trimmed with forceps as needed. Small drops of RNA to be injected were
placed on a piece of parafilm and drawn through suction into the glass needle filled with
light mineral oil (Fisher, Cat # 0121-1) with the help of Drummond Nanoject variable
automatic injector.
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While observing under a dissecting scope, a hair loop and forceps were used to
position each E. coqui embryo at the 4-8 cell stage with its animal pole up. RNAs were
injected as a single shot of 4.6 nl, 9.2 nl or 13.8 nl at an angle to the undivided vegetal
half of the embryo.
For each microinjection experiments, at least six embryos were kept as uninjected controls. All other sets of embryos were injected with either 9.2 nl of DEPCH2O, or EGFP-Smad2 mRNA. In case of the EGFP-Smad2, three separate concentrations
were used: 10 pg, 100 pg and 900 pg.
Once injected, the embryos were transferred to a fresh petri dish containing 5%
Ficoll in 20% Steinberg‟s solution and kept in that medium at least until the next day.
Embryos were transferred to 20% Steinberg‟s solution, and were cultured until they
reached NF10, when they were dissected into the prospective DE and NE tissues. Tissues
were dissociated into individual cells in the dissociation medium as described in section
IV.

X. Whole protein isolation, SDS-PAGE and Western Blot Analysis:
The whole protein preparation from yolky E. coqui embryos was a difficult task
due to the huge amounts of lipids and yolk platelets in them and the lack of existing
protocols. In order to establish a standard protocol to isolate protein from E. coqui
embryos, several recipes for homogenization buffers (HB) were tried. The standard
protein isolation protocol (HB1), used for X. laevis embryos (Birsoy et al., 2005), did not
work well on E. coqui embryos. I altered the recipe 15 times, leading to a series of buffer
recipes HB1 to HB16. HB16, which was modified after Callery et al. (1996), eliminated
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interference by yolk platelets. Proteins extracted using HB16 produced very nice bands
when run on SDS-PAGE. In Table 3, I have listed a few of the HB recipes in order to
have a better understanding of the modifications of the original buffer recipe.
Eight to ten E. coqui whole embryos were homogenized in 150 l of HB16 for 30
seconds on ice using a Kontes Pellet Pestle Cordless Motor (Kimble Chase Kontes, Cat #
K749540-0000). Blue polypropylene, autoclavable Kontes disposable pellet pestles
(Sigma-Aldrich, Cat # Z359947-100EA) were used for grinding the tissues in autoclaved
1.5 ml microfuge tubes until the solution turned milky white. In the case of MZ or VC
from early stages and DE or NE from post-gastrulation stages, 15-16 pieces of dissected
tissues were homogenized in the same volume of HB16 for the same time span.
Extracts were centrifuged at 16,100 xg for 15 minutes on a tabletop
microcentrifuge at 40C. After spinning, the yolky, white masses settled to the bottom of
the tubes. A clear supernatant appeared on top with a very thin, white, almost elastic layer
on the surface. The transparent supernatants were carefully separated to new 1.5 ml
microfuge tubes. If any contamination with the white mass was observed in any of the
new tubes, they were subjected to another 5 minutes spin at the same speed in order to get
rid of contaminants. In each extraction, almost 120 l of transparent supernatant were
obtained. Twenty l of each supernatant was then used with BCA Protein Assay Reagent
kit (Thermo Scientific, Cat # 23225) following the manufacturer‟s protocol to measure
the protein concentration. Meanwhile, equal volume of freshly made 2X Laemmli sample
buffer (BioRad) was mixed thoroughly with the transparent protein supernatants and
boiled for 5-6 minutes [1 ml 2X Laemmli sample buffer = 950 l Laemmli Sample buffer
(BioRad, Cat # 161-0737) + 50 l of 2-Mercaptoethanol (BioRad, Cat # 161-0710)].
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Finally, tubes were spun briefly at room temperature (RT) and stored either on ice or at –
200C until further use. Once the concentrations for each of the protein preparations in an
experiment were determined, they were equalized to the lowest one by adding 1X
Laemmli sample buffer.
Depending on the protein concentration in an experiment, 75 – 100 g protein
were loaded per lane of a 10% Tris-HCl BioRad Ready Gel (10X Cat # 161-1155).
PageRulerTM Prestained Proteins ladder (Thermo Scientific, prod # 26616) was used in
all the gels. All protein gels were run using BioRad Mini PROTEAN® 3 Gel system
following the manufacturer‟s manual (BioRad, Cat # 165-3301). A 10X stock solution for
the Gel Running Buffer was made as follows: 30 g Tris (Base), 144 g Glycine and 10 g
Sodium Dodecyl Sulphate (SDS) in 1000 ml of dIH2O. A 1X working solution was
freshly made for each run. A maximum of two gels were run at a time at 100V for 90
minutes. In all experiments, one gel was always run with all samples for Coomassie
Brilliant Blue (CBB) staining to check the quality of the protein preparations. The CBB
working solution was 0.02% CBB, 50% methanol, and 10% glacial acetic acid in dIH2O.
Staining the gels with freshly made solution was usually enough to visualize the band
patterns on the gels within an hour. Gels were de-stained by incubating them overnight in
a 5% methanol and 10% acetic acid destain solution.
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Table. 3: Recipes for four homogenization buffers to extract protein. HB1 was based
on the recipe provided by Birsoy et al. (2005) for extraction of proteins from Xenopus
embryos. HB14 and HB15 were modifications of HB1, while HB16 was modified from
the recipe described by Callery et al. (1996).
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Table. 3:
HB1 (Birsoy et al., 2005)

Stock solution
100 l

1 M Tris (pH 8.0)
100 mM EDTA

20 l

100 mM EGTA

50 l

25% NP-40 (Sigma)

20 l

250 mM Na- glycerophosphate

100 l

500 mM NaF (Sigma, Cat # 919-25ML)

200 l

100 mM Sodium Pyrophosphate
10 nM CalyculinA (Sigma, Cat # C5552-10UG)
PIC (Sigma, Cat # P-8340)
PMSF (Sigma, Cat # 93482-50ML-F)
dIH2O

100 l
2 l
10 l
5 l
393 l
1000 l

HB11

Stock solution
250 l

100 mM Tris (pH 7.4)
100 mM EDTA

20 l

100 mM MgCl2

100 l

10 nM CalyculinA (Sigma, Cat # C5552-10UG)
PIC (Sigma, Cat # P-8340)

2 l
10 l

PMSF (Sigma, Cat # 93482-50ML-F)
dIH2O

5 l
613 l
1000 l
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HB14

Stock solution
250 l

100 mM Tris (pH 7.4)
100 mM EDTA

20 l

100 mM EGTA

50 l

250 mM Na- glycerophosphate

100 l

100 mM Sodium Pyrophosphate

100 l

10 nM CalyculinA (Sigma, Cat # C5552-10UG)
PIC (Sigma, Cat # P-8340)
PMSF (Sigma, Cat # 93482-50ML-F)
dIH2O

2 l
10 l
5 l
463 l
1000 l

HB16 (Modified after Callery et al., 1996)

Stock solution
300 l

100 mM Tris (pH 7.4)
100 mM EDTA

40 l

100 mM MgCl2

100 l

10 nM CalyculinA (Sigma, Cat # C5552-10UG)

10 l

PIC (Sigma, Cat # P-8340)

20 l

PMSF (Sigma, Cat # 93482-50ML-F)
23.8 mM NaF (Sigma, Cat # 919-25ML)
dIH2O

20 l
210 l
300 l
1000 l
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Gels for western blotting were incubated in dIH2O on a shaker for 5 minutes
followed by a 30 minute equilibration in transfer buffer, along with other components of
the transfer cassette sandwich (2X Fiber pads, 4X filter papers, 1X PVDF membrane).
Immun-Blot PVDF membrane (BioRad, Cat #162-0177) was used for transfers and each
time before equilibration in the transfer buffer, they were soaked in methanol for 30
seconds. The transfer sandwich was assembled in a large tray submerged under the cold
transfer buffer following the BioRad instruction manual. Transfer buffer was: 3.0 g Tris
(Base), 14.4 g Glycine and 200 ml Methanol in 1000 ml total volume. The transfer buffer
was made fresh each time and stored in the cold room. Proteins were transferred at 150 V
for 80 – 90 minutes in a tank on a magnetic stirrer with a stir bar inside the tank to
circulate the heat well.
Once the transfer was finished, the transfer cassette was dislodged from the tank
and disassembled in a tray under dIH2O. The PVDF membranes were incubated in
Ponceau S stain (0.1% (w/v) Ponceau S in 1% (v/v) acetic acid) for 30 seconds to check
for the presence of protein bands on the membrane. After staining and visualization of
bands, the membrane was transferred into water for two washes of 5 minutes each.
Finally the membranes were removed and incubated in TBST (10.0 mM Tris pH 8, 0.15
M NaCl, 1% BSA, 0.05% Tween-20) for 20 minutes on a shaker. Membranes were
blocked in 5% Non Fat Dry Milk (NFDM) in TBST for an hour and half or overnight.
After blocking, membranes were incubated in primary antibody dilutions (Table 4) made
in blocking medium, overnight at 40C on a shaker. The next morning, each membrane
was washed in TBST 3x15 minutes. Only in case of anti-PSmad2 antibody, the
membrane was incubated after washing in Peroxidase Suppressor (Thermo Scientific,
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Prod # 35000) for 30 minutes to reduce background staining. This was followed by
another 3X15 minutes wash in TBST. All membranes were incubated in their respective
HRP-tagged secondary antibody, made in 2% NFDM in TBST for two hours at RT.
Membranes were washed for 3X15 minutes in TBST. Finally each membrane was treated
with SuperSignal® West Femto Maximum Sensitivity Substrate (Thermo Scientific, Prod
# 34096). Membranes were incubated in the mixture for 5 minutes and wrapped in a
plastic sheet protector, and the remaining solution was squeezed out.
A Typhoon 8600 Variable Mode Imager (Molecular Dynamics, Sunnyvale, CA)
was used for imaging the western blot. The membrane was placed with its face down on
the glass platen towards a corner to minimize the scanning time. Scan area was selected
using Scanner Control software (Amersham Biosciences), and resolution was selected at
high with mode of scanning selected at Chemiluminiscence. The rest of the parameters
were left in default setting. Developed images were analyzed using Image Quant Version
5.0 (Molecular Dynamics) or Adobe Photoshop CS5 Extended software.

XI. Immunocytochemistry (ICC) and DAPI staining with dissociated cells:
Immunocytochemistry was performed on dissociated cells to detect the cellular
location of selected proteins. After cells were completely dissociated, they were washed
gently in 1XPBS on a horizontal shaker for 3x10 minutes at a low speed. Cells were fixed
in 3.7% formaldehyde solution (J.T.Baker, Cat # 2106-11; Stock solution 37%, diluted in
1X PBS) for 35 minutes with gently shaking. After that, cells were washed in 1X PBS for
3x10 minutes followed by permeabilization. Cells were permeabilized in 0.3% TritonX100 in 1X PBS (ICN Biomedicals, Inc., Cat # 07426) for 35 minutes with constant gentle

87

shaking. Cells were washed in 1X PBS for 3x10 minutes. Cells were then blocked in 10%
Goat Serum (GIBCO, Cat # 16210-064) in 1X PBS for 90 minutes on a shaker.
Different primary antibodies were diluted in 10% Goat Serum in 1X PBS
according to the desired concentration (Table 4). Cells were incubated in a dilution of
specific primary antibody overnight at 40C with gentle shaking. The next morning, cells
were washed in 1% Goat Serum in 1X PBS for 3x15 minutes, followed by incubation in
the appropriate dilution of a specific secondary antibody (Table 4) for at least an hour at
room temperature on a shaker. As all the secondary antibodies were tagged with a
fluorescent label, the incubation containers, flat bottom12 Well Cell Culture plates
(COSTAR, Coring, NY; Cat # 3513) were wrapped with aluminum foil to protect them
from light. All subsequent steps were performed in aluminum wrapping.
Cells were washed again in 1% Goat Serum in 1X PBS for 3x15 minutes followed
by DAPI staining. DAPI stock solution was made by dissolving 1 mg DAPI
(InvitrogenTM/ Molecular Probes, Cat # D1306) in 1 ml DEPC-dIH2O and stored in
aliquots in 1.5 ml microfuge tubes at – 200C. Cells were incubated in 1:500 to 1:1000
dilution of the DAPI stock solution, in 1% Goat Serum in 1X PBS for 20 to 35 minutes
on a shaker, followed by washing in 1% Goat Serum in 1X PBS for 3x15 minutes.
Finally, cells were treated with SlowFade® Antifade kit (InvitrogenTM/ Molecular
Probes, Cat # S2828). When ready, cells were mounted in antifade medium on glass
slides and observed with a Nikon Microphot-SA microscope (Nikon Corporation, Tokyo,
Japan). Photographs were taken after exciting various fields with bright or fluorescent
light through FITC, Rhodamine or UV filters. A QED camera was used to capture
images, and they were processed using QCapture software and Adobe Photoshop.
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Table. 4: Primary and secondary antibodies used in immunocytochemistry (IC) and
western blotting experiments.

Name of the

Primary or

Company and

Dilution used

Dilution used

Antibody

Secondary

Cat #

for IC

for Western

1. Purified Mouse

Primary

BD

monoclonal Anti-

Transduction

Smad2/3*

Laboratories;

1:50

1:300

1:25

1:150

1:50

1:150

1:30

1:150

1:50

N/A

1:50

N/A

1:50

N/A

610842
2. Rabbit

Primary

Polyclonal Anti-

Cell Signaling;
3101

Phospho-Smad2
(Ser465/467)
Antibody**
3. Rabbit Anti-

Primary

Thermo

Smad4 Polyclonal

Scientific;

Antibody

PA1-41292

4. Goat Anti-human

Primary

Activin RIIA

R&D Systems,
Inc.; AF340

Antibody
5. RNA Polymerase

Primary

II 8WG16 Mouse

Covance;
MMS-126R

Monoclonal
Antibody
6. RNA Polymerase

Primary

II H14 Mouse

Covance;
MMS-134R

Monoclonal
Antibody
7. RNA Polymerase
II H5 Mouse

Primary

Covance;
MMS-129R

Monoclonal
Antibody
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Name of the

Primary or

Company and

Dilution used

Dilution used

Antibody

Secondary

Cat #

for IC

for Western

8. Mouse

Primary

abcam; ab7291

N/A

1:40,000

Primary

InvitrogenTM/

1:200

N/A

1:250

N/A

1:250

N/A

1:250

N/A

1:250

N/A

1:250

N/A

Monoclonal Alpha
Tubulin Antibody
(DM1A) – loading
control
Anti-Green
fluorescent protein,

Molecular

Rabbit IgG

Probes;

fraction.

A11122

9. Anti-GFP, rabbit

InvitrogenTM/

polyclonal

Molecular

antibody, Alexa

Probes;

fluor® 488

A21311

conjugate
10. Alexa fluor®

Secondary

InvitrogenTM/

488 Goat Anti-

Molecular

Mouse IgG (H+L)

Probes;
A11029

11. Alexa fluor®

Secondary

InvitrogenTM/

488 Goat Anti-

Molecular

Rabbit IgG (H+L)

Probes;
A11034

12. Alexa fluor®

Secondary

InvitrogenTM/

488 Donkey Anti-

Molecular

Goat IgG (H+L)

Probes;
A11055

13. Alexa fluor®

Secondary

InvitrogenTM/

546 Goat Anti-

Molecular

Mouse IgG (H+L)

Probes;
A11030
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Name of the

Primary or

Company and

Dilution used

Dilution used

Antibody

Secondary

Cat #

for IC

for Western

14. Oregon Green,

Secondary

TM

Invitrogen /

Goat Anti-Rabbit

Molecular

IgG (H+L)

Probes;

1:500

N/A

N/A

1:500 (for

O11038
15. Goat Anti-

Secondary

Sigma; A2304

Mouse IgG (Fab

Anti-Smad2)

specific)

1:40,000 (for

PEROXIDASE

Anti-Alpha

CONJUGATE

Tubulin)

16. Anti-Rabbit

Secondary

Sigma; A0545

N/A

1:200 (for

IgG (Whole

Anti-PSmad2)

Molecule)

1:300 (for

PEROXIDASE

Anti-Smad4)

CONJUGATE
17. Rabbit AntiGoat IgG-HRP

Secondary

Santa Cruz

N/A

Biotechnology;

1:2000 for
Anti-ActRIIA

sc-A1111

* Purified mouse monoclonal Anti-Smad2/3 was raised against mouse Smad2 amino
acid 142 – 263. There is a possibility that due to high sequence conservation between
Smad2 and Smad3, this antibody could also detect Smad3 protein. Previous use of
this antibody in experiments involving X. laevis (Faure et al., 2000; Schohl &
Fagotto, 2002) addressed detection of Smad2 only, not Smad3. Moreover, in
mesendoderm specification in X. laevis, Smad3 plays a lesser role. Due to these
reasons, I will refer to the protein detected by this antibody in E. coqui as Smad2.
** Due to the similar sequence conservation issue, the rabbit polyclonal antiPhospho-Smad2 (Ser465/467) antibody may also detect the equivalent
phosphorylated sites in Smad3. Due to the reasons as stated above, my western blot
experiments in E. coqui involving anti-Phospho-Smad2 antibody will address the
detection of PSmad2 only, not PSmad3.
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CHAPTER THREE: RESULTS
I. Cloning the EcSmad2 gene:
The protein encoded by the Smad gene belongs to the SMAD family of proteins,
similar to the gene products of the D. melanogaster gene 'mothers against
decapentaplegic' (Mad) and the C. elegans gene Sma. Smad2, the essential signal
transducer of Nodal-signaling pathway in vertebrate embryonic development, has been
cloned in several vertebrate species as well as in D. melanogaster and C. elegans.
Cloning EcSmad2 would help to understand the spatial and temporal activation of Nodal
signaling. Two isoforms of X. laevis Smad2 are present, playing a crucial role in
transducing Nodal related TGF- signals into the nucleus to specify endodermal and
mesodermal fates (Faure et al., 2000). Smad2exon3, a shorter alternatively spliced
variant of Smad2 differs from the full length Smad2 functionally (Dennler et al., 1998;
Labbé et al., 1998; Yagi et al., 1999). I have successfully cloned both the full length ORF
of EcSmad2 and the EcSmad2∆exon3 splice variant along with their 5‟-and 3‟-UTRs.

A. Degenerate PCR:
Alignment of Smad2 sequences revealed a high degree of conservation among
vertebrate species. Based on this, the size of EcSmad2 ORF was predicted to be ~1400
bp. To clone the Smad2 gene from E. coqui, several degenerate PCR primer sets were
designed based on a comparison of the Smad2 cDNA sequences of X. laevis, mouse and
human. A series of degenerate PCRs were done on the E. coqui TS3 cDNA templates to
generate fragments of EcSmad2.
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Among the five initial reactions, only two, reaction#4: EcSmad2-F2-EcSmad2R1, and reaction#5: EcSmad2-F3- EcSmad2-R1, gave results. Both the products were
towards the 3‟end of the ORF. The EcSmad2-F2-EcSmad2-R1 band size was ~1100 bp,
whereas EcSmad2-F3- EcSmad2-R1 was ~750 bp (Fig. 10). Surprisingly, in both cases,
doublets of bands were found indicating the presence of both isoforms as seen in other
vertebrate species (Fig. 10). As the product obtained in reaction#4 was bigger than that of
reaction#5, further experiments were performed on those ~1100 bp bands. Cloning and
sequence analysis using NCBI BLAST program confirmed the presence of Smad2
sequences in those clones.

B. Cloning the 3’UTR:
The 3‟UTR region of EcSmad2 was cloned using PCR on Custom SMARTTM E.
coqui ovarian cDNA Library in TriplEx2TM (Clontech, Cat # CS1023u) as described in
VII.B (Fig. 8) of Materials and Methods. Two vector specific primers, 5‟ pTriplEx2 Seq
Pri (forward) and 3‟ pTriplEx2 Seq Pri (reverse), flanking the Multiple Cloning Site
(MCS) were separately used in combination with an exact EcSmad2 forward, EcSmad2F18 designed on the basis of the known sequence. Product was obtained from reaction
with EcSmad2-F18 and 3‟ pTriplEx2 Seq Pri. Sequencing of the amplified PCR product
revealed the presence of 205 bps after the stop codon “TAA” and ending with a poly(A)tail. Clustal W analysis of the deduced EcSmad2 ORF sequence along with the 3‟UTR
revealed 85% and 82% sequence homology with that of X. laevis and X. tropicalis
respectively (Table 8). The fragment also had a polyadenylation signal “AATAAA”,
which marks the cleavage site for the RNA transcript ~30 bp past the signal (Fig 11).
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Fig. 10: PCR fragments of EcSmad2 full length ORF and EcSmad2∆exon3 splice
variant. Lane#1 is the 1Kb plus DNA ladder (usb), Lane#2 shows bands obtained for
two isoforms from the EcSmad2-F2-EcSmad2-R1 reaction. In Lane#3 are the two
products from EcSmad2-F3- EcSmad2-R1 reaction. Lane#4 is the negative control (- ve),
where dIH2O was used instead of a DNA template.
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Fig. 10:
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Fig. 11: Incomplete nucleotide sequence of EcSmad2 ORF along with full 3’UTR.
Section with yellow background () represents the portion of the ORF starting at ~300
bp from the 5‟ start site and ending in the stop codon TAA (). The grey section after
the stop codon represents the 3‟UTR of the gene, which contains the polyadenylation
signal “AATAAA” () and ends with poly(A)-tail ().
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Fig 11:
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In case of the EcSmad2, I found poly-adenylation site present 13 bp after the signal
sequence in the 3‟UTR. The sequence present after poly(A)-tail was of unknown identity.

C. Cloning the 5’UTR and 5’-end of the ORF:
A 5‟RACE PCR kit was used to amplify the initial missing segment of the
EcSmad2 ORF along with the 5‟UTR, following the manufacturer‟s (Invitrogen)
instructions. Two gene specific exact reverse primers - EcSmad2-RP16 GSP1 and
EcSmad2-RP17 GSP2 were designed (Fig. 9). The RACE specific forward primers were
provided with the kit. The primers were used on cDNA templates prepared from E. coqui
TS3 embryos. The PCR product obtained was gel purified, cloned, and sequenced. An
initial round of sequencing revealed the presence of 155 bp of 5‟UTR along with the rest
of the ORF, starting from 5‟ start site “ATG”. The compiled sequence of the full length
ORF along with its 5‟ and 3‟-UTRs is shown in Fig. 12. Two new exact primers,
EcSmad2-RP16 GSP3 and EcSmad2-RP17 GSP4, were designed to use in PCRs to
screen transformant clones for EcSmad2.
Once the full length ORF sequence was deduced, two more primers (Table 1)
were designed to PCR amplify the full ORF from TS3 cDNA template in order to clone
and make freezer stocks. Both isoforms were recovered by cutting the gel, and they were
separately cloned. Sequencing revealed the length of the full ORF to be 1404 bp. ApE
2.0.44 software was used to generate a peptide sequence of 467 amino acids with a
predicted molecular weight of 52.4 kDa. The splice variant, EcSmad2∆exon3, was
recovered using the same primer set, and it had an ORF of 1314 bp. The predicted
peptide was 437 amino acids, and the estimated molecular weight was 49 kDa.
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Fig. 12: Full EcSmad2 ORF along with its 5’ and 3’-UTR. The first starting segment
with BLUE background () represents the 5‟UTR. An ATG start codon () initiates the
ORF (), which ends with the TAA stop codon (). () represents the 3‟UTR which
ends in poly(A)-tail (). A polyadenylation signal “AATAAA” () lies inside the
3‟UTR.
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Alignment of the two amino acid sequences is shown in Fig. 13, which also
indicates the position of 90 bp exon 3. Two clones for each isoform (clone B and K for
the full length form and clone 2 and 3 for the splice variant) were used to make freezer
stocks and stored at – 800C. Alignment of EcSmad2 coding sequences along with its 3‟
and 5‟UTR showed 85% and 82% sequence conservation with those of X. laevis and X.
tropicalis by Clustal W analysis (Table 5). When the full length EcSmad2 ORF
nucleotide (Table 6) sequences were aligned with those of X. laevis and X. tropicalis,
mice and human using Clustal W, the result showed 86% nucleotide identity shared
among the three frogs. EcSmad2 nucleotide sequence was also 82% identical to that of
both human and mice. The EcSmad2 predicted protein sequence alignment with Smad2
of different organisms revealed 99% conservation with those of X. laevis and X.
tropicalis, and 98% with those of human, chicken and mouse (Table 7). Based on the
cloning results, a schematic comparison of both isoforms of EcSmad2 is shown in Fig.
14. The 99% conservation of Smad2 full-length peptide sequence among E. coqui, X.
laevis and X. tropicalis is shown in Fig. 15. It shows the positions of the conserved MH1
and MH2 domains. The C-terminal S465 and S467, phosphorylation of which are essential
for activation of Smad2 under the influence of Nodal-signaling, are conserved among all
three frogs.
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Table 5: Clustal W alignments of the Smad2 ORF along with 3’ and 5’UTRs from
E. coqui, X. laevis and X. tropicalis.

Table 6: Clustal W alignments of Smad2 ORF sequences from E. coqui and other
vertebrates.

Table 7: Clustal W alignments of Smad2 predicted peptide sequences from E. coqui
and other vertebrates.
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Table 5:
SeqA
Name
Len(nt) SeqB
Name
Len(nt) Score
===========================================================
1
E_coqui
1520
2
X_laevis
1454
85
1
E_coqui
1520
3
X_tropicalis
1861
82
2
X_laevis
1454
3
X_tropicalis
1861
94
===========================================================
Table 6:
SeqA
Name
Len(nt) SeqB
Name
Len(nt) Score
===========================================================
1
H_sapiens
1404
2
M_musculus
1404
92
1
H_sapiens
1404
3
X_tropicalis
1394
83
1
H_sapiens
1404
4
X_laevis
1404
83
1
H_sapiens
1404
5
E_coqui
1404
82
2
M_musculus
1404
3
X_tropicalis
1394
83
2
M_musculus
1404
4
X_laevis
1404
82
2
M_musculus
1404
5
E_coqui
1404
82
3
X_tropicalis 1394
4
X_laevis
1404
95
3
X_tropicalis 1394
5
E_coqui
1404
86
4
X_laevis
1404
5
E_coqui
1404
86
===========================================================
Table 7:
SeqA Name
Len(aa)
SeqB
Name
Len(aa) Score
===========================================================
1
E_coqui
467
2
G_gallus
467
98
1
E_coqui
467
3
H_sapiens
467
98
1
E_coqui
467
4
M_musculus
467
98
1
E_coqui
467
5
X_tropicalis
467
99
1
E_coqui
467
6
X_laevis
467
99
2
G_gallus
467
3
H_sapiens
467
99
2
G_gallus
467
4
M_musculus
467
98
2
G_gallus
467
5
X_tropicalis
467
98
2
G_gallus
467
6
X_laevis
467
98
3
H_sapiens
467
4
M_musculus
467
99
3
H_sapiens
467
5
X_tropicalis
467
98
3
H_sapiens
467
6
X_laevis
467
98
4
M_musculus
467
5
X_tropicalis
467
98
4
M_musculus
467
6
X_laevis
467
97
5
X_tropicalis 467
6
X_laevis
467
99
==========================================================
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Fig. 13: Predicted protein sequences of the two Smad2 isoforms. (A) Predicted amino
acid sequences of the full-length ORF (clone B), and (B) Smad2exon3 splice variant
(clone 3) from their nucleotide sequences using ApE software. (C) Clustal W alignment
of the two protein sequences showing the position of exon 3 (highlighted with yellow).
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Fig 14: Comparison of ORFs of EcSmad2 and its splice variant EcSmad2exon3.
The lengths of the full length and the splice variant isoforms are 1404 bp and 1314 bp,
respectively. The highly conserved MH1 and MH2 domains are separated by the less
conserved linker region (light green box). The EcSmad2exon3 ORF is lacking exon 3
(orange box) due to alternative splicing.
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Fig. 15: Conservation of Smad2 predicted peptide sequences from E. coqui, X.
tropicalis and X. laevis. The first box with red boundary and yellow background, shows
the complete conservation of the MH1 domain except for four amino acids. The MH1
domain contains exon 3 (blue background). This segment of amino acids is followed by a
linker region, which is 100% conserved among the three species. Finally, the last segment
of amino acids in the second box, with red boundary and yellow background, represents
the MH2 domain, which is also 100% conserved among all three frogs. At the end of
MH2 domain, there are two serine residues, S465 and S467, phosphorylation of which are
essential for activation of Smad2.

108
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II. Establishing temporal and spatial expression patterns for EcSmad2 in E. coqui
early embryo:
It was important to find out whether EcSmad2 RNA is maternally contributed,
whether it is expressed throughout all the early developmental stages, and whether
expression is spatially restricted, such as to DE only. Based on my original hypothesis, it
was possible that EcSmad2 expression is spatially restricted to the MZ, which forms the
DE. This idea was based on the fact that NE does not differentiate into any adult organs;
it just provides nutrient to the growing embryos. Altogether, it was helpful to generate a
complete profile of temporal and spatial regulation of EcSmad2 gene expression.
The technique that I used for detecting EcSmad2 expression was Ct method of
Real-Time PCR (qPCR), a more quantitative method than RT-PCR. I designed EcSmad2
specific primers (EcSmad2-qPCR FP1 and EcSmad2-qPCR RP1, Table 5) in the
EcSmad2 ORF. qPCR was performed on RNAs isolated from eggs as well as from
different early embryonic stages like pre-gastrulation stage NF8, gastrulation stage NF10
and different post-gastrulation stages from TS3 to TS8. The ribosomal protein-coding
gene EcL8, was previously shown to be expressed in both the MZ (or DE) and VC (or
NE) tissues (Ninomiya et al., 2001), so it was chosen as an endogenous control. EcL8
specific primers (EcL8-F4 and EcL8-R5, Table 5) were used in each experiment. Each
qPCR experiment for temporal or spatial expression was performed three times
independently with RNAs from different sources, and the overall results are discussed
below.

A. Temporal Expression:
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To detect temporal expression, I used RNAs isolated from whole embryos at each
stage denoted as specific stage followed by “W”. I made cDNAs using each RNA extract
as template, and performed qPCR with them. Stages used in these experiments were:
oocyte, NF8W, NF10W, TS3W, TS4W, TS5W, TS6W, TS7W and TS8W. The RQ value
for oocyte was set to one, and the RQ values for other stages were expressed relative to
oocyte. My results revealed a strong maternal contribution of EcSmad2 transcript (Fig.
16). EcSmad2 expression stays high at NF8 and NF10, followed by sharp decline in postgastrulation stages.

B. Spatial Expression:
For spatial expression, RNAs were isolated from dissected embryonic tissues
from each stage. For NF8 and NF10, RNAs were made from dissected MZ and VC
tissues, as shown in Fig. 6 (denoted as specific stage followed by “MZ” or “VC”). For
post-gastrulation stages from TS3 to TS8, the dissected tissues were denoted by the stage
followed by “E” for embryo or “NE” for nutritional endoderm. After gastrulation, the
embryos (E) have differentiated, and the NE has been formed from VC cells. The qPCR
was performed with cDNAs as described before. The RQ values of MZ or E from each
stage were set as one, and the RQ values for VC or NE are expressed relative to MZ or E.
My results indicate higher relative expression of EcSmad2 in VC tissues at both NF8 and
NF10 (Fig. 17). This pattern changes after gastrulation is complete. In all postgastrulation stages, a relatively lower level of EcSmad2 RNA expression is present in
NE.
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Fig. 16: Temporal expression of EcSmad2. The Ct method of qPCR was used to
establish the temporal expression pattern. Relative expression (RQ) at the oocyte stage
was set to 1 to serve as reference, and the corresponding RQ values of all other stages are
plotted relative to oocyte. EcL8, a ribosomal protein-coding gene was used as an
endogenous control. Each green bar represents the mean of 3 independent experiments.
Error bars show the standard deviations.
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Fig. 17: Spatial expression of EcSmad2. The pattern of EcSmad2 expression was
established by the Ct method of qPCR. Relative expression (RQ) of either MZ or E
from each stage was set to 1 (red bars) to serve as a reference for the corresponding RQ
values of the VC or NE samples (blue bars). EcL8 serves as an endogenous control. Mean
values of 3 independent experiments are used in the figure. The NF8 and NF10 stages
showed higher levels of EcSmad2 expression in VC, the prospective nutritional
endodermal tissues. All the post-gastrulation stages tested showed comparatively lower
levels of EcSmad2 expression in nutritional endoderm.

114

Fig. 17:

115

III. Phospho-EcSmad2, EcSmad4 and ActRIIA in the prospective DE vs.
prospective NE:
Nodal signaling leads to the phosphorylation of Smad2, which in turn binds with
its partner Smad4 (Kumar et al., 2001; Lee et al., 2001; Yeo and Whitman, 2001; Ross
and Hill, 2008). Nuclear translocation of this protein complex is an essential event
leading to the specification of endoderm and mesoderm in early embryonic development
(Lee et al., 2001; Yeo and Whitman, 2001; Ross and Hill, 2008). Although the qPCR
results provide information for the presence of EcSmad2 RNA in the prospective
nutritional endoderm tissues of early embryonic stages, it was important to look at the
expression of the native and active forms of Smad2 protein. A cell could express RNA,
but the RNA could get degraded or the translation into its protein product or the
activation of such protein could be blocked due to some regulatory mechanism. To shed
light into the reason behind the absence of differentiation for NE, detection of both native
and active forms of EcSmad2 becomes critical. Detection of native vs. PSmad2 in the
prospective DE vs. prospective NE of early embryos was accomplished by western blot
analysis using anti-Smad2/3 and anti-PSmad2 antibodies.
Before western blot analysis, the first major step was to standardize a technique to
isolate protein samples from E. coqui embryos, which are packed with yolk platelets.
Obtaining a standard high quality of protein preparation was a long process, which
involved painstaking efforts. Sixteen different recipes of homogenization buffers (HB) in
total were tested to isolate a sample of high quality, which looked acceptable on a SDSPAGE gel. It began with HB1 (Table 7), which was based on a recipe mentioned in
Birsoy et al. (2005) to isolate protein samples from X. laevis embryos. As the physical
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characteristics and chemical composition of E. coqui embryos are widely different from
those of X. laevis embryos, HB1 failed to produce a satisfactory protein sample (Fig. 18).
Following several modifications of that original recipe, I ended up with HB16, which
produced a protein sample that looked acceptable on a gel stained with CBB. Fig. 18
shows gels, where the protein samples were prepared using four of the HB recipes. Once
the protein isolation technique was standardized, Western blot analysis was executed
using two antibodies – anti-Smad2/3 and anti-PSmad2 to detect the level of expression of
native and active Smad2, respectively.
For the purpose of western analysis, the concentration of all protein samples was
determined by the BCA method, and equal amounts were loaded in all lanes of a gel. In
all experiments, one gel was run with the protein samples to check protein quality by
CBB staining.

A. Detection of Smad2 and PSmad2:
The antibodies used for the experiments were purified mouse monoclonal antiSmad2/3 (BD Transduction Laboratories; 610842) and rabbit polyclonal PSmad2
(Ser465/467) antibody (Cell Signaling; #3101) against native and the active
phosphorylated forms of Smad2 protein, respectively. Although anti-Smad2/3 antibody
was raised against mouse Smad2 amino acids 142 – 263, it was used successfully to
detect X. laevis Smad2 protein on a western blot (Faure et al., 2000; Birsoy et al., 2005).
The PSmad2 (Ser465/467) antibody was raised against a synthetic phospho-peptide
(KLH-coupled), and detected endogenous levels of Smad2 only when dually
phosphorylated at Ser465 and Ser467. This antibody was also successfully used on

117

Fig. 18: SDS-PAGE of proteins isolated with different homogenization buffers. (A)
HB1: protein preparations were done using the HB1 recipe. Lane#1 – molecular weight
(MW) markers; Lane#2 – protein preparation from Xenopus laevis embryos. Twenty NF8
embryos were homogenized in 200 l of HB1; Lanes A-D – four protein preparations
from E. coqui NF8, NF10, TS3 and TS4 embryos. The same numbers of embryos were
homogenized in equal volumes of HB1 (see Materials and Methods). (B) HB11: Lane#1
– MW markers; Lane#2 – protein preparation from X. laevis NF8 embryos; Lanes A-D –
four protein preparations from E. coqui NF8, NF10, TS3 and TS4 embryos, homogenized
in equal volumes of HB11. (C) HB14: Lane#1 – MW markers; Lanes#2-4 – three
individual protein preparations from E. coqui whole NF8 embryos (NF8W) and of
dissected MZ and VC tissues (NF8MZ and NF8VC) made in HB14. (D) HB16: Lane#1 –
MW markers; lanes#2-4 – a different set of protein preparations from whole and
dissected MZ and VC tissues (NF8W, NF8MZ and NF8VC) made in HB16.
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protein samples prepared from X. laevis embryos (Faure et al., 2000; Birsoy et al., 2005).
Based on my sequencing, the predicted EcSmad2 peptide sequence is a 99% match with
those of X. laevis and X. tropicalis. Therefore there was a high chance that these would
also work on the E. coqui protein samples on western blot.
The temporal expression of both the native and the active forms of EcSmad2 was
detected in protein preparations made from oocytes and embryos at stages NF10, TS3,
TS5 and TS7 (Fig 19). Both forms of EcSmad2 were present in all the stages tested.
Moreover, the antibodies detected both isoforms of EcSmad2. Band intensity increased as
the stages advanced (Fig. 19).
To detect the levels of native and PSmad2 in the prospective DE vs. prospective
NE, western blotting was performed on protein preparations from dissected tissues. Fig.
20A shows the western blot for post-gastrulation stages. Native as well as active forms of
Smad2 were detected in both embryonic and NE tissues. Levels of expressions in NE for
both forms of the protein were lower than those in embryos. Fig. 20B represents a
separate experiment, where the gastrulation stage NF10 and post-gastrulation stages TS3,
TS5 and TS7 were compared. Both Smad2 and PSmad2 were detected in VC at NF10.
Three independent experiments with protein samples prepared from different clutches of
embryos at NF10 showed similar results, with the presence of both native and active
forms of EcSmad2 in VC tissues.

B. Detection of Smad4:
NE does not differentiate into any adult tissue. Based on my Smad2 western
analysis, both native and active forms of Smad2 are present in VC cells of the embryo.
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Therefore it was necessary to look at the expression level of Smad4, the partner of
PSmad2 in nuclear translocation of the protein complex (Kumar et al., 2001; Lee et al.,
2001; Yeo and Whitman, 2001; Ross and Hill, 2008).
Although the EcSmad4 gene has not been cloned, several commercial antibodies
against Smad4 were available. One antibody was rabbit anti-Smad4 polyclonal antibody
(Thermo Scientific; PA1-41292), which was raised against synthetic peptides
corresponding to amino acid 186 – 199 and 509 – 523 of human Smad4. To my
knowledge, this antibody has never been reported to be used for any frog samples, but
based on sequence conservation of the immunogen it was predicted to cross react with X.
laevis. There are two isoforms of Smad4,  and , present in X. laevis (LeSueus and
Graff, 1999; Masuyama et al., 1999; Howell et al., 1999; Hill, 2001). X. laevis Smad4
sequence revealed that Smad4 is larger than that of Smad4. The predicted molecular
weights for X. laevis Smad4 and Smad4 are 60.0 and 61.3 kDa, respectively.
Based on my experience with EcSmad2 and its sequence conservation with that of
X. laevis, I used this antibody against E. coqui protein samples. The EcSmad4 western
results are shown in Fig. 21. Anti-Smad4 polyclonal antibody detected two Smad4
isoforms. My western results, both temporal (Fig. 21A) and spatial (Fig. 21B), indicated
the presence of two bands around 60 kDa. The bigger band (tentatively, Smad4) showed
a higher level of expression compared to the smaller isoform (tentatively Smad4).

C. Detection of ActRIIA:
Activin RIIA is one of the important Nodal receptors, which plays essential role
in the signaling pathway for endoderm-mesoderm specification in X. laevis (Reissman et
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al., 2001; Yeo and Whitman 2001). Goat anti-human Activin RIIA antibody (R&D
Systems, Inc.; AF340), raised against the recombinant human Activin RIIA (rhActivin
RIIA) extracellular domain, is predicted to show less than 2% cross-reactivity with
rhActivin RIIB or any other activin receptor. This antibody has been used successfully to
detect the endogenous levels of the X. laevis homolog on a western blot (Martello et al.,
2007). The predicted molecular weight of rhActivin RIIA is 58 kDa and that of the X.
laevis homolog was 57.9 kDa (Xenbase: XB-GENE-865037), but Martello et al. (2007)
did not provide any size information on their western. I made several attempts to use this
antibody on westerns of E. coqui embryos, (Fig. 22). These always produced a prominent
band around 50 kDa, instead of 60 kDa. In the absence of EcActRIIA sequence data, I
decided not to proceed further.

IV. Cellular location of PSmad2, Smad4 and receptor ActRIIA in prospective DE
vs. prospective NE:
Western blots with antibodies against Smad2, PSmad2, and Smad4 not only detected the
presence of the respective proteins in all the stages of E. coqui development tested, they
also indicated the presence of these TGF- pathway components in both VC and NE.
This data led me to investigate the cellular locations of these proteins. Given that PSmad2
was present in the VC of NF10 embryos (Fig. 20), it was important to see whether the
active protein is nuclear or not. Immunostaining experiments were carried out on
dissociated MZ and VC cells from NF10 embryos. For each of the experiments, separate
sets of cells were treated with “no primary antibody, only secondary antibody” and “no
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Fig. 19: Native and active forms of EcSmad2 in E. coqui development. Western blot
of proteins isolated from E. coqui oocyte, NF10, TS3, TS5 and TS7. Whole embryos or
oocytes were used to extract proteins. The amount of protein loaded in all the lanes was
75 g. The top panel shows anti-Alpha Tubulin antibody staining, which served as a
loading control. The middle panel represents expression of native EcSmad2 detected by
purified mouse monoclonal anti-Smad2/3 (BD Transduction). The bottom panel shows
the presence of active PSmad2 detected by rabbit polyclonal PSmad2 (Ser465/467)
Antibody (Cell Signaling) in all stages tested. There was a general trend of increased
band intensity as the development advanced. The experiment was performed three times
with three independently prepared protein samples from different embryo clutches.
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Fig. 20: Spatial expression of Smad2 and PSmad2 in E. coqui development. (A)
Western blot of dissected embryo (E) and NE tissues from post-gastrulation stages – TS3
to TS7. The left panel represents expression of native EcSmad2 detected by purified
mouse monoclonal anti-Smad2/3 (BD Transduction). Right panel shows detection of
active PSmad2 by rabbit polyclonal PSmad2 (Ser465/467) antibody (Cell Signaling).
There are lower levels of Smad2 and PSmad2 in NE compared to E. (B) Western blot of
dissected MZ and VC from gastrulation stage NF10 and E and NE from post-gastrulation
stages – TS3, TS5 and TS7. The top panel shows the anti-Alpha Tubulin antibody
staining serving as a loading control. Middle panel represents expression of native
EcSmad2 detected by purified mouse monoclonal anti-Smad2/3 (BD Transduction). The
bottom panel shows the presence of active PSmad2 being detected by rabbit polyclonal
PSmad2 (Ser465/467) Antibody (Cell Signaling) in all stages tested. There was almost an
equal amount of Smad2 and PSmad2 in MZ and VC from NF10. Spatial expression
experiments were performed three times with three independently prepared protein
samples from different embryo clutches. Amount of protein loaded in all the lanes was
100 g.
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Fig. 20:
(A)

(B)
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Fig. 21: Western blot of EcSmad4. (A) Temporal expression of EcSmad4 isoforms in
E. coqui. Top panel: -Tubulin was used as a loading control for the experiment.
Bottom panel: Two isoforms of EcSmad4 were detected (red arrow). 100 ug of whole
protein preparations from 3 stages were run and probed with polyclonal rabbit antiSmad4 antibody (Thermo Scientific). (B) Spatial expression of EcSmad4 isoforms in
E. coqui. 100 μg of protein from NF10 whole embryos W, VC and MZ were run and
probed with polyclonal rabbit anti-Smad4 antibody (Thermo Scientific). Two bands
represent the two isoforms of the EcSmad4 protein (red arrow). Based on X. laevis
sequence data, the band with higher molecular weight (MW) is tentatively Smad4 and
the band with lower MW is tentatively Smad4. For both temporal and spatial analysis
purpose, each experiment was run three times with independently isolated protein
extracts from different embryo clutches.
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Fig. 22: Western blot of ActRIIA. An Anti -ActRIIA antibody (Goat Anti-human
Activin RIIA Antibody; R&D Systems) was tested on Western blots. (a) Alpha Tubulin
band at 56 kDa serving as a loading control for the experiment. (b) Although the
predicted size of ActRIIA in human and X. laevis is 58 – 60 kDa, this anti-ActRIIA
antibody detected a band around 50 kDa in E. coqui. 100 ug of whole protein
preparations from three stages were run and probed with the antibody. Each experiment
was run three times with independently isolated protein extracts from different embryo
clutches. (M is the protein marker lane)
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secondary antibody, only primary antibody”, which served as negative controls with no
signal being detected. Each experiment was repeated at least twice. In case of VC or NE,
there were many anuclear cells, so only cells with single or multiple nuclei were scored.

A. Immunostaining for PSmad2:
During late blastula and early gastrula, 100% of the prospective DE cells from
MZ show PSmad2 nuclear localization, but only 12% of VC cells have nuclear
localization (Table 8, Fig. 23). The rest had a scattered cytoplasmic signal.

B. Immunostaining for Smad4:
Smad4 nuclear localization was evident in cells of both MZ and VC. About 50%
of VC cells were positive for nuclear localization of Smad4, whereas 100% of the MZ
cells were positive (Table 8, Fig. 24). There are two isoforms of Smad4,  and ,
reported in X. laevis. The antibody used in immunostaining experiments was the same
one used in western blotting, where it detected two bands at predicted molecular sizes.
There was no way to know whether the nuclear Smad4 was , or .

C. Immunostaining for ActRIIA:
ActRIIA, a Nodal receptor, was found only in 17% of the VC cells and 20% of
MZ cells (Table 8, Fig. 25). In both types of cells, signal was observed on the surface of
the cells. This staining must be interpreted cautiously since the antibody may not have
detected a protein of the correct molecular weight on a western blot (Fig. 22).
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D. A second approach to detect nuclear accumulation of PSmad2:
So far, my immunostaining data strongly suggests that PSmad2 is absent from the
nuclei of VC cells, but almost half of the population was stained positive for Smad4.
Although Smad2-independent nuclear translocation of Smad4 has been reported (Bai et.
al. 2002), absence of PSmad2 in the nuclei of VC cells favors the idea of lack of Nodal
signaling in them. This lack could account for the lack of differentiation of the NE into
endodermal tissue. As an alternative approach to further confirm PSmad2
immunostaining data, I injected EGFP-Smad2 capped RNA into the vegetal half of the 832 cell stage E. coqui embryos.
The pCS105-EGFP-Smad2 construct was generated using X. laevis Smad2
sequence and has been used in experiments involving X. laevis (Skirkanich et al., 2011).
Six E. coqui embryos were kept as un-injected controls and six more embryos were
injected with only DEPC-H2O. For EGFP-Smad2 mRNA, first 900 pg and 100 pg in 9.2
nl were injected. Embryos were cultured until NF10, when they were dissected into MZ
and VC tissues. VC cells were dissociated, fixed and stained with anti-Green fluorescent
protein antibody (InvitrogenTM/ Molecular Probes; A11122) to detect nuclear localization
of the EGFP tagged PSmad2 proteins. Cells were co-stained with DAPI to locate the
nuclei. 100% of the VC cells showed nuclear location of EGFP overlapping with DAPI
(Fig. 26A), but the control embryos injected with DEPC-H2O failed to grow beyond
neural tube formation (TS3). Development of uninjected embryos was normal.
In a further trial, 10 pg in 9.2 nl was injected as a tracer level. Embryos survived
longer, but were developmentally looked behind those injected with DEPC-H2O. When
embryos injected with DEPC-H2O were at TS11, experimental embryos, injected with 10
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pg EGFP-Smad2 mRNA, looked like TS8 (Fig. 26B). This tracer level of injected mRNA
led to a nuclear EGFP signal in only 8% of the VC cells dissociated at NF10. One of
those VC cells is shown in Fig. 26C-E.

V. Determination of transcriptional status of VC cells:
The presence of both PSmad2 and Smad4 in VC cells but no differentiation to
adult tissues, leads to the question whether the VC cells are transcriptionally active.
Depending on the needs of a cell, RNAPII activity is determined by the phosphorylation
state of the CTD heptapeptide YSPTSPS (Corden, 1990; Phatnani and Greenleaf, 2006;
Venkatarama et al., 2010). According to the model shown in Fig. 4, there are four
phosphorylation states. The promoter regions are occupied normally by the
unphosphorylated RNAPII. Ser 5 phosphorylation initiates transcription and Ser 2
phosphorylation leads to elongation.
To determine the transcriptional status of the prospective NE cells, VC and MZ
cells were dissociated from embryos at NF8 and NF10 and NE cells were dissociated
from embryos after gastrulation. Cells were stained with antibodies against RNAPII
CTD-Ser 2 (H5), CTD-Ser 5 (H14) and unphosphorylated RNAPII large subunit
(8WG16) as a positive control. For each of the experiments, separate sets of cells were
treated with “no primary antibody, only secondary antibody” and “no secondary
antibody, only primary antibody”, which served as negative controls. No signals were
detected. Each experiment was repeated at least twice, and each time, a minimum of 50
cells was counted. In the case of VC or NE, anuclear cells were not considered.
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Table 8: Summary of immunostaining results with anti-PSmad2, anti-Smad4 and
anti-ActRIIA antibodies.
MZ Cells

VC Cells

100 % (N = 80)

12% (N = 150)

Nuclear Smad4

100% (N = 100)

50% (N = 150)

ActRIIA

20% (N = 100)

17% (N = 100)

Nuclear Psmad2
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Fig. 23: Nuclear localization of PSmad2 in MZ cells but not VC cells in E. coqui
NF10 embryos. Dissociated cells isolated from dissected MZ and VC tissues were
stained with DAPI (b, e, h, and k) to show the position of nuclei. The same cells were
stained with rabbit polyclonal anti-PSmad2 (Ser465/467) antibody (Cell Signaling,
#3101) to detect nuclear localization of PSmad2 (c, f, i, and l). a, d, g, and j represent
bright field (BF) images of the same fields. All MZ cells showed nuclear signal for
PSmad2 overlapping their respective DAPI signals, whereas most VC cell nuclei were
PSmad2 negative. Scale bar represents 1 µm.
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Fig. 24: Nuclear Smad4 signal in 50% of VC cells, but 100% of MZ cells at
gastrulation. Dissociated MZ and VC cells dissected from NF10 embryos were stained
with polyclonal rabbit anti-Smad4 antibody (Thermo Scientific, #PA1-41292) (c, f, i, l
and o) and counter-stained with DAPI (b, e, h, k and n). a, d, g, j and m represents bright
field (BF) images of the same fields. Scale bar represents 5 µm.
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Fig. 25: Positive ActRIIA signal in 17% of the VC cells and 20% of MZ cells at
gastrulation. Dissociated MZ and VC cells dissected from NF10 embryo were stained
with polyclonal goat anti-human Activin RIIA antibody (R&D, #AF340) (c, f, i, and l)
and counter-stained with DAPI (b, e, h, and k). a, d, g, and j represents bright field (BF)
images of the same fields. Scale bar represents 5 µm.
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Fig. 26: Nuclear localization of EGFP-Smad2 in VC cells at NF10. (A) E. coqui
embryos were injected with 900 and 100 pg EGFP-Smad2 capped RNA at 8-32 cell
stage. Although, 100% of the VC cells dissociated from NF10 embryos showed nuclear
accumulation of the EGFP signal, none of the control embryos grew beyond neural tube
formation. (B) E. coqui embryos were injected with 10 pg EGFP-Smad2 capped RNA at
8-32 cell stage. Embryos were grown until NF10, when they were dissected and
dissociated. Six uninjected embryos and six embryos injected with 9.2 nl DECP-H2O
were used as control. When embryos injected with DECP-H2O reached TS11, embryos
injected with 10 pg EGFP-Smad2 RNA were developmentally behind, at around stage
TS8 and did not survive beyond this point. Dissociated VC cells from NF10 injected
embryos were fixed and stained. (C) represents a bright field (BF) image of one of the
dissociated VC cell isolated from dissected VC tissues at NF10. VC cells were stained
with DAPI to show the position of nuclei (D) to show the position of nuclei. The same
cells were stained with anti-Green fluorescent protein antibody (InvitrogenTM/ Molecular
Probes; A11122) to detect nuclear localization of EGFP-Smad2. (E) represents one of 8%
of VC cell nuclei, which were EGFP positive. No MZ cells showed nuclear signal for
EGFP-Smad2. Scale bar represents 5 µm.
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Fig. 26:
(A)
Volume injected

Concentration
injected

Nuclear EGFP
signal

9.2 nl

900 pg

100% (N = 150)

9.2 nl

100 pg

100% (N = 150)

9.2 nl

10 pg

8% (N = 200)
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At NF8, both MZ and VC cells were positive for unphosphorylated RNA Pol II
CTD (8WG16), but failed to show any signal for transcription initiation (H14) or
transcription elongation (H5) (Table. 9, Fig. 27). At NF10, MZ and VC cells both showed
positive signals for H14 antibody indicating the occurrence of transcription initiation. MZ
cells, but not VC cells, were positive for H5, which marked transcription elongation
(Table. 9, Fig. 28). This indicates that MZ cells were transcriptionally active, whereas VC
cells were not.
At advanced post gastrulation stages, the embryo was already formed. It was hard
to dissociate individual cells from the rigid embryo tissues. For all post-gastrulation
stages, undissociated embryonic tissues were stained and were positive for all three
antibodies used (not shown). NE cells dissociated from TS3 embryos were positive for
8WG16, but showed very faint or no signal for either H14 or H5, indicating a
transcriptionally repressed state (Fig. 29). Similar signaling data was obtained for NE
cells dissociated from all advanced stages including TS8 (Fig. 30), TS11 (Fig. 31) and
TS14 (Fig. 32). These results suggest a global transcriptional suppression for nutritional
endodermal cell throughout development. A summary of the 8WG16, H14 and H5
immunostaining results on cells from all the stages are represented in Table. 9.
X. laevis fertilization is followed by 12 rapid, synchronous cleavage divisions,
which leads to the formation of blastula (Heasman, 2006). After the twelfth division, the
cell cycle shows asynchronous divisions and the appearance of gap phases. This change
in the cell cycle is referred to as MBT, a critical event, which marks the onset of
embryonic gene expression (Gerhart, 1980; Heasman, 2006). In E. coqui, MZ cells were
transcriptionally active at gastrulation (NF10) (Fig. 28) and remained active post-
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gastrulation at TS3, TS8, TS11 and TS14. This was the first evidence for MBT in E.
coqui and suggested that it occurred between NF8 and NF10. Unlike MZ, VC cells did
not become transcriptionally active, before or after gastrulation.
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Fig. 27: Neither transcription initiation nor elongation occurred in MZ and VC at
NF8. Nuclei of both MZ and VC cells dissociated from NF8 were positive for
unphosphorylated RNA Pol II large subunit. MZ and VC cells were stained with
monoclonal mouse 8WG16 antibody (Covance, #MMS-126R) (c, f) and counter-stained
with DAPI (b, e). a and d represent bright field (BF) images of the same fields. 8WG16
recognized unphosphorylated RNA Pol II large subunit and served as a positive control.
MZ and VC cells were stained with monoclonal mouse H14 antibody (Covance, #MMS134R) (i, l) and counter-stained with DAPI (h, k). g and j represent BF images of the
same fields. H14 recognized phosphoserine-5 version of RNA Pol II, which indicated
transcription initiation. Neither MZ nor VC nuclei were stained with H14. MZ and VC
cells were stained with monoclonal mouse H5 antibody (Covance, #MMS-129R) (o, r)
and counter-stained with DAPI (n, q). m and p represent bright field (BF) images of the
same fields. H5 recognized phosphoserine-2 version of RNA Pol II, which is the mark for
transcriptional elongation. Neither VC nor MZ nuclei stained with H5. Scale bar
represents 5 µm.
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Fig. 28: Both MZ and VC initiated transcription at NF10, but transcription
elongation occurred only in MZ. MZ and VC cells dissociated from NF10 embryos
were stained with monoclonal mouse 8WG16 antibody (Covance, #MMS-126R) (c, f)
and counter-stained with DAPI (b, e). a and d represents bright field (BF) images of the
same fields. Nuclei of both cell types were positive for 8WG16. MZ and VC cells were
stained with monoclonal mouse H14 antibody (Covance, #MMS-134R) (i, l) and counterstained with DAPI (h, k). g and j represents bright field (BF) images of the same fields.
Nuclei of both MZ and VC cells were positively stained for H14 antibody. Both types of
cells were stained with monoclonal mouse H5 antibody (Covance, #MMS-129R) (o, r)
and counter-stained with DAPI (n, q). m and p represents bright field (BF) images of the
same fields. Only MZ, and not VC nuclei were positive for H5. Scale bar represents 5
µm.
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Fig. 29: NE cells from TS3 were positive for 8WG16, but showed weak or no signal
for initiation or elongation. NE cells dissociated from TS3 embryos were stained with
8WG16 (c) H14 (f) and H5 (i) antibodies and counter-stained with DAPI (b, e, and h). a,
d and g represent bright field (BF) images of the same fields. Nuclei of NE cells were
positive for 8WG16. Nuclear staining for both transcription initiation (H14) and
elongation (H5) were either very weak or not present. Scale bar represents 5 µm.

Fig. 30: NE cells from TS8 were positive for 8WG16, but showed weak or no signal
for initiation or elongation. NE cells dissociated from TS8 embryos were stained with
8WG16 (c) H14 (f) and H5 (i) antibodies and counter-stained with DAPI (b, e and h). a,
d and g represent bright field (BF) images of the same fields. Nuclei of NE cells were
positive for 8WG16. Nuclear staining for both transcription initiation (H14) and
elongation (H5) were either very weak or not present. Scale bar represents 5 µm.
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Fig. 31: TS11 NE cells were positive for 8WG16, but showed weak or no signal for
initiation or elongation. NE cells dissociated from TS11 embryos were stained with
8WG16 (c) H14 (f) and H5 (i) antibodies and counter-stained with DAPI (b, e and h). a,
d and g represents bright field (BF) images of the same fields. Nuclei of NE cells were
positive for 8WG16. Nuclear staining for both transcription initiation (H14) and
elongation (H5) were either very weak or not present. Scale bar represents 5 µm.

Fig. 32: TS14 NE cells were positive for 8WG16, but weak or no signal for initiation
or elongation. NE cells dissociated from TS14 embryos were stained with 8WG16 (c)
H14 (f) and H5 (i) antibodies and counter-stained with DAPI (b, e and h). a, d and g
represents bright field (BF) images of the same fields. Nuclei of NE cells were positive
for 8WG16. Nuclear staining for both transcription initiation (H14) and elongation (H5)
were either very weak or not present. Scale bar represents 5 µm.
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Fig. 31:

Fig. 32:
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Table 9. Summary of imunostaining with 8WG16, H14 and H5 on MZ and VC cells
from NF8 and NF10, and NE cells from TS3, TS8, TS11 and TS14.

8WG16 nuclear signal

H14 nuclear signal

H5 nuclear signal

Tissue

No.
of
cells

No

Faint

Strong

No.
of
cells

No

Faint

Strong

No.
of
cells

No

Faint

Strong

MZ

100

2

6

92

100

100

0

0

100

100

0

0

VC

200

10

7

183

150

150

0

0

150

150

0

0

MZ

80

0

3

77

150

0

6

144

150

0

2

148

VC

200

7

0

193

200

187

13

0

200

195

5

0

TS3

NE

200

2

18

180

200

194

6

0

200

191

8

0

TS8

NE

200

6

8

186

200

198

2

0

200

195

5

0

TS11

NE

200

2

2

196

200

189

11

0

200

195

5

0

TS14

NE

200

0

2

198

200

185

15

0

200

186

14

0

Stage

NF8

NF10
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CHAPTER FOUR: DISCUSSION

Activin and Nodal-related proteins of the TGF-β family of growth factors, which
initiate the Nodal-signaling pathway, play central roles in endoderm/mesoderm
specification in mouse, X. laevis, chick and zebrafish (Whitman, 2001; Shen 2007). In X.
laevis embryos, maternal VegT and Vg1 RNAs, localized in the vegetal blastomeres,
regulate expression of Nodal ligands (Joseph and Melton, 1998; Heasman, 2006; White
and Heasman, 2008). The whole vegetal half of X. laevis embryo initiates Nodalsignaling under the influence of maternal VegT expression (Zhang et al., 1998; Clements
et al., 1999; Kofron et al., 1999; Xanthos et al., 2001), and these cells became committed
to form the definitive endoderm. Maternal VegT also regulates expression of the
endoderm specific transcription factor Xsox17a directly (Howard et al., 2007). VegT
induced expression of Xsox17a at the midblastula transition is then maintained by Nodal
signals (Engleka et al., 2001).
Based on expression profiles of EcVegT and EcVg1 RNA (Beckham et al., 2003;
Pérez et al., 2007), it was hypothesized for E. coqui that the early embryonic VC cells,
which form the NE, would be devoid of the molecular determinants required for
endoderm/mesoderm specification (Ninomiya et al., 2001). Absence of EcVegT RNA and
mesoderm inducing activity in the VC of E. coqui embryos (Beckham et al., 2003;
Ninomiya et al., 2001) implied an absence of endoderm/ mesoderm inducing activities in
these cells. In contrast, Karadge (2012) indicated that VC cells from NF8 contained RNA
for Activin ligands like EcActivinB and EcDerriere. Moreover, their expressions were
upregulated at NF10, when gastrulation begins. Sun et al. (1999) reported that the VegT
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expression in X. laevis regulates Derriere expression in the vegetal half of the embryo.
One possible explanation for the finding in E. coqui is that the maternal supply of
EcDerriere in the early embryo was sufficient to autoregulate its zygotic expression in
VC cells at NF10 (Karadge, 2012). Karadge (2012) also suggested the presence of a weak
mesoderm inducing activity in VC cells rather than a total absence from the VC, as
reported by Ninomiya et al. (2001). The weak mesoderm inducing activity, which
appeared later than in the MZ cells, apparently did not commit VC cells to differentiate as
mesendoderm (Karadge, 2012).
For my work, I looked at the expression of Smad2, an essential transcription
factor of the Nodal-signaling pathway. I showed that EcSmad2 RNA is maternally
supplied, and the level remained high until end of gastrulation. Moreover, during pregastrulation and early gastrulation, EcSmad2 expression was greater in VC cells
compared to MZ cells. Not only the RNA, but also both native and the active forms of
EcSmad2 protein were expressed in VC and MZ cells. Immunostaining of NF10
embryos showed nuclear localization of PSmad2 in 100% of the MZ cells, whereas only
12% of VC cells were positive for nuclear PSmad2 signal. Nuclear Smad4 signal was
detected in 100% MZ cells, but in 50% of the VC cells at NF10. I have summarized the
similarities and differences between the early embryonic events in terms of Smad2 and
Smad4 expressions between the E. coqui and X. laevis in Table 9. Based on my western
and immunostaining results with EcSmad2 and EcSmad4 (Table 9), Nodal-signaling
differs substantially between X. laevis and E. coqui VC cells.
I also investigated the nature of the VC with respect to its transcriptional activity,
which led to a further understanding of why VC cells do not commit to differentiation.
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Immunostaining to detect the functional status of RNAPII revealed two important facts.
First, I provide evidence for the occurrence of MBT at early gastrulation (NF10) in E.
coqui. The MZ cells of NF8 embryos are transcriptionally repressed and become active at
NF10. Second, I show that VC cells remain transcriptionally silent, not only during
gastrulation, but throughout development.
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Table 10. Differential Smad2 and Smad4 expression during early embryogenesis
between X. laevis and E. coqui. This comparison is focused on two of the early stages,
namely blastula (NF8) and early gastrula (NF10). It illustrates how the temporal and
spatial expressions of the Smad2 and Smad4 proteins are similar or different.
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Table 10:
Protein
Smad2

X. laevis

E. coqui

1. Native Smad2 protein was

1. Native EcSmad2 protein was

present through all early embryonic

detected through early embryogenesis.

stages.
2. Active PSmad2 expression began 2. No specific temporal expression
around NF8 and peaked at NF9.5.

pattern for active EcSmad2 was
observed.

3. PSmad2 expression remains high

3. Activation of EcSmad2 was

until late gastrulation and decreased

observed in later post-gastrulation

at NF12.

stages.

4. At early gastrulation, Smad2 and

4. Both MZ and VC at NF10 showed

PSmad2 proteins were detected in

expression of native and active

both MZ and VC cells, but not in

EcSmad2, but expression in VC is

animal cap cells.

much lower.

5. Both Smad2 isoforms were

5. Activation of both isoforms was not

phosphorylated in all the stages

clearly evident. Usually one prominent

proteins were detected.

band for active EcSmad2 was
detected.

(Faure et al., 2000)
6. During early gastrulation,

6. During early gastrulation, 100% of

PSmad2 signal was high in VC and

MZ cells and only 12% of VC cells

moderate in MZ. There was nuclear

showed nuclear accumulation of

accumulation of PSmad2 in both

PSmad2.

cell types, but no cell counts were
provided.
(Schohl & Fagotto, 2002)
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Protein
Smad4

X. laevis

E. coqui

1. Two isoforms of X. laevis

1. Both Smad4 isoforms were

Smad4, XSmad4 and XSmad4

detected.

were reported to show different
temporal expression patterns during
early embryogenesis.
2. From MBT (NF8) until

2. At NF10, EcSmad4 expression

midgastrulation (NF11), expression

predominated.

of XSmad4 was much higher than
that of XSmad4. During this
period, XSmad4 regulate Nodalsignaling.
3. After mid-gastrulation,

3. Expression patterns of the two

expression of XSmad4

isoforms did not change after mid-

predominated and responded to

gastrulation. Expression of EcSmad4

Nodal-signal.

remained low during post-gastrulation.

4. There have been no reports of

4. Spatial expression of the isoforms

spatial expression of Smad4

differed radically between MZ and VC

isoforms.

at NF10. EcSmad4 expression was
higher than EcSmad4 in MZ tissue.
(Howell et al., 1999) Both EcSmad4 and EcSmad4
expression was negligible in VC cells.

5. No subcellular localization of

5. At NF10, 100% of MZ cells showed

Smad4 protein by immunostaining

nuclear Smad4 signal, whereas 50% of

has been reported.

VC were positive for Smad4 nuclear
signal.
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I. EcSmad2 RNA is maternally contributed and expressed in VC during early
gastrulation.
Previous work from our lab provided evidence in favor of VC cells expressing
Nodal ligand genes like EcActivinB and EcDerriere (Karadge, 2012) and the transcription
factor EcSox17 (Buchholz et al., 2007) during early gastrulation. These results suggest
that the Nodal-signaling pathway is active in VC cells. In order to investigate this
possibility, I examined the expression patterns of EcSmad2, which resides immediately
downstream of the Nodal-receptors in the signaling cascade and which in X. laevis,
carries the signal into the nucleus for endoderm/mesoderm specification.
I used degenerate PCR and 5‟RACE to clone both the full length as well as the
shorter splice variant of EcSmad2 cDNA. Both the isoforms, Smad2 and Smad2exon3,
have been cloned and characterized in X. laevis (Graff et al., 1996; Faure et al., 2000) and
in human (Takenoshita et al., 1998). The EcSmad2 sequence revealed a high level of
evolutionary conservation. When the nucleotide sequence of EcSmad2 cDNA was
aligned with that from human, mouse, X. laevis and X. tropicalis, there was 86%
sequence conservation among the frog species, whereas the E. coqui sequence was 82%
similar to those from human and mouse (Table 6). Alignment of the predicted peptide
sequences indicated 99% conservation of the EcSmad2 amino acid sequence with those
of X. laevis and X. tropicalis and 98% conservation with human, mouse and chicken
Smad2 sequences (Table 7). Like in X. laevis, the splice variant, EcSmad2exon3, is 90
bp shorter than the full-length isoform. In the full-length isoform, exon3 codes for an
insert in the MH1 domain preventing the protein from binding DNA (Faure et al., 2000).
In X. laevis, deletion of the exon3 from the full-length ORF was sufficient to introduce
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DNA binding activity to Smad2 (Dennler et al., 1998). Like X. laevis, the EcSmad2
protein also has MH1 (amino acid 11 to 171) and MH2 (amino acid 268 – 467) domains
(Fig. 15). Based on the sequence conservation with X. laevis and X. tropicalis, amino
acids 79 to 108 within the MH1 domain represents the position of the exon3 encoded
region.
I used the Ct method of qPCR to detect the temporal and spatial expression of
EcSmad2. The primers designed for the reaction span the exon3 region, so that the
reaction results include both isoforms. EcL8, a ribosomal protein-coding gene was used
as an endogenous control for all of my expression studies. Temporal expression data for
EcSmad2 RNA indicated a strong maternal contribution (Fig. 16). During NF8 and NF10,
EcSmad2 RNA amounts remained high, followed by a gradual decrease with
development.
For spatial expression analysis, I compared MZ and VC for NF8 and NF10, and
between embryonic tissues and NE in post-gastrulation stages. Like EcVegT and EcVeg1
expression, I expected absence of EcSmad2 RNA in VC. In contrast, the VC tissue had
higher amounts of EcSmad2 RNA than MZ at both NF8 and NF10. Moreover, for NF10
VC cells, the EcSmad2 RNA level was more than that in NF8 VC cells (Fig. 17). There
are two possible explanations for this higher expression of EcSmad2 RNA in NF10 VC
cells. First, more EcSmad2 RNA may be made in VC cells during early gastrulation. This
seems unlikely given the transcriptional repression that I found in VC cells. Second, the
magnitude of EcSmad2 RNA degradation in MZ may be higher compared to VC. This
would result in a relatively higher EcSmad2 expression in VC cells. At post gastrulation
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stages, the expression profile became more like what I expected. Expression of EcSmad2
was much lower in NE compared to the embryo at later stages.
In summary, EcSmad2 RNA was maternally contributed, and the RNA level
remained high until gastrulation. The spatial expression results contradicted my
speculation that VC was devoid of molecular determinants. These results support the
possibility of an active Nodal-signaling pathway in VC, and they provide evidence for
differential expression patterns in MZ vs. VC cells. Based on the available results, I
speculate that MZ cells, which become committed to form endoderm and mesoderm in
the gastrulating embryo, have sufficient EcSmad2 RNA to carry out the required level of
Nodal-signaling. This would lead to the proper specification of endoderm and mesoderm.
On the other hand, VC cells have more EcSmad2 RNA than required, leading to improper
Nodal-signal and resulting in faulty or no differentiation.
However, speculating final outcomes based on RNA amounts does not provide us
with the real picture. Functional activity of a gene depends on variety of parameters like
protein translation from RNA, proper processing of the protein products, and posttranslational modifications leading to either activation or degradation of the protein. To
analyze the behavior of the EcSmad2 proteins, I performed western blotting.

II. VC cells from E. coqui early gastrulae have Smad2.
Investigation of the endogenous Nodal-signaling pathway is important to
understand its temporal and spatial activity and how it influences early embryogenesis.
Faure et al. (2000) reported that in X. laevis, Smad2 and Smad2exon3 are highly
phosphorylated towards the vegetal pole of X. laevis embryos during early gastrulation.
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The expression of active Smad2/Smad2exon3 is moderate near marginal zones and
undetectable in the animal cap (Faure et al., 2000). Anti-Smad2/3 (BD transduction) and
anti-PSmad2 (Ser465/467) antibodies (Cell Signaling) were used to detect the native and the
active form of the protein respectively in X. laevis (Faure et al., 2000). They also detected
the presence of shorter splice variant (Faure et al., 2000). In X. laevis,
Smad2/Smad2exon3 activation coincides with the expression of VegT protein. VegT
protein is exclusively and extensively present in the nuclei of the cells from vegetal
hemisphere of blastulae, which become committed to form endoderm during gastrulation
(Stennard et al., 1999). At the onset of gastrulation, VegT was not only detected in
endoderm, but also in presumptive mesoderm (Stennard et al., 1999).
I used anti-Smad2/3 (BD transduction) and anti-PSmad2 (Cell Signaling)
antibodies to detect the native and the active form of EcSmad2 on western blots.

A. EcSmad2exon3 is expressed, but not activated in VC cells.
Detection of EcSmad2exon3 in both temporal (Fig. 19) as well as spatial (Fig.
20) expression experiments is significant. The intrinsic DNA-binding activity is present
in Smad2exon3, but not in Smad2 (Dennler et al., 1998; Takenoshita et al., 1998).
Smad3 shares this property of Smad2exon3 (Yagi et al., 1999). Goosecoid, a homeobox
gene, known as a marker of gastrulation and anterior mesoderm induction, is an early
target of Smad2/3-FAST mediated transcription complex under Activin/Vg1 signaling in
mouse and X. laevis (Blum et al., 1992; Cho et al., 1991; Labbé et al., 1998). When
Smad2 was replaced with Smad3 in a FAST mediated complex targeting the mouse
goosecoid promoter, transcription was repressed instead of activated (Labbé et al., 1998).
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Due to the presence of similar DNA-binding property between Smad3 and
Smad2exon3, this result could indicate an opposing behavior for the exon3, differing
significantly from Smad2. Although these two functionally different isoforms are coregulated in the same pathway, they could display significant differences in their
responses to Nodal ligands during early embryonic development (Faure et al., 2000;
Labbé et al., 1998).
My results indicate that not only the alternatively spliced mRNA, but also the
protein product is maternally contributed. Following fertilization, the inactive
EcSmad2exon3 is present in all stages. Western blots with anti-PSmad2 (Ser465/467)
antibody detected one strong band in most cases (Fig. 19 and 20). Based on size markers,
phosphorylation of the shorter isoform was not detected in the stages examined. Although
EcSmad2exon3 is expressed in the oocytes and in both MZ and VC regions of early
embryos, it is not activated. These results suggest no functional role for EcSmad2exon3.

B. EcSmad2 is expressed and activated in VC cells at gastrulation.
Full length EcSmad2, on the other hand, was not only expressed but also was
activated in oocytes as well as in MZ and in VC of early gastrulae (Fig. 20). During early
gastrulation when specification of the germ layers was initiated, Nodal-signaling via
active Smad2 played the pivotal role in X. laevis. The vegetal half of the embryo
expressed VegT protein (Stennard et al., 1999), which in turn activated Sox17 expression.
VC cells were also characterized by extensive expression of Smad2, which finally
committed these cells to become endoderm and mesoderm (Faure et al., 2000).
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In E. coqui, the VC cells contain Sox17 RNA but lack EcVegT RNA. Although
my western blotting results indicated expression and activation of EcSmad2 in VC cells,
it is not sufficient to answer the question why E. coqui VC cells do not commit to
endoderm/mesoderm and become undifferentiated nutritional reserve. Presence of the
active form of a signal transducer in a cell, however, does not necessarily mean that the
signaling pathway is active. Lack of differentiation definitely argues against an active
Nodal-signaling in VC cells.
Based on Fig. 20B, one can raise the question whether the single band recognized
by the anti-PSmad2 antibody was EcSmad2exon3, rather than EcSmad2. In that case, a
selective phosphorylation of EcSmad2exon3 could be proposed, which would lead to
inhibition of transcription, as reported by Labbé et al. (1998) in X. laevis. Although that
could explain why VC cells do not commit to endoderm/mesoderm specification, the
position of the size marker on the western blot did not support this idea.
Therefore, these results could indicate another possibility, namely a potential
block for Nodal-signaling downstream of Smad2 activation. The next step in nodalsignaling is the association of active Smad2 with its co-Smad partner, Smad4. This
protein complex translocates inside the nucleus to turn on endoderm/mesodermspecifying genes in vertebrates (Lagna et al., 1996; Zhang et al., 1996). The outcome of
my western analysis of EcSmad2 led me to investigate the expression of EcSmad4.

III. VC cells from gastrulating embryos express Smad4.
There are no previous records for use of anti-Smad4 antibody to detect
endogenous levels of Smad4 expression in X. laevis. I used rabbit anti-Smad4 polyclonal
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antibody (Thermo Scientific), which was raised against the human Smad4 protein and
which was predicted to cross-react with the X. laevis homolog based on sequence
similarity. In the absence of EcSmad4 sequence and based on my previous experience
with EcSmad2 conservation with other species, I decided to use this antibody on western
blots to detect endogenous levels of EcSmad4 expression.
Unlike human, there are two isoforms of Smad4 proteins in X. laevis (LeSueus
and Graff, 1999; Masuyama et al., 1999; Howell et al., 1999; Hill, 2001). The potential X.
laevis ortholog of hSmad4 is XSmad4, whereas XSmad4 is a novel one that does not
have a homolog in other species. It is also known as Smad10 (Howell et al., 1999;
LeSueus and Graff, 1999; Masuyama et al., 1999). Based on the reported ORF sequences,
the predicted molecular weights for XSmad4 and XSmad4 are 59.8 kDa and 61.2 kDa,
respectively (Masuyama et al., 1999; XSmad4 Genebank ID: AB022721.1 and
XSmad4 Genebank ID: AB022722.1). My western blot results (Fig. 21A and B) show
the presence of two isoforms of Smad4 in E. coqui around 60 kDa.
Both the Smad4  and  isoforms are expressed at NF8, NF10, and TS5. As I did
not clone EcSmad4, it is unclear which band corresponds to which isoform. Based on the
protein size prediction in X. laevis, the higher molecular weight band is tentatively,
EcSmad4 and the lower molecular weight band is EcSmad4.
Spatial expression analysis was performed only on proteins from NF10 embryos,
as this could be the time for pattern formation. Investigating EcSmad4 expression at
NF10 could boost our understanding of nature of Nodal signaling at this time. From the
spatial expression pattern of EcSmad4 (Fig. 21B), both isoforms were detected in whole
embryo preparations, as well as from MZ and VC. In both whole and MZ protein
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preparations, the expression of EcSmad4 was higher than that of EcSmad4. In
contrast, VC showed a lower expression of EcSmad4, almost equal to that of
EcSmad4. Overall, expressions of both isoforms were much less in VC compared to
MZ or the whole embryo (Table 9).
According to Howell et al. (1999), Smad4 isoforms show strikingly different
temporal expression patterns in early X. laevis embryos (Table 9). Adult tissues were also
characterized by their expression in different ratios, which suggests their different and
specific roles. First, the subcellular distributions for these two isoforms are different. Due
to the lack of NES, Smad4 is exclusively nuclear. Therefore, it is Smad4, which
predominantly resides in cytoplasm and mediates Nodal-signaling via binding with active
Smad2/3. XSmad4 protein expression is high during pre-gastrulation and early
gastrulation in X. laevis (Howell et al., 1999; Hill, 2001). At mid-gastrulation, the ratio of
the two isoforms changes depending on the availability of different sets of Nodal ligands,
and expression of Smad4 predominates (Howell et al., 1999). There are some reports,
which suggest that until early gastrulation, the complex formation between active Smad2
and Smad4 can occur inside the nucleus (Hill, 2001; Howell, 1999). The complex
formation inside the nucleus could also work for Smad4, as it could be present on either
side of the nuclear membrane (Hill, 2001). Also Liu et al. (1997) showed that it is not
always necessary for R-Smads to bind Smad4 to accumulate inside the nucleus. These
reports leave us with multiple possibilities on which isoform is needed at a specific stage
of development and where it is localized.
My EcSmad4 temporal expression result (Fig. 21A) shows that the expression of
EcSmad4 increased as the embryo developed, like what I found for EcSmad2. This
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temporal expression pattern is not in agreement with that reported in X. laevis (Table 9).
According to reports in X. laevis (Howell et al., 1999; Masuyama et al., 1999), after midgastrulation expression of Smad4 is higher than that of Smad4. My result (Fig. 21A)
for EcSmad4 isoforms showed gradual increase in the intensity of tentative EcSmad4
band with development. None of the post-gastrulation stages showed higher expression of
EcSmad4 than EcSmad4 (Fig. 21A).
On the other hand, the EcSmad4 spatial expression result (Fig. 21B) is more
informative. According to the established concept in X. laevis (Howell et al., 1999;
Masuyama et al., 1999) Smad4 is required to mediate Nodal-signaling from MBT until
mid-gastrulation. Western blot analysis of the E. coqui early gastrula indicated the
predominance of EcSmad4 in MZ tissues, which will differentiate to mesendoderm. In
contrast, VC cells had a very low level of EcSmad4 expression (Table 9). Based on my
results, I suggest that the low level of EcSmad4 expression prevents VC cells from
differentiation. Unlike MZ cells, a lack of enough EcSmad4, whether inside the nucleus
or outside in the cytoplasm, could prevent Nodal-signaling, leading to the development of
undifferentiated NE.

IV. ActRIIA, an activin receptor type II, may be present during early
embryogenesis.
Karadge (2012) provided evidence that different activin ligands are expressed in
prospective NE of E. coqui. This observation raised the possibility that TGF- receptors
might also be expressed. Although a couple of TGF cDNAs were cloned in our lab
(Karadge, 2012), no receptor genes had been looked at. Martello et al. (2007) used anti-
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human Activin RIIA antibody (R&D Systems) against the X. laevis receptor protein on
western blots. Although the antibody was predicted to show less than 2% cross-reactivity
with human Activin RIIB or any other Activin receptor, it detected the endogenous levels
of the X. laevis homolog (Martello et al., 2007).
I used this antibody on western blots of E. coqui embryonic protein preparations.
The predicted molecular weight of human Activin RIIA is 58 kDa and that of the X.
laevis homolog is 57.9 kDa (Xenbase: XB-GENE-865037), but Martello et al. (2007) did
not provide size information on their western blots. I made several attempts to use this
antibody on western blots with E. coqui embryos (Fig. 22). In all my experiments, a
specific band was detected at ~50 kDa, instead of 58 kDa. The same size band was
detected consistently in NF8, NF10 and TS4. This could mean that the E. coqui Activin
RIIA homolog is a shorter one, but shorter by almost 100 amino acids is not very likely,
especially when these signaling proteins are usually highly conserved. I tried the same
antibody to immunostain MZ and VC cells dissociated from NF10 embryos. Although
only a few populations of both MZ (20%) and VC (17%) cells showed label on the
surface (Fig. 25), there is nothing conclusive about it. In the absence of EcActRIIA
sequence data, it is not known whether the band obtained around 50 kDa is actually E.
coqui ActRIIA. Therefore, I decided not to proceed further with this study, which would
best be advanced by cloning of the gene.

V.

During gastrulation, only 12% of VC cells show nuclear localization of active
Smad2, but 50% are positive for Smad4.
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My results indicated that the VC cells at gastrulation contain EcSmad2 transcripts,
native and active forms of the EcSmad2 proteins, and the Smad2 partner, EcSmad4.
However, these results do not indicate whether these proteins are translocated into the
nucleus or are just resident in the cytoplasm of the VC cells. It was important to know the
cellular location of these proteins to conclude whether Nodal-signaling is active in VC
cells. The most reliable method of characterizing the events of a specific signaling
cascade is the direct detection of its components in their active state. Upon Nodalstimulation, the active Smad2 in combination with Smad4 should localize in the nucleus
(Cobb and Goldsmith, 2000; Heldin et al., 1997; Massagué, 1998). As an exception, both
active Smad2 (Liu et al., 1997) as well as Smad4 (Bai et al., 2002) can translocate into
the nucleus independently of each other.
Identification of activated Smad2 and its localization by means of
immunostaining has been reported in X. laevis (Christen and Slack, 1999; Faure et al.,
2000; Schohl and Fagotto, 2002). All previously reported immunolocalization data were
obtained using whole mount procedures or immunofluorescence on cryosections (Fagotto
and Gumbiner, 1994; Fagotto, 1999). These techniques are not ideal for studying large
embryos filled with yolk. I performed my immunostaining on individual cells dissociated
from the dissected MZ and VC from the E. coqui early gastrulae.
I used the same anti-PSmad2 antibody, which was used for my western blotting
experiments. Dissociated NF10 MZ and VC cells were stained with the antibody and
counter stained with DAPI to identify the nucleus. In all attempts, 100% of the MZ cells
showed nuclear accumulation of PSmad2 as evident by the strong PSmad2 signal
overlapping with DAPI. On the other hand only 12% of VC cells with single or multiple
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nuclei were positive for such overlap (Table 8; Fig. 23). The remaining cells showed
either scattered cytoplasmic distribution of the active protein or no labeling. VC cells are
characterized by a varying number of nuclei, ranging from no nucleus to 3-4 nuclei in one
cell (Karadge, 2012). Therefore, extra precaution was taken to count only the VC cells, in
which at least one nucleus was detected. Although there is nuclear accumulation of
PSmad2, 12% is low to draw a conclusion as to its effects.
I investigated the nuclear localization of Smad2 protein into the VC nuclei using
an alternative approach. 8-16 cell embryos were injected with tracer level of 10 pg
EGFP-Smad2 capped mRNAs and grown until early NF10. Dissociated cells from
dissected VC tissues were stained with anti-GFP antibody to detect the location of the
tagged Smad2 proteins. Only 8% of VC cells showed nuclear accumulation of
recombinant protein (Fig. 26). This result strengthens my finding with endogenous
EcSmad2 nuclear localization (Fig. 23).
MZ and VC cells from NF10 were also stained with anti-Smad4 antibody, which
detected EcSmad4 on western blots. For MZ cells, 100% were positive for nuclear
EcSmad4 localization, but only 50% of VC cells were positive for a nuclear EcSmad4
signal (Table 8; Fig. 24). Moreover almost half of the VC cells, which lacked nuclear
signal, also lacked any cytoplasmic staining. The positive nuclear signal was observed
even for multinuclear cells, and nuclear staining was uniform.
The 12% and 50% of VC cells, which showed nuclear location of the PSmad2 and
Smad4, respectively, provide many possible explanations. First, it may be that PSmad2
and Smad4 translocate inside the nucleus of only subpopulations of VC cells, and this is
quantitatively not strong enough to carry on Nodal-signaling for endoderm/mesoderm
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specification. It is possible that those cells, which reside inside the overlapping domain
between 12% VC cells for active Smad2 and 50% VC cells for Smad4, could carry out
Nodal-signaling. To confirm this hypothesis, I needed co-immunostaining with
antibodies against both active Smad2 and Smad4. Co-immunostaining was not currently
possible to do, since both of these antibodies were raised in rabbit.
Second, the overall expression of EcSmad4 may not be sufficient to carry on
Nodal-signaling. According to the reports in X. laevis, Smad4 is exclusive to the
nucleus, whereas Smad4 shuttles between cytoplasm and nucleus (Howell et al., 1999;
Masuyama et al., 1999). At pre-gastrulation and early gastrulation in X. laevis, it is
Smad4, not Smad4 (Howell et al., 1999; Masuyama et al., 1999) that predominates in
expression. Western blots using anti-Smad4 antibody revealed that at early gastrulation,
expression of both Smad4 isoforms in VC cells is weak compared to MZ cells (Fig. 21A
& B). Although, the immunostaining signal for VC cells was bright when compared to
that for MZ, we are looking at individual cells. Western blot, on the other hand, represent
a broader view by looking at the whole tissue.
Third, Smad4 can act as a transcriptional activator that is independent of Smad2mediated Nodal-signaling. That was evident in case of SMIF, a protein that translocates
into the nucleus along with Smad4 without involving Smad2/3 (Bai et al., 2002).
Continuous nucleocytoplasmic shuttling of Smad4 on its own has been suggested by
Pierreus et al. (2000), Watanabe et al. (2000) and Shi and Massagué (2003), but this is
true only for human Smad4 and X. laevis Smad4, which share the NES motif in their
MH1 domain. Hence, the nuclear signal for EcSmad4 in those 50% VC cells could be
due to Smad4, which is brought inside the nucleus along with some unidentified protein
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rather than Smad2/3. In addition to the differential expression of Nodal-signaling, all
these possibilities suggest the presence of another regulatory block, further downstream
in the pathway, which ultimately determines the fate of VC cells.

VI. Global transcriptional repression may prevent VC cells from differentiation.
Although several lines of evidence in this work suggest a block of the Nodalsignaling pathway in the E. coqui VC, I also investigated the global transcriptional status
of the VC cells. Staining of NF10 VC cells with antibodies against phosphorylated
RNAPII CTD-Ser 2, phosphorylated CTD-Ser 5 and unphosphorylated RNAPII large
subunit showed a lack of transcriptional elongation.
MZ cells, which form endoderm/mesoderm, showed positive staining for all three
antibodies at NF10. This means that MZ cells underwent transcription initiation as well
as transcription elongation. Unlike MZ cells, VC cells were positive for
unphosphorylated RNAPII and phosphorylated CTD-Ser 5. Not only was RNAPII
present in nuclei of VC cells, but also they underwent transcription initiation. VC cells
lacked any signal for phosphorylated RNAPII CTD-Ser 2, which means no transcription
elongation (Fig. 27). A small number of VC cells showed a faint signal for RNAPII
CTD-Ser 2, which could indicate that there was a low level of transcription. Based on
these results, I conclude that VC cells at NF10 stage are transcriptionally repressed
globally. On the other hand, MZ cells shows proper transcription initiation and elongation
during early gastrulation, which would allow them to commit to endoderm/mesoderm
formation.
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The global transcriptional repression existed for both MZ and VC cells at NF8
(Fig. 27). Only a few MZ and VC cells were positive for transcription initiation, but
neither cell type showed transcription elongation. At the onset of gastrulation, MZ cells
became transcriptionally active (Fig. 28) and remained active at every developmental
stage examined. VC cells failed to undergo transcription elongation at gastrulation (Fig.
28) and remained transcriptionally silent through development. By the end of
gastrulation, VC becomes nutritional endoderm (NE). I tested dissociated NE cells from
post-gastrulation stages TS3, TS8, TS11 and TS14, a stage right before hatching (Fig. 29,
30, 31 and 32). No sign of transcription initiation or elongation was detected in them with
the exception of a few NE cells from each stage, which showed a faint signal for
transcription initiation or elongation. This may indicate that although VC cells of the preand early-gastrulating embryos and NE cells post-gastrulation, are transcriptionally
repressed globally, there could be a few genes, which are actively transcribing. The E.
coqui thyroid hormone receptor gene (EcTR) could represent one such gene, whose
RNA level was upregulated by TS14 (Singamsetty and Elinson, 2010).
Similar global transcriptional repression events have been reported in X. laevis
PGC formation (Venkatrama et al., 2010). Cells containing germ plasm are
transcriptionally repressed while neighboring cells of endoderm lineage are
transcriptionally active. Similar events are reported in C. elegans (Guven-Ozkan et al.,
2008) and D. melanogaster (Hanyu-Nakamura et al., 2008). In mouse, PGCs are formed
after gastrulation, and they do not require germ plasm. Seki et al. (2007) showed that the
migrating mouse PGCs were negative for P-Ser5 or P-Ser2, also suggesting no
transcription initiation or elongation.
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VII. MBT in E. coqui may occur by NF10.
During early embryogenesis, MBT is a landmark event. Before MBT, early
embryonic cells are transcriptionally quiescent, and survive on maternal supplies of
proteins and RNAs (Newport and Kirshner, 1982; Kisielewska and Blow, 2012).
Embryonic gene expression is initiated at MBT (Gerhart, 1980; Heasman, 2006;
Shiokawa, 2012). In X. laevis, NF8 is designated as MBT.
In E. coqui, MBT has never been defined, but the global transcriptional status of
MZ cells provides strong evidence for MBT in E. coqui. At NF8, MZ cells showed no
sign of transcriptional initiation or elongation (Fig. 27). At NF10, MZ cells became
transcriptionally active, as they were positive for both transcription initiation and
elongation (Fig. 28). This event of global transcriptional activation in MZ cells marks the
onset of zygotic gene expression during E. coqui early embryogenesis, thus establishing
MBT by NF10.

VIII. A model for Nutritional Endoderm formation.
Taking all of these finding into consideration, I propose a model for the
differences in the state of differentiation of MZ and VC cells (Fig. 33). My data suggests
that in E. coqui the Nodal-signaling pathway (Fig. 1) could account for endoderm and
mesoderm specification in MZ cells as occurs in X. laevis. VC cells, on the other hand,
differ from the specification pathway, at two levels: first, by differential expression of
Nodal-signaling components like Smad2 and Smad4, and second, by global
transcriptional repression. My model (Fig. 33) represents the modifications of the
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specification pathway and incorporates different possibilities for the generation of NE
from VC cells.
This model proposes a two-phase regulation of NE development from VC cells at
NF10. In the first phase, there are two possibilities. According to possibility „A‟, only the
alternatively spliced variant, EcSmad2exon3 is activated and undergoes nuclear
translocation before association with Smad4, or after associating with Smad4 in the
cytoplasm. EcSmad2exon3 inside the nucleus could exert an inhibitory effect, as
described in X. laevis, and block the Nodal-pathway. According to possibility „B‟, it is
the full length EcSmad2, which is activated and translocates inside the nucleus in
association with poorly expressed Smad4 (in the cytoplasm) or Smad4 (inside the
nucleus). This event is then subjected to a second phase of regulation. In the absence of
P-Ser2 at CTD of RNAPII, a global transcriptional repression prevails in the vegetal half,
blocking any effects of Nodal-signaling. This repression could also explain why
EcSox17, whose RNA is present in VC cells (Buchholz et al., 2007), does not cause
endodermal differentiation. Even if EcSox17 RNA were translated, this transcription
factor would not be able to activate downstream endodermal genes.
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Fig. 33: Two-phase regulation for deciding the fate of VC cells. At NF10, both Smad4
isoforms are expressed weakly. Smad4 resides in cytoplasm and Smad4 localizes
exclusively in the nucleus. Phase 1 regulation: Regulation of Nodal-signaling. There are
two possibilities. (A) If the spliced variant, EcSmad2exon3, is the only form that is
phosphorylated, its association with either of the Smad4 isoforms would lead to
inhibition of Nodal-signaling. (B) If it is EcSmad2, which is phosphorylated, it could
associate with Smad4 isoforms and may induce Nodal-signaling in a small subpopulation
of VC cells. Phase 2 regulation: Global transcriptional repression. Repression occurs via
absence of P-Ser2 at CTD of RNAPII, leading to no elongation. If an active PSmad2Smad4 complex were present inside the nucleus of VC cells, it will not turn on the
transcription machinery, as CTD of RNAPII is not properly phosphorylated. This leads to
the development of NE instead of DE.
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Fig. 33:
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IX. Future perspective.
My findings have indicated a probable mode of NE development. Smad2 is a well
characterized TGF-β pathway intermediate performing many roles during vertebrate and
invertebrate development. The role of Smad2 in germ layer specification has been well
documented in X. laevis, but nothing was known for direct developing frogs. I addressed
the question whether NE develops because of the absence of the molecular determinants
in the VC cells. My work clearly indicated that the VC was not devoid of molecular
determinants; rather during early embryogenesis, it expressed some of the Nodal-pathway
specific proteins, especially Smad2. Characterization of EcSmad2 and EcSmad4
expressions in E. coqui early embryos showed us how differential expression in different
regions of embryo may lead to the development of NE and DE. Finally, determination of
the transcriptional status of early E. coqui embryonic cells furnished us with another layer
of regulation. My studies revealed that MZ cells, the precursors of future definitive
endoderm, became transcriptionally active at early gastrulation and remained active
thereafter. On the other hand, the large, yolky VC cells stayed transcriptionally repressed
throughout development and served only as nutritional reserves.
My results raised some interesting questions regarding E. coqui early
embryogenesis. There is a possibility of a small population VC cells containing nuclear
PSmad2 and Smad4. It would be interesting to do a dual immunostaining for Smad2 as
well as Smad4 in the same cells. In that case, specific antibodies against Smad2 and
Smad4 have to be raised in different animal species. Availability of such antibodies could
provide us with more direct and detailed analysis. In future, this question could be
addressed with the application of more sophisticated tools. Use of Bimolecular
179

Fluorescence Complementation (BiFC) (Hu et al., 2002) to investigate the association
between PSmad2 and Smad4 in vivo in dissociated MZ and VC cells could furnish a
clearer picture on the molecular interactions and nuclear translocation of the Smad2Smad4 complex. This technique has been optimized for use in X. laevis embryos by the
use a mutant version of VENUS (Saka et. al., 2007, 2008). It is a semi-quantitative
approach, which would permit a real-time analysis of Nodal signaling by monitoring the
different signaling events during E. coqui normal development.
The idea emerged from my transcriptional activity assays that VC cells did not
show transcriptional initiation or elongation. In some instances, however, there were a
few cells, which showed faint nuclear signals. VC cells are not dead, and they are
definitely involved in trafficking of vesicles containing nutrients. This must require at
least a minimal set of gene products to be active. It raises the question what genes in the
VC could be transcribed and whether they are PSmad2/Smad4 targets. There are several
approaches ways to address these questions. One such approach would be to perform
chromatin immunoprecipitation (ChIP) with antibodies against Smad2 or Smad4. ChIP
has been successful in identification of several important genes involved in the early
embryogenesis of X. laevis (Blythe et al., 2009).
To understand the complex molecular mechanisms underlying the early
embryonic development, whole transcriptome analysis would be of great interest.
Analysis of VC RNA expression would provide us with insights into the molecular
mechanisms of different signaling pathways, which determines the fate of NE. A
successful whole transcriptome analysis depends on the quality of the RNA and efficient
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production to cDNA libraries. Annotation of the resulting sequences could be a potential
problem, because the absence of an E. coqui genome currently making gene identification
difficult.
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